<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Fluid and pharmacological agents for adhesion prevention after gynaecological surgery - Ahmad, G - 2020 | Cochrane Library</title> <meta content="Fluid and pharmacological agents for adhesion prevention after gynaecological surgery - Ahmad, G - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001298.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Fluid and pharmacological agents for adhesion prevention after gynaecological surgery - Ahmad, G - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001298.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD001298.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Fluid and pharmacological agents for adhesion prevention after gynaecological surgery" name="citation_title"/> <meta content="Gaity Ahmad" name="citation_author"/> <meta content="Pennine Acute Hospitals NHS Trust" name="citation_author_institution"/> <meta content="gaity.ahmad@pat.nhs.uk" name="citation_author_email"/> <meta content="Matthew Thompson" name="citation_author"/> <meta content="Pennine Acute Hospitals NHS Trust" name="citation_author_institution"/> <meta content="Kyungmin Kim" name="citation_author"/> <meta content="Pennine Acute Hospitals NHS Trust" name="citation_author_institution"/> <meta content="Priya Agarwal" name="citation_author"/> <meta content="Pennine Acute Hospitals NHS Trust" name="citation_author_institution"/> <meta content="Fiona L Mackie" name="citation_author"/> <meta content="Pennine Acute NHS Trust" name="citation_author_institution"/> <meta content="Sofia Dias" name="citation_author"/> <meta content="University of York" name="citation_author_institution"/> <meta content="Mostafa Metwally" name="citation_author"/> <meta content="Sheffield Teaching Hospitals" name="citation_author_institution"/> <meta content="Andrew Watson" name="citation_author"/> <meta content="Tameside &amp; Glossop Acute Services NHS Trust" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD001298.pub5" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/07/19" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001298.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001298.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001298.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anticoagulants [*therapeutic use]; Birth Rate; Dialysis Solutions [therapeutic use]; Gels [therapeutic use]; Glucocorticoids [*therapeutic use]; Gynecologic Surgical Procedures [*adverse effects]; Icodextrin [therapeutic use]; Infertility, Female [prevention &amp; control]; Pelvic Pain [epidemiology]; Plasma Substitutes [*therapeutic use]; Postoperative Complications [epidemiology, *prevention &amp; control]; Pregnancy Rate; Randomized Controlled Trials as Topic; Rehydration Solutions [*therapeutic use]; Second-Look Surgery; Tissue Adhesions [epidemiology, *prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001298.pub5&amp;doi=10.1002/14651858.CD001298.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="f00EizoA";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD001298\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD001298\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001298\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001298\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fa","th","ko","ms","ja"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD001298.pub5",title:"Fluid and pharmacological agents for adhesion prevention after gynaecological surgery",firstPublishedDate:"Jul 19, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecology and Fertility Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=f00EizoA&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001298.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001298.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD001298.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD001298.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001298.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD001298.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD001298.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD001298.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD001298.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD001298.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>5470 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD001298.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-sec-0168"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-sec-0162"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/appendices#CD001298-sec-0173"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/table_n/CD001298StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/table_n/CD001298StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Fluid and pharmacological agents for adhesion prevention after gynaecological surgery</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/information#CD001298-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Gaity Ahmad</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/information#CD001298-cr-0005">Matthew Thompson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/information#CD001298-cr-0006">Kyungmin Kim</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/information#CD001298-cr-0007">Priya Agarwal</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/information#CD001298-cr-0008">Fiona L Mackie</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/information#CD001298-cr-0009">Sofia Dias</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/information#CD001298-cr-0010">Mostafa Metwally</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001298.pub5/information#CD001298-cr-0011">Andrew Watson</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/information/en#CD001298-sec-0184">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 19 July 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD001298.pub5">https://doi.org/10.1002/14651858.CD001298.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD001298-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001298-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001298-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001298-abs-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ko#CD001298-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD001298-abs-0005">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD001298-abs-0001" lang="en"> <section id="CD001298-sec-0001"> <h3 class="title" id="CD001298-sec-0001">Background</h3> <p>Adhesions are fibrin bands that are a common consequence of gynaecological surgery. They are caused by conditions that include pelvic inflammatory disease and endometriosis. Adhesions are associated with comorbidities, including pelvic pain, subfertility, and small bowel obstruction. Adhesions also increase the likelihood of further surgery, causing distress and unnecessary expenses. Strategies to prevent adhesion formation include the use of fluid (also called hydroflotation) and gel agents, which aim to prevent healing tissues from touching one another, or drugs, aimed to change an aspect of the healing process, to make adhesions less likely to form. </p> </section> <section id="CD001298-sec-0002"> <h3 class="title" id="CD001298-sec-0002">Objectives</h3> <p>To evaluate the effectiveness and safety of fluid and pharmacological agents on rates of pain, live births, and adhesion prevention in women undergoing gynaecological surgery. </p> </section> <section id="CD001298-sec-0003"> <h3 class="title" id="CD001298-sec-0003">Search methods</h3> <p>We searched: the Cochrane Gynaecology and Fertility Specialised Register, CENTRAL, MEDLINE, Embase, PsycINFO, and Epistemonikos to 22 August 2019. We also checked the reference lists of relevant papers and contacted experts in the field. </p> </section> <section id="CD001298-sec-0004"> <h3 class="title" id="CD001298-sec-0004">Selection criteria</h3> <p>Randomised controlled trials investigating the use of fluid (including gel) and pharmacological agents to prevent adhesions after gynaecological surgery. </p> </section> <section id="CD001298-sec-0005"> <h3 class="title" id="CD001298-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures recommended by Cochrane. We assessed the overall quality of the evidence using GRADE methods. Outcomes of interest were pelvic pain; live birth rates; incidence of, mean, and changes in adhesion scores at second look‐laparoscopy (SLL); clinical pregnancy, miscarriage, and ectopic pregnancy rates; quality of life at SLL; and adverse events. </p> </section> <section id="CD001298-sec-0006"> <h3 class="title" id="CD001298-sec-0006">Main results</h3> <p>We included 32 trials (3492 women), and excluded 11.</p> <p>We were unable to include data from nine studies in the statistical analyses, but the findings of these studies were broadly in keeping with the findings of the meta‐analyses. </p> <p><b>Hydroflotation agents versus no hydroflotation agents (10 RCTs)</b> </p> <p>We are uncertain whether hydroflotation agents affected pelvic pain (odds ratio (OR) 1.05, 95% confidence interval (CI) 0.52 to 2.09; one study, 226 women; very low‐quality evidence). </p> <p>It is unclear whether hydroflotation agents affected live birth rates (OR 0.67, 95% CI 0.29 to 1.58; two studies, 208 women; low‐quality evidence) compared with no treatment. </p> <p>Hydroflotation agents reduced the incidence of adhesions at SLL when compared with no treatment (OR 0.34, 95% CI 0.22 to 0.55, four studies, 566 women; high‐quality evidence). The evidence suggests that in women with an 84% chance of having adhesions at SLL with no treatment, using hydroflotation agents would result in 54% to 75% having adhesions. </p> <p>Hydroflotation agents probably made little or no difference to mean adhesion score at SLL (standardised mean difference (SMD) ‐0.06, 95% CI ‐0.20 to 0.09; four studies, 722 women; moderate‐quality evidence). </p> <p>It is unclear whether hydroflotation agents affected clinical pregnancy rate (OR 0.64, 95% CI 0.36 to 1.14; three studies, 310 women; moderate‐quality evidence) compared with no treatment. This suggests that in women with a 26% chance of clinical pregnancy with no treatment, using hydroflotation agents would result in a clinical pregnancy rate of 11% to 28%. </p> <p>No studies reported any adverse events attributable to the intervention.</p> <p><b>Gel agents versus no treatment (12 RCTs)</b> </p> <p>No studies in this comparison reported pelvic pain or live birth rate. (SMD ‐0.24, 95% CI ‐0.55 to 0.08) </p> <p>Gel agents reduced the incidence of adhesions at SLL compared with no treatment (OR 0.26, 95% CI 0.12 to 0.57; five studies, 147 women; high‐quality evidence). This suggests that in women with an 84% chance of having adhesions at SLL with no treatment, the use of gel agents would result in 39% to 75% having adhesions. </p> <p>It is unclear whether gel agents affected mean adhesion scores at SLL (SMD ‐0.24, 95% CI ‐0.55 to 0.08; four studies, 159 women; moderate‐quality evidence), or clinical pregnancy rate (OR 0.20, 95% CI 0.02 to 2.02; one study, 30 women; low‐quality evidence). </p> <p>No studies in this comparison reported on adverse events attributable to the intervention.</p> <p><b>Gel agents versus hydroflotation agents when used as an instillant (3 RCTs)</b> </p> <p>No studies in this comparison reported pelvic pain, live birth rate or clinical pregnancy rate. </p> <p>Gel agents probably reduce the incidence of adhesions at SLL when compared with hydroflotation agents (OR 0.50, 95% CI 0.31 to 0.83; three studies, 538 women; moderate‐quality evidence). This suggests that in women with a 46% chance of having adhesions at SLL with a hydroflotation agent, the use of gel agents would result in 21% to 41% having adhesions. </p> <p>We are uncertain whether gel agents improved mean adhesion scores at SLL when compared with hydroflotation agents (MD ‐0.79, 95% CI ‐0.82 to ‐0.76; one study, 77 women; very low‐quality evidence). </p> <p>No studies in this comparison reported on adverse events attributable to the intervention.</p> <p><b>Steroids (any route) versus no steroids (4 RCTs)</b> </p> <p>No studies in this comparison reported pelvic pain, incidence of adhesions at SLL or mean adhesion score at SLL. </p> <p>It is unclear whether steroids affected live birth rates compared with no steroids (OR 0.65, 95% CI 0.26 to 1.62; two studies, 223 women; low‐quality evidence), or clinical pregnancy rates (OR 1.01, 95% CI 0.66 to 1.55; three studies, 410 women; low‐quality evidence). </p> <p>No studies in this comparison reported on adverse events attributable to the intervention.</p> </section> <section id="CD001298-sec-0007"> <h3 class="title" id="CD001298-sec-0007">Authors' conclusions</h3> <p>Gels and hydroflotation agents appear to be effective adhesion prevention agents for use during gynaecological surgery, but we found no evidence indicating that they improve fertility outcomes or pelvic pain, and further research is required in this area. It is also worth noting that for some comparisons, wide confidence intervals crossing the line of no effect meant that clinical harm as a result of interventions could not be excluded. Future studies should measure outcomes in a uniform manner, using the modified American Fertility Society score. Statistical findings should be reported in full. No studies reported any adverse events attributable to intervention. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD001298-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001298-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001298-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001298-abs-0004">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ja#CD001298-abs-0012">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD001298-abs-0008">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD001298-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/th#CD001298-abs-0006">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD001298-abs-0002" lang="en"> <h3>Use of fluids and pharmacological agents (medicinal drugs) to prevent the formation of adhesions (scar tissue) after surgery of the female pelvis </h3> <p><b>Review question:</b> This Cochrane Review evaluated the use of fluid and pharmacological agents that aim to prevent adhesion formation after gynaecological surgery (we defined gels as fluid agents). </p> <p><b>Background:</b> Adhesions are a type of scar tissue, which can cause two normally separate surfaces within the body to stick together. Adhesions often form within the pelvis following surgery, infection, or due to endometriosis. Adhesions caused by gynaecological surgery can cause pain and reduced fertility. Women with adhesions often require further surgery. Strategies to prevent adhesion formation include the use of fluid and gel agents, which aim to prevent healing tissues from touching one another, or drugs, aimed to change an aspect of the healing process, to make adhesions less likely to form. </p> <p><b>Study characteristics:</b> We included 32 randomised controlled trials (3492 women). We pooled the results of 23 trials (2796 women). We were unable to pool the results from the remaining nine trials, because investigators either measured adhesions in a way that would not allow us to pool the findings with other data, or did not report important statistical information. We searched all evidence up to August 2019. </p> <p><b>Key results:</b> </p> <p>Fluids and gels appear to be effective in reducing adhesions, but more information is needed to determine whether they affect pelvic pain or live birth rates. Large, high‐quality studies should be conducted in which investigators use the standardised way of measuring adhesions, developed by the American Fertility Society (the modified AFS score). </p> <p><b>For the outcome of pain:</b> one study reported uncertain results of the effect of a fluid agent (4% icodextrin, a glucose polymer) on pelvic pain. No studies reported pelvic pain outcomes with any other interventions. </p> <p><b>For the outcome of fertility:</b> the pooled results of two studies of fluid agents (dextran, another glucose polymer) found uncertain effects on live birth rates. The data suggest that in women with a 13% chance of giving birth with no treatment, 4% to 19% would give birth if treated with fluid agents. The pooled results of two studies of steroids found uncertain effects on live birth rates. The data suggest that in women with a 13% chance of giving birth with no treatment, 4% to 19% would give birth if treated with steroids. No studies reported live birth rate with any other interventions. </p> <p>We are uncertain whether fluid agents, gel agents, or steroids affect clinical pregnancy rates compared with no treatment. No studies comparing the effect of fluid agents with gel agents reported clinical pregnancy rates. </p> <p><b>For the outcome of adhesions at SLL:</b> four studies found that fluid agents reduced the incidence of adhesions at second‐look laparoscopy (SLL) compared with no treatment (high‐quality evidence). This suggests that in women with an 84% chance of having adhesions at SLL with no treatment, the use of fluid agents would result in 54% to 75% having adhesions. Five studies found that gel agents reduced the incidence of adhesions at SLL compared with no treatment (high‐quality evidence). This suggests that in women with an 84% chance of having adhesions at SLL with no treatment, using gel agents would result in 39% to 75% having adhesions. Three studies found that gel agents probably reduced the incidence of adhesions at SLL compared with fluid agents (moderate‐quality evidence). This suggests that in women with a 46% chance of having adhesions at SLL with a fluid agent, using gel agents would result in 21% to 41% having adhesions. </p> <p>Eight studies examined the effect of gel agents or fluid agents on mean adhesion score. We are uncertain if they have an effect when compared with no treatment, or with each other. </p> <p>No studies reported the effect of steroids on adhesion incidence or mean adhesion scores at SLL. </p> <p><b>For the outcome of adverse events:</b> no studies reported any adverse events caused by the intervention being investigated. </p> <p><b>Quality of the evidence:</b> The quality of the evidence ranged from very‐low to high. The main reasons for downgrading evidence were imprecision (small sample sizes and wide confidence intervals that crossed the line of no effect), and poor reporting of methods. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD001298-sec-0168" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD001298-sec-0168"></div> <h3 class="title" id="CD001298-sec-0169">Implications for practice</h3> <section id="CD001298-sec-0169"> <p>Overall, hydroflotation and gel agents appear to reduce adhesion formation after gynaecological surgery, compared with no treatment. However, there is a large gap in evidence regarding actual effects on clinical outcomes, which are more important to women than the extent of their adhesions. For many pregnancy‐related comparisons in particular, wide confidence intervals crossing the line of no effect, and poor‐quality evidence, meant that the potential for clinical harm as a result of the intervention could not be excluded. </p> </section> <h3 class="title" id="CD001298-sec-0170">Implications for research</h3> <section id="CD001298-sec-0170"> <p>Studies evaluating anti‐adhesion agents should report outcomes in a uniform way, using the modified American Fertility Society endometriosis scale (mAFS). The statistics should be reported in full, as is good practice. The effects that adhesion prevention agents and adhesions themselves have on pelvic pain, live birth rate, and quality of life should be explored in greater detail. Knowledge regarding the effects that different adhesion prevention strategies have on various patient subgroups (e.g. patients with and without active endometriosis or pelvic inflammatory disease), and differences noted between de novo and re‐formed adhesions are also required. The long‐term effects on outcomes, such as small bowel obstruction, should be evaluated. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD001298-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD001298-sec-0008"></div> <div class="table" id="CD001298-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Hydroflotation agents versus no hydroflotation agents (or placebo) for adhesion prevention after gynaecological surgery</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Hydroflotation agents</b> versus<b>no hydroflotation agents (or placebo)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women undergoing gynaecological surgery<br/><b>Settings:</b> hospital<br/><b>Intervention:</b> hydroflotation agents<br/><b>Control:</b> no hydroflotation agents (or placebo) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>No hydroflotation agents (or placebo)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Hydroflotation agents</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pelvic pain</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>806 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>814 per 1000</b><br/>(684 to 897) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.05</b> <br/>(0.52 to 2.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>226<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Live birth rate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>129 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>90 per 1000</b><br/>(41 to 189) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.67</b> <br/>(0.29 to 1.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>208<br/>(2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of adhesions at second‐look laparoscopy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>842 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>645 per 1000</b><br/>(540 to 746) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.34</b> <br/>(0.22 to 0.55) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>566<br/>(4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean adhesion score at second‐look laparoscopy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean adhesion score at second‐look laparoscopy ranged across the control groups from <b>2.19 to 8.42</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean adhesion score at second‐look laparoscopy in the intervention groups was <b>0.06 standard deviations lower</b> (0.2 lower to 0.09 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>722<br/>(4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.06 (‐0.2 to 0.09)<sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical pregnancy rate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>256 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>180 per 1000</b><br/>(110 to 281) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.64</b> <br/>(0.36 to 1.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>310<br/>(3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>No studies reported any adverse events attributable to the intervention</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the median control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>SMD</b> : standardised mean difference; <b>mAFS</b>: modified American Fertility Society </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/><b>High quality.</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality.</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality.</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality.</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of attrition bias in <a href="./references#CD001298-bbs2-0001" title="BrownCB , LucianoAA , MartinD , PeersE , ScrimgeourA , diZeregaGS . Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomised, controlled study. Fertility and Sterility2007;88(5):1413-26. PeersEM , BrownCB , Adept Adhesion Study Group. American Fertility Society score as a measure of effectiveness of 4% icodextrin in a pivotal adhesion reduction trial in the USA. Fertility and Sterility2005;84(Suppl 1):S160. ">Brown 2007</a><br/><sup>b</sup>Downgraded two levels due to imprecision: insufficient sample size to provide adequate statistical power, wide 95% confidence intervals that cross the line of no effect, and fail to exclude both appreciable benefit and harm<br/><sup>c</sup>Scale: mean of the 'mean adhesion score' used. A lower mean 'mean adhesion score' represents an improvement in adhesion disease. A variety of adhesion scoring systems were used (e.g. Hulka, mAFS or system developed by authors for purpose of study); therefore for comparison, we calculated standardised mean difference.<br/><sup>d</sup>Downgraded one level due to imprecision: wide 95% confidence intervals that cross the line of no effect, and insufficient sample size to provide adequate statistical power </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001298-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Gel agents versus no gel agents (or placebo) for adhesion prevention after gynaecological surgery</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Gel agents</b> versus<b>no gel agents (or placebo)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women undergoing gynaecological surgery<br/><b>Settings:</b> hospital<br/><b>Intervention:</b> gel agents<br/><b>Control</b>: no gel agents (or placebo) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>No gel agents (or placebo)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Gel agents</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pelvic pain</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="middle"> <p>Not reported by any studies in this comparison</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Live birth rate</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="middle"> <p>Not reported by any studies in this comparison</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of adhesions at second‐look laparoscopy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>842 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>581 per 1000</b> </p> <p>(391 to 752)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.26</b> <br/>(0.12 to 0.57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>147<br/>(5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean adhesion score at second‐look laparoscopy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean adhesion score at second‐look laparoscopy ranged across the control groups from <b>2.19 to 8.42</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean adhesion score at second‐look laparoscopy in the intervention groups was 0.24<b>standard deviations lower</b> (0.55 lower to 0.08 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>159<br/>(4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.24 (‐0.55 to 0.08)<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical pregnancy</b> </p> <p><b>rate</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>256 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>64 per 1000</b> </p> <p>(6 to 410)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.20</b> </p> <p>(0.02 to 2.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝</p> <p>Low<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>No studies reported any adverse events attributable to the intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the median control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>SMD</b> : standardised mean difference; <b>mAFS</b>: modified American Fertility Society </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/><b>High quality.</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality.</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality.</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality.</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to imprecision: insufficient sample size to produce adequate statistical power.<br/><sup>b</sup>Scale: mean of the 'mean adhesion score' used. A lower mean 'mean adhesion score' represents an improvement in the adhesion disease. A variety of adhesion scoring systems were used (e.g. Hulka, mAFS, system developed by trial authors for purpose of study); therefore for comparison, we calculated standardised mean difference.<br/><sup>c</sup>Downgraded two levels due to imprecision: insufficient sample size to provide adequate statistical power, wide 95% confidence intervals that cross the line of no effect, and fail to exclude both appreciable benefit and harm </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001298-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Gel agents versus hydroflotation agents used as instillants for adhesion prevention after gynaecological surgery</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Gel agents versus hydroflotation agents used as instillants</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women during gynaecological surgery<br/><b>Settings:</b> hospital<br/><b>Intervention:</b> gel agents<br/><b>Comparison:</b> hydroflotation agents used as instillants </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Hydroflotation agents used as instillants</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Gel agents</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pelvic pain</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Not reported by any study in this comparison</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Live birth rate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Not reported by any study in this comparison</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of adhesions at second‐look laparoscopy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>457 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>297 per 1000</b> </p> <p>(207 to 412)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.50</b> <br/>(0.31 to 0.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>538<br/>(3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean adhesion score at second‐look laparoscopy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean adhesion score at second‐look laparoscopy in the hydroflotation group was <b>1.25</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean adhesion score at second‐look laparoscopy in the intervention group was <b>0.79 lower</b> (0.82 to 0.76 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical pregnancy rate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Not reported by any study in this comparison</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>No studies reported any adverse events attributable to the interventions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the median hydroflotation group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>MD</b> : mean difference; <b>mAFS</b>: modified American Fertility Society </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/><b>High quality.</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality.</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality.</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality.</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to inconsistency of results (substantial heterogeneity, I² = 53%)<br/><sup>b</sup>Downgraded one level due to imprecision: insufficient sample size to provide adequate statistical power.<br/><sup>c</sup>Downgraded two levels due to high risk of bias: standard deviations reported by study authors appeared far too small to be accurate in a study with so few participants. Data were imputed assuming standard errors were mistakenly reported as standard deviations, however, caution is urged in interpretation, due to apparently erroneous data reported by study authors.<br/><sup>d</sup>Scale: a lower mean 'mean adhesion score' represents an improvement in the adhesion disease. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001298-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Steroids (any route) versus no steroids (or placebo) for adhesion prevention after gynaecological surgery</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Steroids (any route)</b> versus<b>no steroids (or placebo)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women after gynaecological surgery<br/><b>Settings:</b> postsurgical<br/><b>Intervention:</b> steroids (any route)<br/><b>Control:</b> no steroids (or placebo) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>No steroids (or placebo)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Steroids (any route)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pelvic pain</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Not reported by any study in this comparison</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Live birth rate</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>129 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>88 per 1000</b><br/>(38 to 194) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.65</b> <br/>(0.26‐1.62) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>223<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of adhesions at second‐look laparoscopy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Not reported by any study in this comparison</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean adhesion score at second‐look laparoscopy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Not reported by any study in this comparison</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical pregnancy rate</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>256 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>258 per 1000</b><br/>(185 to 348) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.01</b> <br/>(0.66 to 1.55) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>410<br/>(3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>No studies reported any adverse events attributable to the intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the median control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/><b>High quality.</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality.</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality.</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality.</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels due to imprecision: insufficient sample size to provide adequate statistical power, wide 95% confidence intervals that cross the line of no effect, and fail to exclude both appreciable benefit and harm.<br/><sup>b</sup>We used unpublished data from study author for <a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a>, but there was little information about characteristics of study; therefore, caution in interpreting this result is urged. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD001298-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD001298-sec-0009"></div> <section id="CD001298-sec-0010"> <h3 class="title" id="CD001298-sec-0010">Description of the condition</h3> <p>Adhesions are fibrin bands that form as the result of aberrant peritoneal healing (<a href="./references#CD001298-bbs2-0047" title="Practice Committee of American Society for Reproductive Medicine in collaboration with Society of Reproductive Surgeons. Pathogenesis, consequences, and control of peritoneal adhesions in gynecologic surgery: a committee opinion. Fertility and Sterility2013;99(6):1550-5.">ASRM 2013</a>). Normally, peritoneal damage causes an inflammatory response; this activates the coagulation cascade, and a fibrin plug is formed over the damaged mesothelium, which is then broken down to reveal regenerated peritoneum. However, in adhesion formation, fibrinolysis of the fibrin plug is decreased, and consequently, a fibrin matrix develops. Adhesions may be defined as ‘de novo', meaning they formed at a location that was previously free from adhesions, or ‘re‐formed’, which means they recurred post adhesiolysis. A variety of factors influence the extent of adhesion formation, including type of surgery performed (i.e. laparoscopic or open), haemostasis, and the presence of endometriosis and infection, particularly pelvic inflammatory disease (<a href="./references#CD001298-bbs2-0051" title="DiamondMP , FreemanML . Clinical implications of postsurgical adhesions. Human Reproduction Update2001;7:567-76.">Diamond 2001</a>). Although the aetiologies are different, the pathogenesis is similar.    </p> </section> <section id="CD001298-sec-0011"> <h3 class="title" id="CD001298-sec-0011">Description of the intervention</h3> <p>Adhesion prevention agents can be divided into three types: fluid, pharmacological, and barrier. This review examines fluid and pharmacological agents. A separate review evaluates barrier agents (<a href="./references#CD001298-bbs2-0046" title="AhmadG , KimK , ThompsonM , AgarwalP , O'FlynnH , HindochaA , WatsonA . Barrier agents for adhesion prevention after gynaecological surgery. Cochrane Database of Systematic Reviews2020, Issue 3. Art. No: CD000475. [DOI: 10.1002/14651858.CD000475.pub4]">Ahmad 2020</a>). </p> <p>Fluid agents include both hydroflotation products and gels. Examples of hydroflotation devices are 4% icodextrin solution (Adept, Baxter, Berkshire, UK), an iso‐osmolar and non‐viscous high molecular weight glucose polymer; and 32% dextran (Hyskon Pharmacia, Uppsala, Sweden), a polysaccharide‐containing solution that is no longer approved for use as an anti‐adhesion agent. Both agents can be used as intraperitoneal irrigants or instillants. </p> <p>Derivatives of hyaluronic acid form the basis of a number of anti‐adhesion gels. Hyaluronic acid is a linear polysaccharide with repeating disaccharide units, composed of sodium D‐glucuronate and <i>N</i> ‐acetyl‐D‐glucosamine. SepraSpray (Genzyme Corporation, Cambridge, MA, USA) contains hyaluronic acid in addition to carboxymethylcellulose powder, and is applied to relevant tissues using a preloaded delivery device. SepraCoat (Genzyme Corporation) is a dilute hyaluronic acid solution that is applied before and after surgery. Hyalobarrier gel (Nordic Pharma, Reading, UK) and HyaRegen gel (BioRegen Biomedical CO., Ltd.) contain cross‐linked hyaluronic acid. Intergel (Gynecare, Lifecore Biomedical, Chaska, MN, USA) contains ferrous hyaluronic acid, although it has been withdrawn from the market. <i>N,O</i>‐carboxymethyl chitosan is a derivative of chitin, and is similar in structure to hyaluronic acid and carboxymethylcellulose. It is formed when the gel and solution components are combined. Polyethylene glycol (PEG)‐based gels are also available. CoSeal (Baxter) is formed by mixing a powder and a liquid intraoperatively, both of which contain PEG, which is then applied as a gel to relevant surfaces, using a specific instrument. SprayGel (Confluent Surgical Inc., Waltham, MA, USA) is formed by two PEG‐containing liquid precursors, which create a cross‐linked gel when combined. Intercoat (FzioMed, San Luis Obispo, CA, USA) is a viscoelastic gel composed of polyethylene oxide (PEO), which is very similar to PEG, but has a different molecular weight, and carboxymethylcellulose. </p> <p>Steroids have been used to prevent adhesions and can be administered in a number of ways, including systemically before, during, and after surgery; intraperitoneally during surgery; and via hydrotubation postoperatively. Other pharmacological agents used to prevent adhesions include: noxytioline, an antibacterial agent; promethazine, an antihistamine; and reteplase, a thrombolytic drug, all of which are instilled intraperitoneally; as well as heparin, an anticoagulant used for intraoperative irrigation. A nasal gonadotrophin‐releasing hormone agonist (GnRHa) has also been used preoperatively and postoperatively. </p> </section> <section id="CD001298-sec-0012"> <h3 class="title" id="CD001298-sec-0012">How the intervention might work</h3> <p>Hyaluronic acid is a major component of many body tissues and fluids, where it provides physically supportive and mechanically protective roles (<a href="./references#CD001298-bbs2-0013" title="JohnsBD , KeyportGM , HoehlerF , diZeregaG . Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery. Fertility and Sterility2001;76(3):595-604. ">Johns 2001</a>). PEG is a polymer; when the two PEG‐containing liquids are sprayed simultaneously, they form a cross‐linked gel. Gels are thought to decrease adhesion formation mainly by preventing denuded tissues from touching. </p> <p>Steroids and antihistamines (e.g. promethazine) act as immunomodulating agents, and were used in the belief that they promoted fibrinolysis during healing, without hindering the healing process. GnRHa may work by decreasing oestrogen‐related growth factors, and promoting fibroblasts. Fluid agents, such as icodextrin and dextran, work through the act of hydroflotation, whereby the fluid separates raw opposing surfaces until the healing process has been completed. Fluid agents are believed to remain in the peritoneal cavity for up to 4 days, compared with crystalloids such as normal saline and Hartmann's solution which are effectively fully reabsorbed within 24 hours.This prolonged period before reabsorption is thought to give added protection against the formation of adhesions, which form within eight days of surgery (<a href="./references#CD001298-bbs2-0051" title="DiamondMP , FreemanML . Clinical implications of postsurgical adhesions. Human Reproduction Update2001;7:567-76.">Diamond 2001</a>; <a href="./references#CD001298-bbs2-0055" title="HosieK , GilbertJA , KerrD , BrownCB , PeersEM . Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin. Drug Delivery2001;8:9-12.">Hosie 2001</a>). </p> </section> <section id="CD001298-sec-0013"> <h3 class="title" id="CD001298-sec-0013">Why it is important to do this review</h3> <p>Adhesiolysis is the only available treatment for adhesions, although its long‐term efficacy is unclear (<a href="./references#CD001298-bbs2-0064" title="Van den BeukelBA , deReeR , vanLeuvenS , BakkumEA , StrikC , vanGoorH , et al. Surgical treatment of adhesion-related chronic abdominal and pelvic pain after gynaecological and general surgery: a systematic review and meta-analysis. Human Reproduction Update2017;23(3):276-88. [DOI: https://doi.org/10.1093/humupd/dmx004]">Van Den Beukel 2017</a>). In many cases, the focus of adhesion management is now on prevention of adhesions during the initial surgery (<a href="./references#CD001298-bbs2-0050" title="De WildeRL , BrölmannH , KoninckxPR , LundorffP , LowerAM , WattiezA , et al, the Anti-Adhesions in Gynecology Expert Panel (ANGEL). Prevention of adhesions in gynaecological surgery: the 2012 European field guideline. Gynecological Surgery2012;9(4):365-8.">De Wilde 2012</a>). Intraperitoneal adhesions are associated with considerable comorbidities, and have large economic and public health repercussions. They are the most common complication of gynaecological surgery, forming in 25% to 92% of women (<a href="./references#CD001298-bbs2-0060" title="OkabayashiK , AshrafianH , ZacharakisE , HasegawaH , KitagawaY , AthanasiouT , et al. Adhesions after abdominal surgery: a systematic review of the incidence, distribution and severity. Surgery Today2014;44(3):405-20.">Okabayashi 2014</a>). Women present with secondary effects of adhesions, including dyspareunia, subfertility, bowel obstruction, and chronic pelvic pain, although the latter has a controversial association with adhesions, as no correlation between the extent of adhesions and severity of pain is apparent. Nevertheless, these consequences can greatly decrease a woman’s well‐being, and require further surgery. Subsequent surgery in women with adhesions is more difficult, often takes longer, and is associated with a higher complication rate. It is estimated that in the first year after lower abdominal surgery, the cost of adhesion‐related readmissions in the UK is £24.2 million, which increases to £95.2 million over the subsequent nine years (<a href="./references#CD001298-bbs2-0065" title="WilsonMS , MenziesD , KnightAD , CroweAM . Demonstrating the clinical and cost effectiveness of adhesion reduction strategies. Colorectal Disease2002;4:355-60.">Wilson 2002</a>). The Surgical and Clinical Adhesions Research (SCAR) study found that 5% (n = 245) of readmissions, 10 years after open gynaecological surgery, were due to adhesions (<a href="./references#CD001298-bbs2-0057" title="LowerAM , HawthornRJ , EllisH , O'BrienF , BuchanS , CroweAM . The impact of adhesions on hospital readmissions over ten years after 8849 open gynaecological operations: an assessment from the Surgical and Clinical Adhesions Research Study. BJOG2000;107:855-62.">Lower 2000</a>; <a href="./references#CD001298-bbs2-0058" title="LowerAM , HawthornRJ , ClarkD , BoydJH , FinlaysonAR , KnightAD , et al. Adhesion-related readmissions following gynaecological laparoscopy or laparotomy in Scotland: an epidemiological study of 24 046 patients. Human Reproduction2004;19:1877-85.">Lower 2004</a>). An English study estimated that the National Health Service (NHS) could save £700,000 per year if an anti‐adhesion agent that reduced adhesions by 25% and cost £110 was used; at worst, this approach would be cost‐neutral (<a href="./references#CD001298-bbs2-0048" title="CheongY , SadekK , WatsonA , MetwallyM , LiTC . Adhesion reduction agents in gynaecological procedures: can NHS afford it?Journal of Obstetrics and Gynaecology2011;31:631-5.">Cheong 2011</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD001298-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD001298-sec-0014"></div> <p>To evaluate the effectiveness and safety of fluid and pharmacological agents on rates of pain, live births, and adhesion prevention in women undergoing gynaecological surgery. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD001298-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD001298-sec-0015"></div> <section id="CD001298-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD001298-sec-0017"> <h4 class="title">Types of studies</h4> <p>Published and unpublished randomised controlled trials (RCTs) investigating the use of fluid and pharmacological agents to prevent adhesion formation after gynaecological surgery were eligible for inclusion. We defined gels as fluid agents. </p> <p>We excluded non‐randomised trials and studies using a cross‐over design.</p> </section> <section id="CD001298-sec-0018"> <h4 class="title">Types of participants</h4> <p>Females, in any age group, who underwent gynaecological surgery (by laparoscopy or laparotomy). </p> <p>We excluded studies investigating adhesion prevention in non‐gynaecological specialities.</p> </section> <section id="CD001298-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We grouped interventions for meta‐analysis according to physical state and main mechanism of action: hydroflotation agents (including dextran, 4% icodextrin solution), gel agents (including hyaluronic acid‐based gels, polyethylene‐glycol‐based gels, and polyethylene oxide and carboxymethylcellulose‐based gels), and pharmacological agents. We included the following comparisons. </p> <p> <ol id="CD001298-list-0001"> <li> <p>Hydroflotation agent versus no hydroflotation agent (or placebo)</p> </li> <li> <p>Gel agent versus no treatment (or placebo)</p> </li> <li> <p>Gel agent versus hydroflotation agent used as an instillant</p> </li> <li> <p>Steroid (including systemic, intraperitoneal, preoperative and postoperative) versus no steroid (or placebo) </p> </li> <li> <p>Intraperitoneal noxytioline versus no noxytioline (or placebo)</p> </li> <li> <p>Intraperitoneal heparin versus no heparin (or placebo)</p> </li> <li> <p>Systemic promethazine versus no promethazine (or placebo)</p> </li> <li> <p>GnRHa versus no GnRHa (or placebo)</p> </li> <li> <p>Reteplase plasminogen activator versus no reteplase plasminogen activator (or placebo)</p> </li> <li> <p><i>N,O</i> ‐carboxymethyl chitosan versus no <i>N,O</i>‐carboxymethyl chitosan (or placebo) </p> </li> </ol> </p> <p>We made the decision to group hydroflotation agents and gel agents during the development of the 2014 update to this review (<a href="./references#CD001298-bbs2-0067" title="AhmadG , MackieFL , IlesDA , O'FlynnH , DiasS , MetwallyM , et al. Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database of Systematic Reviews2014, Issue 7. Art. No: CD001298. [DOI: 10.1002/14651858.CD001298.pub4]">Ahmad 2014</a>). To ease comparison between this update and the previous update we retained these groupings. </p> </section> <section id="CD001298-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD001298-sec-0021"> <h5 class="title">Primary outcomes</h5> <p>1. Pelvic pain (improvement, worsening, no change in pain at second‐look laparoscopy (SLL)), independent of the method used to assess pelvic pain </p> <p>2. Live birth rate, as defined by the individual study</p> </section> <section id="CD001298-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p>3. Incidence of adhesions at SLL</p> <p>4. Mean adhesion score at SLL per participant, recorded on whichever scale the study authors used, but with preference given to the mAFS score </p> <p>5. Clinical pregnancy rate as defined by the individual study</p> <p>6. Improvement in adhesion score at SLL, recorded on whichever scale the study authors used, but with preference given to the modified American Fertility Society (mAFS) score </p> <p>7. Worsening of adhesion score at SLL, recorded on whichever scale the study authors used, but with preference given to the mAFS score </p> <p>8. Miscarriage rate, defined as loss of pregnancy before 24 weeks' gestation</p> <p>9. Ectopic pregnancy rate</p> <p>10. Improvement in quality of life (QoL) at SLL, recorded on whichever scale the study authors used, but with preference given to Short Form (SF)‐36 </p> <p>11. Adverse outcomes, local and systemic, thought to be due to the anti‐adhesion agent, in studies stating this as one of their outcomes, as opposed to observation </p> <p>We included articles independent of the adhesion scoring method used. We included articles that met the inclusion criteria but did not report any of the outcomes of interest in this review in the qualitative analysis. </p> </section> </section> </section> <section id="CD001298-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <p>This is an update of the review by Ahmad and colleagues (<a href="./references#CD001298-bbs2-0067" title="AhmadG , MackieFL , IlesDA , O'FlynnH , DiasS , MetwallyM , et al. Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database of Systematic Reviews2014, Issue 7. Art. No: CD001298. [DOI: 10.1002/14651858.CD001298.pub4]">Ahmad 2014</a>). The Cochrane Gynaecology and Fertility (CGF) Information Specialist designed the search strategy. We applied no language restrictions. See the Review Group <a href="https://cgf.cochrane.org/sites/cgf.cochrane.org/files/public/uploads/uploads/deveolpment_of_cgf_specialised_register.pdf" target="_blank">website</a> for additional details on the make‐up of the Specialised Register. </p> <section id="CD001298-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We searched these electronic databases:</p> <p> <ol id="CD001298-list-0002"> <li> <p>The Cochrane Gynaecology and Fertility Specialised Register, PROCITE platform, searched 22 August 2019 (<a href="./appendices#CD001298-sec-0174">Appendix 1</a>) </p> </li> <li> <p>CENTRAL, OVID platform, searched Issue 7 July, on 22 August 2019 (<a href="./appendices#CD001298-sec-0175">Appendix 2</a>) </p> </li> <li> <p>MEDLINE, OVID platform, searched from 1946 to 22 August 2019 (<a href="./appendices#CD001298-sec-0176">Appendix 3</a>) </p> </li> <li> <p>Embase, OVID platform, searched from 1980 to 22 August 2019 (<a href="./appendices#CD001298-sec-0177">Appendix 4</a>) </p> </li> <li> <p>PsycINFO, OVID platform, searched from 1806 to 22 August 2019 (<a href="./appendices#CD001298-sec-0178">Appendix 5</a>) </p> </li> <li> <p>International Clinical Trials Registry Platform (ICTRP), Web platform, searched 22 August 2019 (<a href="./appendices#CD001298-sec-0179">Appendix 6</a>) </p> </li> <li> <p>Clinicaltrials.gov, Web platform, searched 22 August 2019 (<a href="./appendices#CD001298-sec-0180">Appendix 7</a>). </p> </li> </ol> </p> </section> <section id="CD001298-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We handsearched grey literature in August 2019, specifically, abstracts presented at meetings of the British Society of Gynaecological Endoscopy, the European Society of Gynaecological Endoscopy, the American Association of Gynecological Laparoscopists, and the British Fertility Society. We also searched the reference lists of included studies and communicated with experts in the field. </p> </section> </section> <section id="CD001298-sec-0026"> <h3 class="title" id="CD001298-sec-0026">Data collection and analysis</h3> <section id="CD001298-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Three review authors (KK, MT, PA) independently performed an initial screen of titles and abstracts to assess reports for suitability of inclusion in accordance with the eligibility criteria. GA, KK, MT, and PA independently examined the full‐text articles and abstracts to confirm eligibility. If necessary, we contacted investigators to obtain further information. We settled discrepancies by consensus between GA, KK, and MT. </p> </section> <section id="CD001298-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Three review authors (KK, MT, PA) independently extracted the data. Data were transcribed onto a Microsoft Word data collection form designed for this review, before they entered them into Review Manager 5. We used the statistical package included in Review Manager 5, provided by Cochrane, to analyse and synthesise the data. We contacted study authors for further information as required. If we did not receive a reply, and the information was related to bias, we denoted this as unclear; if the information required was statistical, and the information lacking prevented inclusion in the meta‐analysis, we did not include the study in that outcome analysis, although it was still considered an 'included study'. GA, KK, and MT resolved disagreements by consensus. </p> </section> <section id="CD001298-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (KK, MT) independently assessed the risk of bias of all studies deemed eligible. The 'Risk of bias' domains included allocation (random sequence generation and allocation concealment); blinding of women, personnel, and outcome assessors; incomplete outcome data; selective reporting, and other biases. We settled disagreements regarding interpretation of data by consensus between GA, KK, and MT. We assessed the quality of trials with the 'Risk of bias' tool, recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> and entered our assessment into the 'Risk of bias' tables (<a href="./references#CD001298-bbs2-0054" title="HigginsJPT , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). </p> </section> <section id="CD001298-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We used an odds ratio (OR) for dichotomous data (e.g. number of women with worsening adhesion score). We used a standardised mean difference (SMD) for continuous measures that used different scales (e.g. mean adhesion score at SLL). When the same scale was used, we used a mean difference (MD) for this specific scale. We presented 95% confidence intervals (CIs) for all outcomes. </p> </section> <section id="CD001298-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>The included primary studies were analysed per woman. We excluded studies that used an internal control, and listed them as such. </p> </section> <section id="CD001298-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We contacted Investigators to request missing data. If data were insufficient to include the study in a particular analysis, we did not include it. </p> </section> <section id="CD001298-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used the Chi² test and the I² statistic to determine significant heterogeneity. We considered an I² measurement &gt; 30% to be moderate heterogeneity, &gt; 50% substantial heterogeneity, and &gt; 70% high heterogeneity. </p> </section> <section id="CD001298-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>In consideration of the difficulty of detecting and correcting publication bias and other reporting bias, we aimed to minimise the impact by ensuring that we performed a robust and comprehensive search. We planned to create a funnel plot to assess the risk of reporting bias if we included 10 or more studies in a meta‐analysis.  </p> </section> <section id="CD001298-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We performed statistical analysis in accordance with guidelines developed by Cochrane. We combined data from the primary studies in Review Manager 5, using the fixed‐effect model. An increase in OR or SMD or MD was indicated if it fell to the right of the central line of the forest plot; a decrease was indicated if it fell to the left of the central line. Whether this favoured treatment or control depended on the outcome analysed, but we labelled the axes accordingly. </p> </section> <section id="CD001298-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>When we identified significant heterogeneity, we explored the cause, and performed a sensitivity analysis using the random‐effects model. We highlighted this in the results section, and noted any variation in the direction of effect. We would have performed a subgroup analysis comparing the effects of antiadhesion agents on de novo adhesions versus re‐formed adhesions, if sufficient data were available. </p> </section> <section id="CD001298-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>We performed a sensitivity analysis to determine whether the results were robust to decisions made regarding eligibility of the studies and analysis. If we considered that a study had a high risk of bias, or we identified an apparent outlier, we investigated the reason for the significant heterogeneity, whether this was believed to be clinical or methodological, and we conducted an analysis to evaluate whether including the study significantly affected the results. We reported results of the sensitivity analysis in the <a href="#CD001298-sec-0051">Risk of bias in included studies</a> subsection of the results section. </p> </section> <section id="CD001298-sec-0038"> <h4 class="title">Overall quality of the body of evidence and 'Summary of findings' table</h4> <p>We prepared 'Summary of findings' tables using GRADEpro GDT software and Cochrane methods (<a href="./references#CD001298-bbs2-0052" title="McMaster University (developed by Evidence Prime, Inc.)GRADEpro GDT. Version accessed 4 May 2020. Hamilton (ON): McMaster University (developed by Evidence Prime, Inc.). Available at gradepro.org.">GRADEpro GDT</a>; <a href="./references#CD001298-bbs2-0054" title="HigginsJPT , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>) for the following comparisons; hydroflotation agents versus no hydroflotation agents (or placebo); gel agents versus no gel agents (or placebo); gel agents versus hydroflotation agents used as instillants; and steroids (any route) versus no steroids (or placebo), all for adhesion prevention after gynaecological surgery. These tables evaluate the overall quality of the body of evidence for the main review outcomes (pelvic pain, live birth rate, incidence of adhesions at SLL, mean adhesion score at SLL, clinical pregnancy rate, and adverse events) using GRADE criteria (study limitations (i.e. risk of bias), consistency of effect, imprecision, indirectness, and publication bias). We justified our judgements about the quality of the evidence quality (high, moderate, low, or very low), and documented and incorporated them into the reporting of results for each outcome. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD001298-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD001298-sec-0039"></div> <section id="CD001298-sec-0040"> <h3 class="title">Description of studies</h3> <section id="CD001298-sec-0041"> <h4 class="title">Results of the search</h4> <p>We identified 44 studies as potentially eligible for inclusion. We included 32 studies. For a summary of each included study, see the section <a href="./references#CD001298-sec-0190" title="">Characteristics of included studies</a>. Reasons for study exclusion are detailed in the <a href="./references#CD001298-sec-0191" title="">Characteristics of excluded studies</a> section. For details of the screening and selection process, see <a href="#CD001298-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD001298-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD001298-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD001298-sec-0042"> <h4 class="title">Included studies</h4> <section id="CD001298-sec-0043"> <h5 class="title">Study design and setting</h5> <p>Of the 32 included studies, 20 were conducted at multiple centres, and 12 at a single centre. Nine were conducted in the USA, seven in Europe, three in Australia, one in the USA and Europe, two in the Netherlands, two in Italy, one in Sweden, one in the UK, one in Germany, one in China, and one in Germany, Canada, and the Netherlands Antilles; three studies did not state their location. </p> <p>We were unable to include the results from nine of the included trials in any statistical analyses. In some cases, the study authors used different ways of assessing adhesions, such as reporting only individual sections of the modified American Fertility Society endometriosis scale (mAFS) (<a href="./references#CD001298-bbs2-0009" title="HellebrekersBWJ , Trimbos-KemperTCM , BoestenL , JansenFW , KolkmanW , TrimbosJB , et al. Preoperative predictors of postsurgical adhesion formation and the prevention of adhesions with plasminogen activator (PAPA-study): results of a clinical pilot study. Fertility and Sterility2009;91(4):1204-14. ">Hellebrekers 2009</a>; <a href="./references#CD001298-bbs2-0006" title="DiamonMP , LucianoA , JohnsA , DunnR , YoungP , Bieber E. Reduction of postoperative adhesions by N, O-carboxymethylchitosan: a pilot study. Fertility and Sterility2003;80(3):631-6. ">Diamond 2003</a>); the adhesion area (cm²), as in <a href="./references#CD001298-bbs2-0004" title="CoddingtonC , GrowD , AhmedM , TonerJ , CookE , DiamondM . Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial. Fertility and Sterility2009;91:1909-13. ">Coddington 2009</a>, or change in adhesion score at SLL as in <a href="./references#CD001298-bbs2-0020" title="MettlerL , HuckeJ , BojahrB , TinnebergHR , LeylandN , AvelarR . A safety and efficacy study of a resorbable hydrogel for reduction of post-operative adhesions following myomectomy. Human Reproduction2008;23(5):1093-100. ">Mettler 2008</a>. </p> <p>We could not include <a href="./references#CD001298-bbs2-0017" title="LundorffP , DonnezJ , KorellM , AudebertAJM , BlockK , diZeregaGS . Clinical evaluation of a viscoelastic gel for reduction of adhesions following gynaecological surgery by laparoscopy in Europe. Human Reproduction2004;20(2):514-20. ">Lundorff 2005</a> in the statistical analyses, as investigators reported the effect of the anti‐adhesion agent per adnexa, not per participant. </p> <p>Relevant outcome data from <a href="./references#CD001298-bbs2-0025" title="RosenbergSM , BoardJA . High-molecular weight dextran in human infertility surgery. American Journal of Obstetrics and Gynecology1984;148:380-5. ">Rosenberg 1984</a> and <a href="./references#CD001298-bbs2-0029" title="ThorntonMH , JohnsDB , CampeauJD , HoehlerF , DiZeregaGS . Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open label pilot study. Human Reproduction1998;13(6):1480-5. ">Thornton 1998</a> were only displayed in the form of graphs, without any written numerical values. We read the results off the graphs, and presented them in additional tables, but did not include them in the statistical analyses. Caution is needed when interpreting affected data sets, as the exact numerical values are unknown. </p> <p><a href="./references#CD001298-bbs2-0024" title="RoseB , MacNeillC , LarrainR , KopreskiM . Abdominal instillation of high-molecular-weight dextran or lactated Ringer's solution after laparoscopic surgery. Journal of Reproductive Medicine1991;36:537-9. ">Rose 1991</a> and <a href="./references#CD001298-bbs2-0026" title="SitesCK , JensenBA , GlockJL , BlackmanJA , BadgerGJ , JohJV , et al. Transvaginal ultrasonographic assessment of Hyskon and lactated Ringer's solution instillation after laparoscopy. A randomized, controlled trial. Journal of Ultrasound Medicine1997;16(3):195-9. [MEDLINE: 9166816]">Sites 1997</a> did not report any data regarding any of our outcomes of interest, so could not be included in any statistical analysis. </p> <p>Thus, we included 23 trials in the statistical analyses presented below.</p> <p>Eighteen studies stated that they received commercial funding.</p> </section> <section id="CD001298-sec-0044"> <h5 class="title">Participants</h5> <p>There was a wide variety in the number of women in each study, with participant numbers ranging from 9 to 203 in the intervention group, and from 6 to 199 in the control group. All participants were women undergoing a gynaecological procedure, who had a second‐look laparoscopy (SLL). Reasons for surgery included pelvic inflammatory disease (PID), endometriosis, adhesions, fibroids, pelvic pain, pelvic mass, endometrioid cysts, and infertility assessment and treatment (e.g. tubal surgery). </p> </section> <section id="CD001298-sec-0045"> <h5 class="title">Interventions</h5> <p>The numbers of studies entered into any statistical analysis for each comparison are as follows. </p> <p> <ol id="CD001298-list-0003"> <li> <p>Seven studies compared hydroflotation agents versus placebo (<a href="./references#CD001298-bbs2-0001" title="BrownCB , LucianoAA , MartinD , PeersE , ScrimgeourA , diZeregaGS . Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomised, controlled study. Fertility and Sterility2007;88(5):1413-26. PeersEM , BrownCB , Adept Adhesion Study Group. American Fertility Society score as a measure of effectiveness of 4% icodextrin in a pivotal adhesion reduction trial in the USA. Fertility and Sterility2005;84(Suppl 1):S160. ">Brown 2007</a>; <a href="./references#CD001298-bbs2-0002" title="ButtramV , MalinakR , ClearyR , CohenS , CowanB , DaniellJ , et al, Adhesion Study Group. Reduction of postoperative pelvic adhesions with intraperitoneal 32% dextran 70: a prospective, randomized clinical trial. Fertility and Sterility1983;40:612-9. ">Buttram 1983</a>; <a href="./references#CD001298-bbs2-0005" title="DiamondMP . Reduction of de novo postsurgical adhesions by intraoperative pre coating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo-controlled multicenter study. The Sepracoat Adhesion Study Group. Fertility and Sterility1998;69(6):1067-74. ">Diamond 1998</a>; <a href="./references#CD001298-bbs2-0007" title="diZeregaGS , VercoSJ , YoungP , KettelM , KobakW , MartinD , et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Human Reproduction2002;17(4):1031-8. ">diZerega 2002</a>; <a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a>; <a href="./references#CD001298-bbs2-0014" title="LarssonB , LalosO , MarskL , Tronstad S-E, BygdemanM , PehrsonS , JoelssonI . Effect of intraperitoneal instillation of 32% dextran 70 on postoperative adhesion formation after tubal surgery. Acta Obstetricia et Gynecologia Scandinavica1985;64:437-41. ">Larsson 1985</a>; <a href="./references#CD001298-bbs2-0030" title="TrewG , PistofidisG , PadosG , LowerA , MettlerL , WallweinerD , et al. Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomised study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery. Human Reproduction2011;26(8):2015-27. ">Trew 2011</a>). We made a distinction between hydroflotation agents (e.g. dextran, 4% icodextrin, 0.4% hyaluronic acid) designed as anti‐adhesion agents; and liquids, such as saline, which was often used as a control, and was not considered a hydroflotation agent in this review. </p> </li> <li> <p>Nine studies compared gel agents versus no gel agents (<a href="./references#CD001298-bbs2-0003" title="CheongY , BaileyS , ForbesJ . Randomized Controlled Trial of Hyalobarrier Versus No Hyalobarrier on the Ovulatory Status of Women with Periovarian Adhesions: A Pilot Study. Advances in Therapy2017;34(1):199-206. [PMID: 27900662]">Cheong 2017</a>; <a href="./references#CD001298-bbs2-0008" title="FossumGT , SilverbergKM , MillerCE , DiamondMP , HolmdahlL . Gynecologic use of SepraSpray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy: a pilot study. Fertility and Sterility2011;96(2):487-91. ">Fossum 2011</a>; <a href="./references#CD001298-bbs2-0018" title="MaisV , BraccoGI , LittaP , Gargiulo, MelisGB . Reduction of postoperative adhesions with an auto-crosslinked hyaluronan gel in gynaecological laparoscopic surgery: a blinded, controlled, randomised, multicentre study. Human Reproduction2006;21(5):1248-54. ">Mais 2006</a>; <a href="./references#CD001298-bbs2-0019" title="MettlerL , AudebertA , Lehmann-WillenbrockE , SchiveK , JacobsVR . Prospective clinical trial of SprayGel as a barrier to adhesion formation: an interim analysis. Journal of American Association of Gynecologic Laparoscopists2003;10(3):339-44. MettlerL , AudebertA , Lehmann-WillenbrockE , Schive-PeterhansiK , JacobsV . A randomized prospective, controlled, multicenter clinical trial of a sprayable, site specific adhesion barrier system in patients undergoing myomectomy. Fertility and Sterility2004;82(2):398-404. MettlerL . Pelvic adhesions: laparoscopic approach. Annals of the New York Academy of Sciences2003;997:255-68. ">Mettler 2004</a>; <a href="./references#CD001298-bbs2-0021" title="PellicanoM , BramanteS , CirilloD , PalombaS , BifulcoG , ZulloF , et al. Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective, randomized, controlled study. Fertility and Sterility2003;80(2):441-4. ">Pellicano 2003</a>; <a href="./references#CD001298-bbs2-0027" title="TchartchianG , HackethalA , HerrmannA , BojahrB , WallwienerC , OhlingerR , et al. Evaluation of SprayShieldTM Adhesion Barrier in a single center: randomized controlled study in 15 women undergoing reconstructive surgery after laparoscopic myomectomy. Archives of Gynecology and Obstetrics2014;290(4):697-704. [PMID: 24781718]">Tchartchian 2014</a>; <a href="./references#CD001298-bbs2-0028" title="Ten BroekRPG , Kok-KrantN , VerhoeveHR , vanGoorH , BakkumEA . Efficacy of polyethylene glycol adhesion barrier after gynaecological laparoscopic surgery. Gynecological Surgery2012;9:29-35. ">Ten Broek 2012</a>; <a href="./references#CD001298-bbs2-0031" title="TrewG , PistofidisG , ZieglerN , KorrellM , BruckerS , RitterH , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray applied laparoscopically to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynecology2014;21:S90. TrewGH , PistofidisGA , BruckerSY , KrämerB , ZieglerNM , KorellM , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded multicenter study of ActamaxTM Adhesion Barrier. Archives of Gynecology and Obstetrics2017;295(2):383-95. TrewGH , PistofidisGA , BruckerSY , KraemerB , ZieglerNM , KorellM , et al. Twelve month follow-up of a first-In-human (FIH), randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray (Actamax Adhesion Barrier) applied to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynaecology2016;23:S203. ">Trew 2017</a>; <a href="./references#CD001298-bbs2-0032" title="YoungP , JohnsA , TemplemanC , WitzC , WebsterB , FerlandR , et al. Reduction of postoperative adhesions for laparoscopic gynaecological surgery with Oxiplex/AP gel: a pilot study. Fertility and Sterility2005;84(5):1450-6. ">Young 2005</a>) . </p> </li> <li> <p>Three studies compared gel agents versus hydroflotation agents (<a href="./references#CD001298-bbs2-0013" title="JohnsBD , KeyportGM , HoehlerF , diZeregaG . Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery. Fertility and Sterility2001;76(3):595-604. ">Johns 2001</a>; <a href="./references#CD001298-bbs2-0015" title="LiuC , LuQ , ZhangZ , XueM , ZhangY , ZhangY , et al. A randomized controlled trial on the efficacy and safety of a new crosslinked hyaluronan gel in reducing adhesions after gynecologic laparoscopic surgeries. The Journal of Minimally Invasive Gynaecology2015;22(5):853-63. LiuC , ZhangZ , LuQ , ZhangZ . The efficacy and safety of a new cross-linked hyaluronan hydrogel in the reduction of postsurgical adhesions after laparoscopic gynecological surgery: a randomized controlled trial. The Journal of Minimally Invasive Gynaecology2014;21:S59-60. ">Liu 2015</a>; <a href="./references#CD001298-bbs2-0016" title="LundorffP , GeldorpH , TronstadSE , LalosO , LarssonB , JohnsDB , et al. Reduction of postsurgical adhesions with ferric hyaluronate gel: a European study. Human Reproduction2001;16(9):1982-8. ">Lundorff 2001</a>). </p> </li> <li> <p>Four studies compared steroids versus no steroids (or placebo) (<a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a>; <a href="./references#CD001298-bbs2-0012" title="JansenRPS . Controlled clinical approaches to investigating the prevention of peritoneal adhesions. In: Treatment of Postsurgical Adhesions. Vol. 358. New York: Wiley-Liss Inc, 1990:177-92. ">Jansen 1990</a>; <a href="./references#CD001298-bbs2-0022" title="QuerleuD , Vankeerberghen-DeffenseF , BoutevilleC . The effect of noxytioline and systemic corticosteroids in infertility surgery. A prospective randomized study [Traitement adjuvant des plasties tubaires. Etude prospective randomisee des corticoides par voie generale et de la noxytioline]. Journal de Gynecologie Obstetrique et Biologie de la Reproduction1989;18(7):935-40. ">Querleu 1989</a>; <a href="./references#CD001298-bbs2-0023" title="RockJA , SieglerAM , Boer MieselM , HaneyAF , RosenwaksZ , Pardo-VargasF , et al. The efficacy of postoperative hydrotubation: a randomized prospective multicenter clinical trial. Fertility and Sterility1984;42:373-6. ">Rock 1984</a>) . </p> </li> <li> <p>One study compared noxytioline versus no noxytioline (<a href="./references#CD001298-bbs2-0022" title="QuerleuD , Vankeerberghen-DeffenseF , BoutevilleC . The effect of noxytioline and systemic corticosteroids in infertility surgery. A prospective randomized study [Traitement adjuvant des plasties tubaires. Etude prospective randomisee des corticoides par voie generale et de la noxytioline]. Journal de Gynecologie Obstetrique et Biologie de la Reproduction1989;18(7):935-40. ">Querleu 1989</a>). </p> </li> <li> <p>One study compared heparin versus placebo (<a href="./references#CD001298-bbs2-0011" title="JansenRPS . Failure of peritoneal irrigation with heparin during pelvic operations upon young women to reduce adhesions. Surgery, Gynecology &amp; Obstetrics1988;166:154-60. ">Jansen 1988</a>). </p> </li> <li> <p>One study compared promethazine versus no promethazine (<a href="./references#CD001298-bbs2-0012" title="JansenRPS . Controlled clinical approaches to investigating the prevention of peritoneal adhesions. In: Treatment of Postsurgical Adhesions. Vol. 358. New York: Wiley-Liss Inc, 1990:177-92. ">Jansen 1990</a>). </p> </li> </ol> </p> <p><a href="./references#CD001298-bbs2-0004" title="CoddingtonC , GrowD , AhmedM , TonerJ , CookE , DiamondM . Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial. Fertility and Sterility2009;91:1909-13. ">Coddington 2009</a> investigated gonadotrophin‐releasing hormone agonist (GnRH) analogues versus placebo; however, we did not include it in a statistical analysis as it only reported adhesion area, which was not one of our outcomes of interest. </p> <p><a href="./references#CD001298-bbs2-0009" title="HellebrekersBWJ , Trimbos-KemperTCM , BoestenL , JansenFW , KolkmanW , TrimbosJB , et al. Preoperative predictors of postsurgical adhesion formation and the prevention of adhesions with plasminogen activator (PAPA-study): results of a clinical pilot study. Fertility and Sterility2009;91(4):1204-14. ">Hellebrekers 2009</a> investigated plasminogen activator versus placebo; however, we did not include it in any statistical analyses, as it only reported individual sections of the mAFS. </p> <p><a href="./references#CD001298-bbs2-0006" title="DiamonMP , LucianoA , JohnsA , DunnR , YoungP , Bieber E. Reduction of postoperative adhesions by N, O-carboxymethylchitosan: a pilot study. Fertility and Sterility2003;80(3):631-6. ">Diamond 2003</a> investigated the use of <i>N,O</i>‐carboxymethyl chitosan versus placebo; however this study reported only individual sections of the mAFS and incidence as proportion of sites affected rather than true incidence, thus we did not include it in any statistical analyses.. </p> </section> <section id="CD001298-sec-0046"> <h5 class="title">Outcomes</h5> <p>Three studies did not assess adhesions (<a href="./references#CD001298-bbs2-0003" title="CheongY , BaileyS , ForbesJ . Randomized Controlled Trial of Hyalobarrier Versus No Hyalobarrier on the Ovulatory Status of Women with Periovarian Adhesions: A Pilot Study. Advances in Therapy2017;34(1):199-206. [PMID: 27900662]">Cheong 2017</a>; <a href="./references#CD001298-bbs2-0024" title="RoseB , MacNeillC , LarrainR , KopreskiM . Abdominal instillation of high-molecular-weight dextran or lactated Ringer's solution after laparoscopic surgery. Journal of Reproductive Medicine1991;36:537-9. ">Rose 1991</a>; <a href="./references#CD001298-bbs2-0026" title="SitesCK , JensenBA , GlockJL , BlackmanJA , BadgerGJ , JohJV , et al. Transvaginal ultrasonographic assessment of Hyskon and lactated Ringer's solution instillation after laparoscopy. A randomized, controlled trial. Journal of Ultrasound Medicine1997;16(3):195-9. [MEDLINE: 9166816]">Sites 1997</a>). <a href="./references#CD001298-bbs2-0017" title="LundorffP , DonnezJ , KorellM , AudebertAJM , BlockK , diZeregaGS . Clinical evaluation of a viscoelastic gel for reduction of adhesions following gynaecological surgery by laparoscopy in Europe. Human Reproduction2004;20(2):514-20. ">Lundorff 2005</a> presented the results per adnexa. </p> <section id="CD001298-sec-0047"> <h6 class="title">Primary outcomes</h6> <p>One of the 32 studies examined pelvic pain (<a href="./references#CD001298-bbs2-0001" title="BrownCB , LucianoAA , MartinD , PeersE , ScrimgeourA , diZeregaGS . Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomised, controlled study. Fertility and Sterility2007;88(5):1413-26. PeersEM , BrownCB , Adept Adhesion Study Group. American Fertility Society score as a measure of effectiveness of 4% icodextrin in a pivotal adhesion reduction trial in the USA. Fertility and Sterility2005;84(Suppl 1):S160. ">Brown 2007</a>). </p> <p>Three of the 32 studies examined live birth rate (<a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a>; <a href="./references#CD001298-bbs2-0014" title="LarssonB , LalosO , MarskL , Tronstad S-E, BygdemanM , PehrsonS , JoelssonI . Effect of intraperitoneal instillation of 32% dextran 70 on postoperative adhesion formation after tubal surgery. Acta Obstetricia et Gynecologia Scandinavica1985;64:437-41. ">Larsson 1985</a>; <a href="./references#CD001298-bbs2-0023" title="RockJA , SieglerAM , Boer MieselM , HaneyAF , RosenwaksZ , Pardo-VargasF , et al. The efficacy of postoperative hydrotubation: a randomized prospective multicenter clinical trial. Fertility and Sterility1984;42:373-6. ">Rock 1984</a>). </p> </section> <section id="CD001298-sec-0048"> <h6 class="title">Secondary outcomes</h6> <p>Of the 32 studies, 13 examined the incidence of adhesions at SLL (<a href="./references#CD001298-bbs2-0002" title="ButtramV , MalinakR , ClearyR , CohenS , CowanB , DaniellJ , et al, Adhesion Study Group. Reduction of postoperative pelvic adhesions with intraperitoneal 32% dextran 70: a prospective, randomized clinical trial. Fertility and Sterility1983;40:612-9. ">Buttram 1983</a>; <a href="./references#CD001298-bbs2-0005" title="DiamondMP . Reduction of de novo postsurgical adhesions by intraoperative pre coating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo-controlled multicenter study. The Sepracoat Adhesion Study Group. Fertility and Sterility1998;69(6):1067-74. ">Diamond 1998</a>; <a href="./references#CD001298-bbs2-0007" title="diZeregaGS , VercoSJ , YoungP , KettelM , KobakW , MartinD , et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Human Reproduction2002;17(4):1031-8. ">diZerega 2002</a>; <a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a>; <a href="./references#CD001298-bbs2-0013" title="JohnsBD , KeyportGM , HoehlerF , diZeregaG . Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery. Fertility and Sterility2001;76(3):595-604. ">Johns 2001</a>; <a href="./references#CD001298-bbs2-0015" title="LiuC , LuQ , ZhangZ , XueM , ZhangY , ZhangY , et al. A randomized controlled trial on the efficacy and safety of a new crosslinked hyaluronan gel in reducing adhesions after gynecologic laparoscopic surgeries. The Journal of Minimally Invasive Gynaecology2015;22(5):853-63. LiuC , ZhangZ , LuQ , ZhangZ . The efficacy and safety of a new cross-linked hyaluronan hydrogel in the reduction of postsurgical adhesions after laparoscopic gynecological surgery: a randomized controlled trial. The Journal of Minimally Invasive Gynaecology2014;21:S59-60. ">Liu 2015</a>; <a href="./references#CD001298-bbs2-0016" title="LundorffP , GeldorpH , TronstadSE , LalosO , LarssonB , JohnsDB , et al. Reduction of postsurgical adhesions with ferric hyaluronate gel: a European study. Human Reproduction2001;16(9):1982-8. ">Lundorff 2001</a>; <a href="./references#CD001298-bbs2-0018" title="MaisV , BraccoGI , LittaP , Gargiulo, MelisGB . Reduction of postoperative adhesions with an auto-crosslinked hyaluronan gel in gynaecological laparoscopic surgery: a blinded, controlled, randomised, multicentre study. Human Reproduction2006;21(5):1248-54. ">Mais 2006</a>; <a href="./references#CD001298-bbs2-0019" title="MettlerL , AudebertA , Lehmann-WillenbrockE , SchiveK , JacobsVR . Prospective clinical trial of SprayGel as a barrier to adhesion formation: an interim analysis. Journal of American Association of Gynecologic Laparoscopists2003;10(3):339-44. MettlerL , AudebertA , Lehmann-WillenbrockE , Schive-PeterhansiK , JacobsV . A randomized prospective, controlled, multicenter clinical trial of a sprayable, site specific adhesion barrier system in patients undergoing myomectomy. Fertility and Sterility2004;82(2):398-404. MettlerL . Pelvic adhesions: laparoscopic approach. Annals of the New York Academy of Sciences2003;997:255-68. ">Mettler 2004</a>; <a href="./references#CD001298-bbs2-0021" title="PellicanoM , BramanteS , CirilloD , PalombaS , BifulcoG , ZulloF , et al. Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective, randomized, controlled study. Fertility and Sterility2003;80(2):441-4. ">Pellicano 2003</a>; <a href="./references#CD001298-bbs2-0027" title="TchartchianG , HackethalA , HerrmannA , BojahrB , WallwienerC , OhlingerR , et al. Evaluation of SprayShieldTM Adhesion Barrier in a single center: randomized controlled study in 15 women undergoing reconstructive surgery after laparoscopic myomectomy. Archives of Gynecology and Obstetrics2014;290(4):697-704. [PMID: 24781718]">Tchartchian 2014</a>; <a href="./references#CD001298-bbs2-0028" title="Ten BroekRPG , Kok-KrantN , VerhoeveHR , vanGoorH , BakkumEA . Efficacy of polyethylene glycol adhesion barrier after gynaecological laparoscopic surgery. Gynecological Surgery2012;9:29-35. ">Ten Broek 2012</a>; <a href="./references#CD001298-bbs2-0029" title="ThorntonMH , JohnsDB , CampeauJD , HoehlerF , DiZeregaGS . Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open label pilot study. Human Reproduction1998;13(6):1480-5. ">Thornton 1998</a>). </p> <p>Of the 32 studies, nine examined the mean adhesion score at SLL per woman (<a href="./references#CD001298-bbs2-0001" title="BrownCB , LucianoAA , MartinD , PeersE , ScrimgeourA , diZeregaGS . Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomised, controlled study. Fertility and Sterility2007;88(5):1413-26. PeersEM , BrownCB , Adept Adhesion Study Group. American Fertility Society score as a measure of effectiveness of 4% icodextrin in a pivotal adhesion reduction trial in the USA. Fertility and Sterility2005;84(Suppl 1):S160. ">Brown 2007</a>; <a href="./references#CD001298-bbs2-0002" title="ButtramV , MalinakR , ClearyR , CohenS , CowanB , DaniellJ , et al, Adhesion Study Group. Reduction of postoperative pelvic adhesions with intraperitoneal 32% dextran 70: a prospective, randomized clinical trial. Fertility and Sterility1983;40:612-9. ">Buttram 1983</a>; <a href="./references#CD001298-bbs2-0014" title="LarssonB , LalosO , MarskL , Tronstad S-E, BygdemanM , PehrsonS , JoelssonI . Effect of intraperitoneal instillation of 32% dextran 70 on postoperative adhesion formation after tubal surgery. Acta Obstetricia et Gynecologia Scandinavica1985;64:437-41. ">Larsson 1985</a>; <a href="./references#CD001298-bbs2-0016" title="LundorffP , GeldorpH , TronstadSE , LalosO , LarssonB , JohnsDB , et al. Reduction of postsurgical adhesions with ferric hyaluronate gel: a European study. Human Reproduction2001;16(9):1982-8. ">Lundorff 2001</a>; <a href="./references#CD001298-bbs2-0018" title="MaisV , BraccoGI , LittaP , Gargiulo, MelisGB . Reduction of postoperative adhesions with an auto-crosslinked hyaluronan gel in gynaecological laparoscopic surgery: a blinded, controlled, randomised, multicentre study. Human Reproduction2006;21(5):1248-54. ">Mais 2006</a>; <a href="./references#CD001298-bbs2-0028" title="Ten BroekRPG , Kok-KrantN , VerhoeveHR , vanGoorH , BakkumEA . Efficacy of polyethylene glycol adhesion barrier after gynaecological laparoscopic surgery. Gynecological Surgery2012;9:29-35. ">Ten Broek 2012</a>; <a href="./references#CD001298-bbs2-0029" title="ThorntonMH , JohnsDB , CampeauJD , HoehlerF , DiZeregaGS . Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open label pilot study. Human Reproduction1998;13(6):1480-5. ">Thornton 1998</a>; <a href="./references#CD001298-bbs2-0030" title="TrewG , PistofidisG , PadosG , LowerA , MettlerL , WallweinerD , et al. Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomised study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery. Human Reproduction2011;26(8):2015-27. ">Trew 2011</a>; <a href="./references#CD001298-bbs2-0031" title="TrewG , PistofidisG , ZieglerN , KorrellM , BruckerS , RitterH , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray applied laparoscopically to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynecology2014;21:S90. TrewGH , PistofidisGA , BruckerSY , KrämerB , ZieglerNM , KorellM , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded multicenter study of ActamaxTM Adhesion Barrier. Archives of Gynecology and Obstetrics2017;295(2):383-95. TrewGH , PistofidisGA , BruckerSY , KraemerB , ZieglerNM , KorellM , et al. Twelve month follow-up of a first-In-human (FIH), randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray (Actamax Adhesion Barrier) applied to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynaecology2016;23:S203. ">Trew 2017</a>). </p> <p>Of the 32 studies, six examined the clinical pregnancy rate. All of the women in these studies were actively seeking pregnancy during the study time period (<a href="./references#CD001298-bbs2-0002" title="ButtramV , MalinakR , ClearyR , CohenS , CowanB , DaniellJ , et al, Adhesion Study Group. Reduction of postoperative pelvic adhesions with intraperitoneal 32% dextran 70: a prospective, randomized clinical trial. Fertility and Sterility1983;40:612-9. ">Buttram 1983</a>; <a href="./references#CD001298-bbs2-0003" title="CheongY , BaileyS , ForbesJ . Randomized Controlled Trial of Hyalobarrier Versus No Hyalobarrier on the Ovulatory Status of Women with Periovarian Adhesions: A Pilot Study. Advances in Therapy2017;34(1):199-206. [PMID: 27900662]">Cheong 2017</a>; <a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a>; <a href="./references#CD001298-bbs2-0014" title="LarssonB , LalosO , MarskL , Tronstad S-E, BygdemanM , PehrsonS , JoelssonI . Effect of intraperitoneal instillation of 32% dextran 70 on postoperative adhesion formation after tubal surgery. Acta Obstetricia et Gynecologia Scandinavica1985;64:437-41. ">Larsson 1985</a>; <a href="./references#CD001298-bbs2-0022" title="QuerleuD , Vankeerberghen-DeffenseF , BoutevilleC . The effect of noxytioline and systemic corticosteroids in infertility surgery. A prospective randomized study [Traitement adjuvant des plasties tubaires. Etude prospective randomisee des corticoides par voie generale et de la noxytioline]. Journal de Gynecologie Obstetrique et Biologie de la Reproduction1989;18(7):935-40. ">Querleu 1989</a>; <a href="./references#CD001298-bbs2-0023" title="RockJA , SieglerAM , Boer MieselM , HaneyAF , RosenwaksZ , Pardo-VargasF , et al. The efficacy of postoperative hydrotubation: a randomized prospective multicenter clinical trial. Fertility and Sterility1984;42:373-6. ">Rock 1984</a>). </p> <p>Of the 32 studies, 12 examined improvement in adhesion score at SLL (<a href="./references#CD001298-bbs2-0001" title="BrownCB , LucianoAA , MartinD , PeersE , ScrimgeourA , diZeregaGS . Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomised, controlled study. Fertility and Sterility2007;88(5):1413-26. PeersEM , BrownCB , Adept Adhesion Study Group. American Fertility Society score as a measure of effectiveness of 4% icodextrin in a pivotal adhesion reduction trial in the USA. Fertility and Sterility2005;84(Suppl 1):S160. ">Brown 2007</a>; <a href="./references#CD001298-bbs2-0002" title="ButtramV , MalinakR , ClearyR , CohenS , CowanB , DaniellJ , et al, Adhesion Study Group. Reduction of postoperative pelvic adhesions with intraperitoneal 32% dextran 70: a prospective, randomized clinical trial. Fertility and Sterility1983;40:612-9. ">Buttram 1983</a>; <a href="./references#CD001298-bbs2-0007" title="diZeregaGS , VercoSJ , YoungP , KettelM , KobakW , MartinD , et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Human Reproduction2002;17(4):1031-8. ">diZerega 2002</a>; <a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a>; <a href="./references#CD001298-bbs2-0011" title="JansenRPS . Failure of peritoneal irrigation with heparin during pelvic operations upon young women to reduce adhesions. Surgery, Gynecology &amp; Obstetrics1988;166:154-60. ">Jansen 1988</a>; <a href="./references#CD001298-bbs2-0012" title="JansenRPS . Controlled clinical approaches to investigating the prevention of peritoneal adhesions. In: Treatment of Postsurgical Adhesions. Vol. 358. New York: Wiley-Liss Inc, 1990:177-92. ">Jansen 1990</a>; <a href="./references#CD001298-bbs2-0013" title="JohnsBD , KeyportGM , HoehlerF , diZeregaG . Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery. Fertility and Sterility2001;76(3):595-604. ">Johns 2001</a>; <a href="./references#CD001298-bbs2-0014" title="LarssonB , LalosO , MarskL , Tronstad S-E, BygdemanM , PehrsonS , JoelssonI . Effect of intraperitoneal instillation of 32% dextran 70 on postoperative adhesion formation after tubal surgery. Acta Obstetricia et Gynecologia Scandinavica1985;64:437-41. ">Larsson 1985</a>; <a href="./references#CD001298-bbs2-0016" title="LundorffP , GeldorpH , TronstadSE , LalosO , LarssonB , JohnsDB , et al. Reduction of postsurgical adhesions with ferric hyaluronate gel: a European study. Human Reproduction2001;16(9):1982-8. ">Lundorff 2001</a>; <a href="./references#CD001298-bbs2-0019" title="MettlerL , AudebertA , Lehmann-WillenbrockE , SchiveK , JacobsVR . Prospective clinical trial of SprayGel as a barrier to adhesion formation: an interim analysis. Journal of American Association of Gynecologic Laparoscopists2003;10(3):339-44. MettlerL , AudebertA , Lehmann-WillenbrockE , Schive-PeterhansiK , JacobsV . A randomized prospective, controlled, multicenter clinical trial of a sprayable, site specific adhesion barrier system in patients undergoing myomectomy. Fertility and Sterility2004;82(2):398-404. MettlerL . Pelvic adhesions: laparoscopic approach. Annals of the New York Academy of Sciences2003;997:255-68. ">Mettler 2004</a>; <a href="./references#CD001298-bbs2-0031" title="TrewG , PistofidisG , ZieglerN , KorrellM , BruckerS , RitterH , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray applied laparoscopically to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynecology2014;21:S90. TrewGH , PistofidisGA , BruckerSY , KrämerB , ZieglerNM , KorellM , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded multicenter study of ActamaxTM Adhesion Barrier. Archives of Gynecology and Obstetrics2017;295(2):383-95. TrewGH , PistofidisGA , BruckerSY , KraemerB , ZieglerNM , KorellM , et al. Twelve month follow-up of a first-In-human (FIH), randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray (Actamax Adhesion Barrier) applied to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynaecology2016;23:S203. ">Trew 2017</a>; <a href="./references#CD001298-bbs2-0032" title="YoungP , JohnsA , TemplemanC , WitzC , WebsterB , FerlandR , et al. Reduction of postoperative adhesions for laparoscopic gynaecological surgery with Oxiplex/AP gel: a pilot study. Fertility and Sterility2005;84(5):1450-6. ">Young 2005</a>). </p> <p>Of the 32 studies, nine examined the number of women with a worse adhesion score at SLL (<a href="./references#CD001298-bbs2-0007" title="diZeregaGS , VercoSJ , YoungP , KettelM , KobakW , MartinD , et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Human Reproduction2002;17(4):1031-8. ">diZerega 2002</a>; <a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a>; <a href="./references#CD001298-bbs2-0011" title="JansenRPS . Failure of peritoneal irrigation with heparin during pelvic operations upon young women to reduce adhesions. Surgery, Gynecology &amp; Obstetrics1988;166:154-60. ">Jansen 1988</a>; <a href="./references#CD001298-bbs2-0012" title="JansenRPS . Controlled clinical approaches to investigating the prevention of peritoneal adhesions. In: Treatment of Postsurgical Adhesions. Vol. 358. New York: Wiley-Liss Inc, 1990:177-92. ">Jansen 1990</a>; <a href="./references#CD001298-bbs2-0013" title="JohnsBD , KeyportGM , HoehlerF , diZeregaG . Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery. Fertility and Sterility2001;76(3):595-604. ">Johns 2001</a>; <a href="./references#CD001298-bbs2-0016" title="LundorffP , GeldorpH , TronstadSE , LalosO , LarssonB , JohnsDB , et al. Reduction of postsurgical adhesions with ferric hyaluronate gel: a European study. Human Reproduction2001;16(9):1982-8. ">Lundorff 2001</a>; <a href="./references#CD001298-bbs2-0019" title="MettlerL , AudebertA , Lehmann-WillenbrockE , SchiveK , JacobsVR . Prospective clinical trial of SprayGel as a barrier to adhesion formation: an interim analysis. Journal of American Association of Gynecologic Laparoscopists2003;10(3):339-44. MettlerL , AudebertA , Lehmann-WillenbrockE , Schive-PeterhansiK , JacobsV . A randomized prospective, controlled, multicenter clinical trial of a sprayable, site specific adhesion barrier system in patients undergoing myomectomy. Fertility and Sterility2004;82(2):398-404. MettlerL . Pelvic adhesions: laparoscopic approach. Annals of the New York Academy of Sciences2003;997:255-68. ">Mettler 2004</a>; <a href="./references#CD001298-bbs2-0022" title="QuerleuD , Vankeerberghen-DeffenseF , BoutevilleC . The effect of noxytioline and systemic corticosteroids in infertility surgery. A prospective randomized study [Traitement adjuvant des plasties tubaires. Etude prospective randomisee des corticoides par voie generale et de la noxytioline]. Journal de Gynecologie Obstetrique et Biologie de la Reproduction1989;18(7):935-40. ">Querleu 1989</a>; <a href="./references#CD001298-bbs2-0032" title="YoungP , JohnsA , TemplemanC , WitzC , WebsterB , FerlandR , et al. Reduction of postoperative adhesions for laparoscopic gynaecological surgery with Oxiplex/AP gel: a pilot study. Fertility and Sterility2005;84(5):1450-6. ">Young 2005</a>). </p> <p>None of the 32 studies examined the miscarriage rate.</p> <p>Of the 32 studies, four examined the ectopic pregnancy rate (<a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a>; <a href="./references#CD001298-bbs2-0014" title="LarssonB , LalosO , MarskL , Tronstad S-E, BygdemanM , PehrsonS , JoelssonI . Effect of intraperitoneal instillation of 32% dextran 70 on postoperative adhesion formation after tubal surgery. Acta Obstetricia et Gynecologia Scandinavica1985;64:437-41. ">Larsson 1985</a>; <a href="./references#CD001298-bbs2-0022" title="QuerleuD , Vankeerberghen-DeffenseF , BoutevilleC . The effect of noxytioline and systemic corticosteroids in infertility surgery. A prospective randomized study [Traitement adjuvant des plasties tubaires. Etude prospective randomisee des corticoides par voie generale et de la noxytioline]. Journal de Gynecologie Obstetrique et Biologie de la Reproduction1989;18(7):935-40. ">Querleu 1989</a>; <a href="./references#CD001298-bbs2-0023" title="RockJA , SieglerAM , Boer MieselM , HaneyAF , RosenwaksZ , Pardo-VargasF , et al. The efficacy of postoperative hydrotubation: a randomized prospective multicenter clinical trial. Fertility and Sterility1984;42:373-6. ">Rock 1984</a>). </p> <p>None of the 32 studies examined quality of life (QoL).</p> <p>Of the 32 studies, 30 examined adverse outcomes. <a href="./references#CD001298-bbs2-0003" title="CheongY , BaileyS , ForbesJ . Randomized Controlled Trial of Hyalobarrier Versus No Hyalobarrier on the Ovulatory Status of Women with Periovarian Adhesions: A Pilot Study. Advances in Therapy2017;34(1):199-206. [PMID: 27900662]">Cheong 2017</a> and <a href="./references#CD001298-bbs2-0025" title="RosenbergSM , BoardJA . High-molecular weight dextran in human infertility surgery. American Journal of Obstetrics and Gynecology1984;148:380-5. ">Rosenberg 1984</a> were the only studies that did not examine adverse outcomes. </p> </section> </section> </section> <section id="CD001298-sec-0049"> <h4 class="title">Excluded studies</h4> <p>We excluded 10 studies. <a href="./references#CD001298-bbs2-0033" title="Abu-ElhasanAM , AbdellahMS , HamedHO . Safety and efficacy of postoperative continuous intra-peritoneal wash with lactated Ringer's for minimizing post-myomectomy pelvic adhesions: a pilot clinical trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2014 Dec;183:78-82. ">Abu‐Elhasan 2014</a> used the same fluid agent for both the control and intervention group. <a href="./references#CD001298-bbs2-0037" title="JohnsDA , FerlandR , DunnR . Initial feasibility study of a sprayable hydrogel adhesion barrier system in patients undergoing laparoscopic ovarian surgery. Journal of the American Association of Gynecologic Laparoscopists2003;10(3):334-8. ">Johns 2003</a> used an internal control. <a href="./references#CD001298-bbs2-0034" title="DiamondMP , KorellM , MartinezS , KurmanE , KamarM , Adhexil Adhesion Study Group. A prospective, controlled, randomized, multicenter, exploratory pilot study evaluating the safety and potential trends in efficacy of Adhexil. Fertility and Sterility2011;95:1086-90. ">Diamond 2011</a> and <a href="./references#CD001298-bbs2-0042" title="TulandiT . Effects of fibrin sealant on tubal anastomosis and adhesion formation. Fertility and Sterility1991;56:136-8. ">Tulandi 1991</a> used internal controls, which was not explicitly stated in the abstract. One trial was not randomised (<a href="./references#CD001298-bbs2-0040" title="TsujiS , TakahashiK , YomoH , FujiwaraM , KitaN , TakebayashiK , et al. Effectiveness of antiadhesion barriers in preventing adhesion after myomectomy in patients with uterine leiomyoma. European Journal of Obstetrics and Gynecology2005;123:244-8. ">Tsuji 2005</a>). One study did not state that it was randomised (<a href="./references#CD001298-bbs2-0038" title="PellicanoM , GuidaM , BramanteS , AcunzoG , Di Spiezio SardoA , TommaselliG , et al. Reproductive outcome after autocrosslinked hyaluronic acid gel application in infertile patients who underwent laparoscopic myomectomy. Fertility and Sterility2005;83:498-500. ">Pellicano 2005</a>), although it appeared to include the same study group as was used in <a href="./references#CD001298-bbs2-0021" title="PellicanoM , BramanteS , CirilloD , PalombaS , BifulcoG , ZulloF , et al. Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective, randomized, controlled study. Fertility and Sterility2003;80(2):441-4. ">Pellicano 2003</a>. This was not explicitly stated in the methods, nor was the fact that the study was randomised, thus we excluded <a href="./references#CD001298-bbs2-0038" title="PellicanoM , GuidaM , BramanteS , AcunzoG , Di Spiezio SardoA , TommaselliG , et al. Reproductive outcome after autocrosslinked hyaluronic acid gel application in infertile patients who underwent laparoscopic myomectomy. Fertility and Sterility2005;83:498-500. ">Pellicano 2005</a>. One study was quasi‐randomised (<a href="./references#CD001298-bbs2-0039" title="SwolinK . The effect of a massive Intraperitoneal dose of a glucocorticoid on the formation of postoperative adhesions. Clinical studies using laparoscopy in patients operated on for extrauterine pregnancy [Die einwirkung von grossen intraperitonealen dosen glukokortikoid auf die bildung von postoperativen adhasionen]. Acta Obstetricia et Gynaecologica Scandinavica1967;46(2):204-10. ">Swolin 1967</a>). One study assessed adhesions at caesarean section, so did not meet our review's inclusion criteria (<a href="./references#CD001298-bbs2-0036" title="ImaiA , SugiyamaT , FuruiA , TakahashiS , TamayaT . Gonadotrophin-releasing hormones agonist therapy increases peritoneal fibrinolytic activity and prevents adhesion formation after myomectomy. Journal of Obstetrics and Gynaecology2003;23(6):660-3. ">Imai 2003</a>). <a href="./references#CD001298-bbs2-0041" title="TulandiT . Effect of intraperitoneal 32% dextran 70 on blood coagulation and serum electrolytes. Journal of Reproductive Medicine1985;30:431-4. ">Tulandi 1985</a> was included in the original review, however it has been excluded as it does not report fertility or adhesion outcomes. </p> <p><a href="./references#CD001298-bbs2-0035" title="DiZeregaGS , CoadJ , DonnezJ . Clinical evaluation of endometriosis and differential response to surgical therapy with and without application of Oxiplex/AP* adhesion barrier gel. Fertility and Sterility2007;87:485-9. ">DiZerega 2007</a> was included in the previous update of the review (<a href="./references#CD001298-bbs2-0067" title="AhmadG , MackieFL , IlesDA , O'FlynnH , DiasS , MetwallyM , et al. Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database of Systematic Reviews2014, Issue 7. Art. No: CD001298. [DOI: 10.1002/14651858.CD001298.pub4]">Ahmad 2014</a>) however at this update it was noted that this study reported composite data from two previous studies already included in the review (<a href="./references#CD001298-bbs2-0017" title="LundorffP , DonnezJ , KorellM , AudebertAJM , BlockK , diZeregaGS . Clinical evaluation of a viscoelastic gel for reduction of adhesions following gynaecological surgery by laparoscopy in Europe. Human Reproduction2004;20(2):514-20. ">Lundorff 2005</a> and <a href="./references#CD001298-bbs2-0032" title="YoungP , JohnsA , TemplemanC , WitzC , WebsterB , FerlandR , et al. Reduction of postoperative adhesions for laparoscopic gynaecological surgery with Oxiplex/AP gel: a pilot study. Fertility and Sterility2005;84(5):1450-6. ">Young 2005</a>). <a href="./references#CD001298-bbs2-0035" title="DiZeregaGS , CoadJ , DonnezJ . Clinical evaluation of endometriosis and differential response to surgical therapy with and without application of Oxiplex/AP* adhesion barrier gel. Fertility and Sterility2007;87:485-9. ">DiZerega 2007</a> did not recruit any new participants, therefore it could not be considered at true RCT and as it presented composite data its results could not be wholly attributed to either <a href="./references#CD001298-bbs2-0017" title="LundorffP , DonnezJ , KorellM , AudebertAJM , BlockK , diZeregaGS . Clinical evaluation of a viscoelastic gel for reduction of adhesions following gynaecological surgery by laparoscopy in Europe. Human Reproduction2004;20(2):514-20. ">Lundorff 2005</a> or <a href="./references#CD001298-bbs2-0032" title="YoungP , JohnsA , TemplemanC , WitzC , WebsterB , FerlandR , et al. Reduction of postoperative adhesions for laparoscopic gynaecological surgery with Oxiplex/AP gel: a pilot study. Fertility and Sterility2005;84(5):1450-6. ">Young 2005</a>. As <a href="./references#CD001298-bbs2-0035" title="DiZeregaGS , CoadJ , DonnezJ . Clinical evaluation of endometriosis and differential response to surgical therapy with and without application of Oxiplex/AP* adhesion barrier gel. Fertility and Sterility2007;87:485-9. ">DiZerega 2007</a> reported results per adnexa rather than per participant, data it presented were not incorporated in any statistical analysis, meaning its exclusion does not affect our conclusions. </p> </section> <section id="CD001298-sec-0050"> <h4 class="title">Studies awaiting classification</h4> <p>Three studies are awaiting classification, pending publication of sufficient data to allow their inclusion (<a href="./references#CD001298-bbs2-0043" title="HudecekR , IvanovaZ , SmerdovaM , PankovaS , KrajcovicovaR . Effect of GnRH analogues pre-treatment on myomectomy outcomes in reproductive age women. Ceska Gynekologie / Ceska Lekarska Spolecnost J. Ev. Purkyne2009;77(2):109-17. ">Hudecek 2012</a>; <a href="./references#CD001298-bbs2-0044" title="LittaP , PluchinoN , FreschiL , BorgatoS , AngioniS . Evaluation of adhesions after laparoscopic myomectomy using the Harmonic Ace and the auto-crosslinked hyaluronan gel vs Ringer's lactate solution. Clinical and Experimental Obstetrics and Gynecology2013;2:210-4. ">Litta 2013</a>; <a href="./references#CD001298-bbs2-0045" title="RobertsonLM , RislundDC , Lim, HJ, PiersonRA , TulandiT , GargiuloAR , et al. A novel therapeutic approach to prevent adhesion: a double blind randomized study (DBRCT) of intraperitoneal L-Alanyl-L-Glutamine (A-G or EvitarTM) for the prevention of adhesion in laparoscopic myomectomies. The Journal of Minimally Invasive Gynaecology2018;25(7):S158. ">Robertson 2018</a>). </p> </section> </section> <section id="CD001298-sec-0051"> <h3 class="title">Risk of bias in included studies</h3> <p>The risk of bias for each included study can be seen in the <a href="./references#CD001298-sec-0190" title="">Characteristics of included studies</a> section. <a href="#CD001298-fig-0002">Figure 2</a> presents a summary of risk of bias of all included studies. <a href="#CD001298-fig-0003">Figure 3</a> depicts the proportions of studies within each judgement for each 'Risk of bias' element. </p> <div class="figure" id="CD001298-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study" data-id="CD001298-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study </p> </div> </div> </div> <div class="figure" id="CD001298-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item, presented as percentages across all included studies" data-id="CD001298-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item, presented as percentages across all included studies </p> </div> </div> </div> <section id="CD001298-sec-0052"> <h4 class="title">Allocation</h4> <section id="CD001298-sec-0053"> <h5 class="title">Sequence generation</h5> <p>We did not assess any studies at high risk of sequence generation bias.</p> <p>Twenty studies adequately explained an appropriate method of sequence generation; thus, we deemed them at low risk (<a href="./references#CD001298-bbs2-0001" title="BrownCB , LucianoAA , MartinD , PeersE , ScrimgeourA , diZeregaGS . Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomised, controlled study. Fertility and Sterility2007;88(5):1413-26. PeersEM , BrownCB , Adept Adhesion Study Group. American Fertility Society score as a measure of effectiveness of 4% icodextrin in a pivotal adhesion reduction trial in the USA. Fertility and Sterility2005;84(Suppl 1):S160. ">Brown 2007</a>; <a href="./references#CD001298-bbs2-0003" title="CheongY , BaileyS , ForbesJ . Randomized Controlled Trial of Hyalobarrier Versus No Hyalobarrier on the Ovulatory Status of Women with Periovarian Adhesions: A Pilot Study. Advances in Therapy2017;34(1):199-206. [PMID: 27900662]">Cheong 2017</a>; <a href="./references#CD001298-bbs2-0005" title="DiamondMP . Reduction of de novo postsurgical adhesions by intraoperative pre coating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo-controlled multicenter study. The Sepracoat Adhesion Study Group. Fertility and Sterility1998;69(6):1067-74. ">Diamond 1998</a>; <a href="./references#CD001298-bbs2-0007" title="diZeregaGS , VercoSJ , YoungP , KettelM , KobakW , MartinD , et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Human Reproduction2002;17(4):1031-8. ">diZerega 2002</a>; <a href="./references#CD001298-bbs2-0009" title="HellebrekersBWJ , Trimbos-KemperTCM , BoestenL , JansenFW , KolkmanW , TrimbosJB , et al. Preoperative predictors of postsurgical adhesion formation and the prevention of adhesions with plasminogen activator (PAPA-study): results of a clinical pilot study. Fertility and Sterility2009;91(4):1204-14. ">Hellebrekers 2009</a>; <a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a>; <a href="./references#CD001298-bbs2-0011" title="JansenRPS . Failure of peritoneal irrigation with heparin during pelvic operations upon young women to reduce adhesions. Surgery, Gynecology &amp; Obstetrics1988;166:154-60. ">Jansen 1988</a>; <a href="./references#CD001298-bbs2-0013" title="JohnsBD , KeyportGM , HoehlerF , diZeregaG . Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery. Fertility and Sterility2001;76(3):595-604. ">Johns 2001</a>; <a href="./references#CD001298-bbs2-0014" title="LarssonB , LalosO , MarskL , Tronstad S-E, BygdemanM , PehrsonS , JoelssonI . Effect of intraperitoneal instillation of 32% dextran 70 on postoperative adhesion formation after tubal surgery. Acta Obstetricia et Gynecologia Scandinavica1985;64:437-41. ">Larsson 1985</a>; <a href="./references#CD001298-bbs2-0015" title="LiuC , LuQ , ZhangZ , XueM , ZhangY , ZhangY , et al. A randomized controlled trial on the efficacy and safety of a new crosslinked hyaluronan gel in reducing adhesions after gynecologic laparoscopic surgeries. The Journal of Minimally Invasive Gynaecology2015;22(5):853-63. LiuC , ZhangZ , LuQ , ZhangZ . The efficacy and safety of a new cross-linked hyaluronan hydrogel in the reduction of postsurgical adhesions after laparoscopic gynecological surgery: a randomized controlled trial. The Journal of Minimally Invasive Gynaecology2014;21:S59-60. ">Liu 2015</a>; <a href="./references#CD001298-bbs2-0016" title="LundorffP , GeldorpH , TronstadSE , LalosO , LarssonB , JohnsDB , et al. Reduction of postsurgical adhesions with ferric hyaluronate gel: a European study. Human Reproduction2001;16(9):1982-8. ">Lundorff 2001</a>; <a href="./references#CD001298-bbs2-0017" title="LundorffP , DonnezJ , KorellM , AudebertAJM , BlockK , diZeregaGS . Clinical evaluation of a viscoelastic gel for reduction of adhesions following gynaecological surgery by laparoscopy in Europe. Human Reproduction2004;20(2):514-20. ">Lundorff 2005</a>; <a href="./references#CD001298-bbs2-0018" title="MaisV , BraccoGI , LittaP , Gargiulo, MelisGB . Reduction of postoperative adhesions with an auto-crosslinked hyaluronan gel in gynaecological laparoscopic surgery: a blinded, controlled, randomised, multicentre study. Human Reproduction2006;21(5):1248-54. ">Mais 2006</a>; <a href="./references#CD001298-bbs2-0019" title="MettlerL , AudebertA , Lehmann-WillenbrockE , SchiveK , JacobsVR . Prospective clinical trial of SprayGel as a barrier to adhesion formation: an interim analysis. Journal of American Association of Gynecologic Laparoscopists2003;10(3):339-44. MettlerL , AudebertA , Lehmann-WillenbrockE , Schive-PeterhansiK , JacobsV . A randomized prospective, controlled, multicenter clinical trial of a sprayable, site specific adhesion barrier system in patients undergoing myomectomy. Fertility and Sterility2004;82(2):398-404. MettlerL . Pelvic adhesions: laparoscopic approach. Annals of the New York Academy of Sciences2003;997:255-68. ">Mettler 2004</a>; <a href="./references#CD001298-bbs2-0020" title="MettlerL , HuckeJ , BojahrB , TinnebergHR , LeylandN , AvelarR . A safety and efficacy study of a resorbable hydrogel for reduction of post-operative adhesions following myomectomy. Human Reproduction2008;23(5):1093-100. ">Mettler 2008</a>; <a href="./references#CD001298-bbs2-0021" title="PellicanoM , BramanteS , CirilloD , PalombaS , BifulcoG , ZulloF , et al. Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective, randomized, controlled study. Fertility and Sterility2003;80(2):441-4. ">Pellicano 2003</a>; <a href="./references#CD001298-bbs2-0023" title="RockJA , SieglerAM , Boer MieselM , HaneyAF , RosenwaksZ , Pardo-VargasF , et al. The efficacy of postoperative hydrotubation: a randomized prospective multicenter clinical trial. Fertility and Sterility1984;42:373-6. ">Rock 1984</a>; <a href="./references#CD001298-bbs2-0024" title="RoseB , MacNeillC , LarrainR , KopreskiM . Abdominal instillation of high-molecular-weight dextran or lactated Ringer's solution after laparoscopic surgery. Journal of Reproductive Medicine1991;36:537-9. ">Rose 1991</a>; <a href="./references#CD001298-bbs2-0026" title="SitesCK , JensenBA , GlockJL , BlackmanJA , BadgerGJ , JohJV , et al. Transvaginal ultrasonographic assessment of Hyskon and lactated Ringer's solution instillation after laparoscopy. A randomized, controlled trial. Journal of Ultrasound Medicine1997;16(3):195-9. [MEDLINE: 9166816]">Sites 1997</a>; <a href="./references#CD001298-bbs2-0027" title="TchartchianG , HackethalA , HerrmannA , BojahrB , WallwienerC , OhlingerR , et al. Evaluation of SprayShieldTM Adhesion Barrier in a single center: randomized controlled study in 15 women undergoing reconstructive surgery after laparoscopic myomectomy. Archives of Gynecology and Obstetrics2014;290(4):697-704. [PMID: 24781718]">Tchartchian 2014</a>). </p> <p>Twelve studies described the methods of random sequence generation inadequately; we deemed them at unclear risk (<a href="./references#CD001298-bbs2-0002" title="ButtramV , MalinakR , ClearyR , CohenS , CowanB , DaniellJ , et al, Adhesion Study Group. Reduction of postoperative pelvic adhesions with intraperitoneal 32% dextran 70: a prospective, randomized clinical trial. Fertility and Sterility1983;40:612-9. ">Buttram 1983</a>; <a href="./references#CD001298-bbs2-0004" title="CoddingtonC , GrowD , AhmedM , TonerJ , CookE , DiamondM . Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial. Fertility and Sterility2009;91:1909-13. ">Coddington 2009</a>; <a href="./references#CD001298-bbs2-0006" title="DiamonMP , LucianoA , JohnsA , DunnR , YoungP , Bieber E. Reduction of postoperative adhesions by N, O-carboxymethylchitosan: a pilot study. Fertility and Sterility2003;80(3):631-6. ">Diamond 2003</a>; <a href="./references#CD001298-bbs2-0008" title="FossumGT , SilverbergKM , MillerCE , DiamondMP , HolmdahlL . Gynecologic use of SepraSpray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy: a pilot study. Fertility and Sterility2011;96(2):487-91. ">Fossum 2011</a>; <a href="./references#CD001298-bbs2-0012" title="JansenRPS . Controlled clinical approaches to investigating the prevention of peritoneal adhesions. In: Treatment of Postsurgical Adhesions. Vol. 358. New York: Wiley-Liss Inc, 1990:177-92. ">Jansen 1990</a>; <a href="./references#CD001298-bbs2-0022" title="QuerleuD , Vankeerberghen-DeffenseF , BoutevilleC . The effect of noxytioline and systemic corticosteroids in infertility surgery. A prospective randomized study [Traitement adjuvant des plasties tubaires. Etude prospective randomisee des corticoides par voie generale et de la noxytioline]. Journal de Gynecologie Obstetrique et Biologie de la Reproduction1989;18(7):935-40. ">Querleu 1989</a>; <a href="./references#CD001298-bbs2-0025" title="RosenbergSM , BoardJA . High-molecular weight dextran in human infertility surgery. American Journal of Obstetrics and Gynecology1984;148:380-5. ">Rosenberg 1984</a>; <a href="./references#CD001298-bbs2-0028" title="Ten BroekRPG , Kok-KrantN , VerhoeveHR , vanGoorH , BakkumEA . Efficacy of polyethylene glycol adhesion barrier after gynaecological laparoscopic surgery. Gynecological Surgery2012;9:29-35. ">Ten Broek 2012</a>; <a href="./references#CD001298-bbs2-0029" title="ThorntonMH , JohnsDB , CampeauJD , HoehlerF , DiZeregaGS . Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open label pilot study. Human Reproduction1998;13(6):1480-5. ">Thornton 1998</a>; <a href="./references#CD001298-bbs2-0030" title="TrewG , PistofidisG , PadosG , LowerA , MettlerL , WallweinerD , et al. Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomised study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery. Human Reproduction2011;26(8):2015-27. ">Trew 2011</a>; <a href="./references#CD001298-bbs2-0031" title="TrewG , PistofidisG , ZieglerN , KorrellM , BruckerS , RitterH , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray applied laparoscopically to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynecology2014;21:S90. TrewGH , PistofidisGA , BruckerSY , KrämerB , ZieglerNM , KorellM , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded multicenter study of ActamaxTM Adhesion Barrier. Archives of Gynecology and Obstetrics2017;295(2):383-95. TrewGH , PistofidisGA , BruckerSY , KraemerB , ZieglerNM , KorellM , et al. Twelve month follow-up of a first-In-human (FIH), randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray (Actamax Adhesion Barrier) applied to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynaecology2016;23:S203. ">Trew 2017</a>; <a href="./references#CD001298-bbs2-0032" title="YoungP , JohnsA , TemplemanC , WitzC , WebsterB , FerlandR , et al. Reduction of postoperative adhesions for laparoscopic gynaecological surgery with Oxiplex/AP gel: a pilot study. Fertility and Sterility2005;84(5):1450-6. ">Young 2005</a>). </p> </section> <section id="CD001298-sec-0054"> <h5 class="title">Allocation concealment</h5> <p>We did not assess any studies at high risk of allocation concealment bias.</p> <p>We assessed 15 studies at low risk of allocation concealment bias, as the authors described an acceptable method of allocation concealment (<a href="./references#CD001298-bbs2-0003" title="CheongY , BaileyS , ForbesJ . Randomized Controlled Trial of Hyalobarrier Versus No Hyalobarrier on the Ovulatory Status of Women with Periovarian Adhesions: A Pilot Study. Advances in Therapy2017;34(1):199-206. [PMID: 27900662]">Cheong 2017</a>; <a href="./references#CD001298-bbs2-0005" title="DiamondMP . Reduction of de novo postsurgical adhesions by intraoperative pre coating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo-controlled multicenter study. The Sepracoat Adhesion Study Group. Fertility and Sterility1998;69(6):1067-74. ">Diamond 1998</a>; <a href="./references#CD001298-bbs2-0007" title="diZeregaGS , VercoSJ , YoungP , KettelM , KobakW , MartinD , et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Human Reproduction2002;17(4):1031-8. ">diZerega 2002</a>; <a href="./references#CD001298-bbs2-0013" title="JohnsBD , KeyportGM , HoehlerF , diZeregaG . Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery. Fertility and Sterility2001;76(3):595-604. ">Johns 2001</a>; <a href="./references#CD001298-bbs2-0015" title="LiuC , LuQ , ZhangZ , XueM , ZhangY , ZhangY , et al. A randomized controlled trial on the efficacy and safety of a new crosslinked hyaluronan gel in reducing adhesions after gynecologic laparoscopic surgeries. The Journal of Minimally Invasive Gynaecology2015;22(5):853-63. LiuC , ZhangZ , LuQ , ZhangZ . The efficacy and safety of a new cross-linked hyaluronan hydrogel in the reduction of postsurgical adhesions after laparoscopic gynecological surgery: a randomized controlled trial. The Journal of Minimally Invasive Gynaecology2014;21:S59-60. ">Liu 2015</a>; <a href="./references#CD001298-bbs2-0016" title="LundorffP , GeldorpH , TronstadSE , LalosO , LarssonB , JohnsDB , et al. Reduction of postsurgical adhesions with ferric hyaluronate gel: a European study. Human Reproduction2001;16(9):1982-8. ">Lundorff 2001</a>; <a href="./references#CD001298-bbs2-0018" title="MaisV , BraccoGI , LittaP , Gargiulo, MelisGB . Reduction of postoperative adhesions with an auto-crosslinked hyaluronan gel in gynaecological laparoscopic surgery: a blinded, controlled, randomised, multicentre study. Human Reproduction2006;21(5):1248-54. ">Mais 2006</a>; <a href="./references#CD001298-bbs2-0019" title="MettlerL , AudebertA , Lehmann-WillenbrockE , SchiveK , JacobsVR . Prospective clinical trial of SprayGel as a barrier to adhesion formation: an interim analysis. Journal of American Association of Gynecologic Laparoscopists2003;10(3):339-44. MettlerL , AudebertA , Lehmann-WillenbrockE , Schive-PeterhansiK , JacobsV . A randomized prospective, controlled, multicenter clinical trial of a sprayable, site specific adhesion barrier system in patients undergoing myomectomy. Fertility and Sterility2004;82(2):398-404. MettlerL . Pelvic adhesions: laparoscopic approach. Annals of the New York Academy of Sciences2003;997:255-68. ">Mettler 2004</a>; <a href="./references#CD001298-bbs2-0020" title="MettlerL , HuckeJ , BojahrB , TinnebergHR , LeylandN , AvelarR . A safety and efficacy study of a resorbable hydrogel for reduction of post-operative adhesions following myomectomy. Human Reproduction2008;23(5):1093-100. ">Mettler 2008</a>; <a href="./references#CD001298-bbs2-0025" title="RosenbergSM , BoardJA . High-molecular weight dextran in human infertility surgery. American Journal of Obstetrics and Gynecology1984;148:380-5. ">Rosenberg 1984</a>; <a href="./references#CD001298-bbs2-0027" title="TchartchianG , HackethalA , HerrmannA , BojahrB , WallwienerC , OhlingerR , et al. Evaluation of SprayShieldTM Adhesion Barrier in a single center: randomized controlled study in 15 women undergoing reconstructive surgery after laparoscopic myomectomy. Archives of Gynecology and Obstetrics2014;290(4):697-704. [PMID: 24781718]">Tchartchian 2014</a>; <a href="./references#CD001298-bbs2-0028" title="Ten BroekRPG , Kok-KrantN , VerhoeveHR , vanGoorH , BakkumEA . Efficacy of polyethylene glycol adhesion barrier after gynaecological laparoscopic surgery. Gynecological Surgery2012;9:29-35. ">Ten Broek 2012</a>; <a href="./references#CD001298-bbs2-0030" title="TrewG , PistofidisG , PadosG , LowerA , MettlerL , WallweinerD , et al. Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomised study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery. Human Reproduction2011;26(8):2015-27. ">Trew 2011</a>; <a href="./references#CD001298-bbs2-0031" title="TrewG , PistofidisG , ZieglerN , KorrellM , BruckerS , RitterH , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray applied laparoscopically to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynecology2014;21:S90. TrewGH , PistofidisGA , BruckerSY , KrämerB , ZieglerNM , KorellM , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded multicenter study of ActamaxTM Adhesion Barrier. Archives of Gynecology and Obstetrics2017;295(2):383-95. TrewGH , PistofidisGA , BruckerSY , KraemerB , ZieglerNM , KorellM , et al. Twelve month follow-up of a first-In-human (FIH), randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray (Actamax Adhesion Barrier) applied to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynaecology2016;23:S203. ">Trew 2017</a>; <a href="./references#CD001298-bbs2-0032" title="YoungP , JohnsA , TemplemanC , WitzC , WebsterB , FerlandR , et al. Reduction of postoperative adhesions for laparoscopic gynaecological surgery with Oxiplex/AP gel: a pilot study. Fertility and Sterility2005;84(5):1450-6. ">Young 2005</a>). </p> <p>Seventeen studies did not provide sufficient information on allocation to permit a judgement, so we considered them at unclear risk (<a href="./references#CD001298-bbs2-0001" title="BrownCB , LucianoAA , MartinD , PeersE , ScrimgeourA , diZeregaGS . Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomised, controlled study. Fertility and Sterility2007;88(5):1413-26. PeersEM , BrownCB , Adept Adhesion Study Group. American Fertility Society score as a measure of effectiveness of 4% icodextrin in a pivotal adhesion reduction trial in the USA. Fertility and Sterility2005;84(Suppl 1):S160. ">Brown 2007</a>; <a href="./references#CD001298-bbs2-0002" title="ButtramV , MalinakR , ClearyR , CohenS , CowanB , DaniellJ , et al, Adhesion Study Group. Reduction of postoperative pelvic adhesions with intraperitoneal 32% dextran 70: a prospective, randomized clinical trial. Fertility and Sterility1983;40:612-9. ">Buttram 1983</a>; <a href="./references#CD001298-bbs2-0004" title="CoddingtonC , GrowD , AhmedM , TonerJ , CookE , DiamondM . Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial. Fertility and Sterility2009;91:1909-13. ">Coddington 2009</a>; <a href="./references#CD001298-bbs2-0006" title="DiamonMP , LucianoA , JohnsA , DunnR , YoungP , Bieber E. Reduction of postoperative adhesions by N, O-carboxymethylchitosan: a pilot study. Fertility and Sterility2003;80(3):631-6. ">Diamond 2003</a>; <a href="./references#CD001298-bbs2-0008" title="FossumGT , SilverbergKM , MillerCE , DiamondMP , HolmdahlL . Gynecologic use of SepraSpray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy: a pilot study. Fertility and Sterility2011;96(2):487-91. ">Fossum 2011</a>; <a href="./references#CD001298-bbs2-0009" title="HellebrekersBWJ , Trimbos-KemperTCM , BoestenL , JansenFW , KolkmanW , TrimbosJB , et al. Preoperative predictors of postsurgical adhesion formation and the prevention of adhesions with plasminogen activator (PAPA-study): results of a clinical pilot study. Fertility and Sterility2009;91(4):1204-14. ">Hellebrekers 2009</a>; <a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a>; <a href="./references#CD001298-bbs2-0011" title="JansenRPS . Failure of peritoneal irrigation with heparin during pelvic operations upon young women to reduce adhesions. Surgery, Gynecology &amp; Obstetrics1988;166:154-60. ">Jansen 1988</a>; <a href="./references#CD001298-bbs2-0012" title="JansenRPS . Controlled clinical approaches to investigating the prevention of peritoneal adhesions. In: Treatment of Postsurgical Adhesions. Vol. 358. New York: Wiley-Liss Inc, 1990:177-92. ">Jansen 1990</a>; <a href="./references#CD001298-bbs2-0014" title="LarssonB , LalosO , MarskL , Tronstad S-E, BygdemanM , PehrsonS , JoelssonI . Effect of intraperitoneal instillation of 32% dextran 70 on postoperative adhesion formation after tubal surgery. Acta Obstetricia et Gynecologia Scandinavica1985;64:437-41. ">Larsson 1985</a>; <a href="./references#CD001298-bbs2-0017" title="LundorffP , DonnezJ , KorellM , AudebertAJM , BlockK , diZeregaGS . Clinical evaluation of a viscoelastic gel for reduction of adhesions following gynaecological surgery by laparoscopy in Europe. Human Reproduction2004;20(2):514-20. ">Lundorff 2005</a>; <a href="./references#CD001298-bbs2-0021" title="PellicanoM , BramanteS , CirilloD , PalombaS , BifulcoG , ZulloF , et al. Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective, randomized, controlled study. Fertility and Sterility2003;80(2):441-4. ">Pellicano 2003</a>; <a href="./references#CD001298-bbs2-0022" title="QuerleuD , Vankeerberghen-DeffenseF , BoutevilleC . The effect of noxytioline and systemic corticosteroids in infertility surgery. A prospective randomized study [Traitement adjuvant des plasties tubaires. Etude prospective randomisee des corticoides par voie generale et de la noxytioline]. Journal de Gynecologie Obstetrique et Biologie de la Reproduction1989;18(7):935-40. ">Querleu 1989</a>; <a href="./references#CD001298-bbs2-0023" title="RockJA , SieglerAM , Boer MieselM , HaneyAF , RosenwaksZ , Pardo-VargasF , et al. The efficacy of postoperative hydrotubation: a randomized prospective multicenter clinical trial. Fertility and Sterility1984;42:373-6. ">Rock 1984</a>; <a href="./references#CD001298-bbs2-0024" title="RoseB , MacNeillC , LarrainR , KopreskiM . Abdominal instillation of high-molecular-weight dextran or lactated Ringer's solution after laparoscopic surgery. Journal of Reproductive Medicine1991;36:537-9. ">Rose 1991</a>; <a href="./references#CD001298-bbs2-0026" title="SitesCK , JensenBA , GlockJL , BlackmanJA , BadgerGJ , JohJV , et al. Transvaginal ultrasonographic assessment of Hyskon and lactated Ringer's solution instillation after laparoscopy. A randomized, controlled trial. Journal of Ultrasound Medicine1997;16(3):195-9. [MEDLINE: 9166816]">Sites 1997</a>; <a href="./references#CD001298-bbs2-0029" title="ThorntonMH , JohnsDB , CampeauJD , HoehlerF , DiZeregaGS . Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open label pilot study. Human Reproduction1998;13(6):1480-5. ">Thornton 1998</a>). </p> </section> </section> <section id="CD001298-sec-0055"> <h4 class="title">Blinding</h4> <p>We rated two studies at low risk for performance bias, as both the women and initial surgical team were blinded to the treatment allocation (<a href="./references#CD001298-bbs2-0021" title="PellicanoM , BramanteS , CirilloD , PalombaS , BifulcoG , ZulloF , et al. Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective, randomized, controlled study. Fertility and Sterility2003;80(2):441-4. ">Pellicano 2003</a>; <a href="./references#CD001298-bbs2-0030" title="TrewG , PistofidisG , PadosG , LowerA , MettlerL , WallweinerD , et al. Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomised study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery. Human Reproduction2011;26(8):2015-27. ">Trew 2011</a>). We rated the remaining studies as unclear risk of bias. In six studies, while the women were blinded to treatment allocation, it was not practical to blind the initial surgical teams, due to the differences between the interventions being compared (<a href="./references#CD001298-bbs2-0003" title="CheongY , BaileyS , ForbesJ . Randomized Controlled Trial of Hyalobarrier Versus No Hyalobarrier on the Ovulatory Status of Women with Periovarian Adhesions: A Pilot Study. Advances in Therapy2017;34(1):199-206. [PMID: 27900662]">Cheong 2017</a>; <a href="./references#CD001298-bbs2-0015" title="LiuC , LuQ , ZhangZ , XueM , ZhangY , ZhangY , et al. A randomized controlled trial on the efficacy and safety of a new crosslinked hyaluronan gel in reducing adhesions after gynecologic laparoscopic surgeries. The Journal of Minimally Invasive Gynaecology2015;22(5):853-63. LiuC , ZhangZ , LuQ , ZhangZ . The efficacy and safety of a new cross-linked hyaluronan hydrogel in the reduction of postsurgical adhesions after laparoscopic gynecological surgery: a randomized controlled trial. The Journal of Minimally Invasive Gynaecology2014;21:S59-60. ">Liu 2015</a>; <a href="./references#CD001298-bbs2-0020" title="MettlerL , HuckeJ , BojahrB , TinnebergHR , LeylandN , AvelarR . A safety and efficacy study of a resorbable hydrogel for reduction of post-operative adhesions following myomectomy. Human Reproduction2008;23(5):1093-100. ">Mettler 2008</a>; <a href="./references#CD001298-bbs2-0025" title="RosenbergSM , BoardJA . High-molecular weight dextran in human infertility surgery. American Journal of Obstetrics and Gynecology1984;148:380-5. ">Rosenberg 1984</a>; <a href="./references#CD001298-bbs2-0027" title="TchartchianG , HackethalA , HerrmannA , BojahrB , WallwienerC , OhlingerR , et al. Evaluation of SprayShieldTM Adhesion Barrier in a single center: randomized controlled study in 15 women undergoing reconstructive surgery after laparoscopic myomectomy. Archives of Gynecology and Obstetrics2014;290(4):697-704. [PMID: 24781718]">Tchartchian 2014</a>; <a href="./references#CD001298-bbs2-0028" title="Ten BroekRPG , Kok-KrantN , VerhoeveHR , vanGoorH , BakkumEA . Efficacy of polyethylene glycol adhesion barrier after gynaecological laparoscopic surgery. Gynecological Surgery2012;9:29-35. ">Ten Broek 2012</a>). In 10 studies, the blinding of the women was not clearly stated, and the initial surgical teams were not blinded, due to the differences between the interventions (<a href="./references#CD001298-bbs2-0001" title="BrownCB , LucianoAA , MartinD , PeersE , ScrimgeourA , diZeregaGS . Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomised, controlled study. Fertility and Sterility2007;88(5):1413-26. PeersEM , BrownCB , Adept Adhesion Study Group. American Fertility Society score as a measure of effectiveness of 4% icodextrin in a pivotal adhesion reduction trial in the USA. Fertility and Sterility2005;84(Suppl 1):S160. ">Brown 2007</a>; <a href="./references#CD001298-bbs2-0007" title="diZeregaGS , VercoSJ , YoungP , KettelM , KobakW , MartinD , et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Human Reproduction2002;17(4):1031-8. ">diZerega 2002</a>; <a href="./references#CD001298-bbs2-0009" title="HellebrekersBWJ , Trimbos-KemperTCM , BoestenL , JansenFW , KolkmanW , TrimbosJB , et al. Preoperative predictors of postsurgical adhesion formation and the prevention of adhesions with plasminogen activator (PAPA-study): results of a clinical pilot study. Fertility and Sterility2009;91(4):1204-14. ">Hellebrekers 2009</a>; <a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a>; <a href="./references#CD001298-bbs2-0011" title="JansenRPS . Failure of peritoneal irrigation with heparin during pelvic operations upon young women to reduce adhesions. Surgery, Gynecology &amp; Obstetrics1988;166:154-60. ">Jansen 1988</a>; <a href="./references#CD001298-bbs2-0012" title="JansenRPS . Controlled clinical approaches to investigating the prevention of peritoneal adhesions. In: Treatment of Postsurgical Adhesions. Vol. 358. New York: Wiley-Liss Inc, 1990:177-92. ">Jansen 1990</a>; <a href="./references#CD001298-bbs2-0016" title="LundorffP , GeldorpH , TronstadSE , LalosO , LarssonB , JohnsDB , et al. Reduction of postsurgical adhesions with ferric hyaluronate gel: a European study. Human Reproduction2001;16(9):1982-8. ">Lundorff 2001</a>; <a href="./references#CD001298-bbs2-0018" title="MaisV , BraccoGI , LittaP , Gargiulo, MelisGB . Reduction of postoperative adhesions with an auto-crosslinked hyaluronan gel in gynaecological laparoscopic surgery: a blinded, controlled, randomised, multicentre study. Human Reproduction2006;21(5):1248-54. ">Mais 2006</a>; <a href="./references#CD001298-bbs2-0025" title="RosenbergSM , BoardJA . High-molecular weight dextran in human infertility surgery. American Journal of Obstetrics and Gynecology1984;148:380-5. ">Rosenberg 1984</a>; <a href="./references#CD001298-bbs2-0032" title="YoungP , JohnsA , TemplemanC , WitzC , WebsterB , FerlandR , et al. Reduction of postoperative adhesions for laparoscopic gynaecological surgery with Oxiplex/AP gel: a pilot study. Fertility and Sterility2005;84(5):1450-6. ">Young 2005</a>). In the remaining studies, there was insufficient information to assess risk of performance bias; therefore, we rated them as unclear risk of bias. </p> <p>We rated 20 studies at low risk for detection bias, as all outcome assessors were unaware of allocation at the time of assessment (<a href="./references#CD001298-bbs2-0003" title="CheongY , BaileyS , ForbesJ . Randomized Controlled Trial of Hyalobarrier Versus No Hyalobarrier on the Ovulatory Status of Women with Periovarian Adhesions: A Pilot Study. Advances in Therapy2017;34(1):199-206. [PMID: 27900662]">Cheong 2017</a>; <a href="./references#CD001298-bbs2-0004" title="CoddingtonC , GrowD , AhmedM , TonerJ , CookE , DiamondM . Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial. Fertility and Sterility2009;91:1909-13. ">Coddington 2009</a>; <a href="./references#CD001298-bbs2-0005" title="DiamondMP . Reduction of de novo postsurgical adhesions by intraoperative pre coating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo-controlled multicenter study. The Sepracoat Adhesion Study Group. Fertility and Sterility1998;69(6):1067-74. ">Diamond 1998</a>; <a href="./references#CD001298-bbs2-0007" title="diZeregaGS , VercoSJ , YoungP , KettelM , KobakW , MartinD , et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Human Reproduction2002;17(4):1031-8. ">diZerega 2002</a>; <a href="./references#CD001298-bbs2-0008" title="FossumGT , SilverbergKM , MillerCE , DiamondMP , HolmdahlL . Gynecologic use of SepraSpray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy: a pilot study. Fertility and Sterility2011;96(2):487-91. ">Fossum 2011</a>; <a href="./references#CD001298-bbs2-0009" title="HellebrekersBWJ , Trimbos-KemperTCM , BoestenL , JansenFW , KolkmanW , TrimbosJB , et al. Preoperative predictors of postsurgical adhesion formation and the prevention of adhesions with plasminogen activator (PAPA-study): results of a clinical pilot study. Fertility and Sterility2009;91(4):1204-14. ">Hellebrekers 2009</a>; <a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a>; <a href="./references#CD001298-bbs2-0011" title="JansenRPS . Failure of peritoneal irrigation with heparin during pelvic operations upon young women to reduce adhesions. Surgery, Gynecology &amp; Obstetrics1988;166:154-60. ">Jansen 1988</a>; <a href="./references#CD001298-bbs2-0013" title="JohnsBD , KeyportGM , HoehlerF , diZeregaG . Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery. Fertility and Sterility2001;76(3):595-604. ">Johns 2001</a>; <a href="./references#CD001298-bbs2-0015" title="LiuC , LuQ , ZhangZ , XueM , ZhangY , ZhangY , et al. A randomized controlled trial on the efficacy and safety of a new crosslinked hyaluronan gel in reducing adhesions after gynecologic laparoscopic surgeries. The Journal of Minimally Invasive Gynaecology2015;22(5):853-63. LiuC , ZhangZ , LuQ , ZhangZ . The efficacy and safety of a new cross-linked hyaluronan hydrogel in the reduction of postsurgical adhesions after laparoscopic gynecological surgery: a randomized controlled trial. The Journal of Minimally Invasive Gynaecology2014;21:S59-60. ">Liu 2015</a>; <a href="./references#CD001298-bbs2-0016" title="LundorffP , GeldorpH , TronstadSE , LalosO , LarssonB , JohnsDB , et al. Reduction of postsurgical adhesions with ferric hyaluronate gel: a European study. Human Reproduction2001;16(9):1982-8. ">Lundorff 2001</a>; <a href="./references#CD001298-bbs2-0017" title="LundorffP , DonnezJ , KorellM , AudebertAJM , BlockK , diZeregaGS . Clinical evaluation of a viscoelastic gel for reduction of adhesions following gynaecological surgery by laparoscopy in Europe. Human Reproduction2004;20(2):514-20. ">Lundorff 2005</a>; <a href="./references#CD001298-bbs2-0018" title="MaisV , BraccoGI , LittaP , Gargiulo, MelisGB . Reduction of postoperative adhesions with an auto-crosslinked hyaluronan gel in gynaecological laparoscopic surgery: a blinded, controlled, randomised, multicentre study. Human Reproduction2006;21(5):1248-54. ">Mais 2006</a>; <a href="./references#CD001298-bbs2-0024" title="RoseB , MacNeillC , LarrainR , KopreskiM . Abdominal instillation of high-molecular-weight dextran or lactated Ringer's solution after laparoscopic surgery. Journal of Reproductive Medicine1991;36:537-9. ">Rose 1991</a>; <a href="./references#CD001298-bbs2-0025" title="RosenbergSM , BoardJA . High-molecular weight dextran in human infertility surgery. American Journal of Obstetrics and Gynecology1984;148:380-5. ">Rosenberg 1984</a>; <a href="./references#CD001298-bbs2-0027" title="TchartchianG , HackethalA , HerrmannA , BojahrB , WallwienerC , OhlingerR , et al. Evaluation of SprayShieldTM Adhesion Barrier in a single center: randomized controlled study in 15 women undergoing reconstructive surgery after laparoscopic myomectomy. Archives of Gynecology and Obstetrics2014;290(4):697-704. [PMID: 24781718]">Tchartchian 2014</a>; <a href="./references#CD001298-bbs2-0028" title="Ten BroekRPG , Kok-KrantN , VerhoeveHR , vanGoorH , BakkumEA . Efficacy of polyethylene glycol adhesion barrier after gynaecological laparoscopic surgery. Gynecological Surgery2012;9:29-35. ">Ten Broek 2012</a>; <a href="./references#CD001298-bbs2-0030" title="TrewG , PistofidisG , PadosG , LowerA , MettlerL , WallweinerD , et al. Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomised study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery. Human Reproduction2011;26(8):2015-27. ">Trew 2011</a>; <a href="./references#CD001298-bbs2-0031" title="TrewG , PistofidisG , ZieglerN , KorrellM , BruckerS , RitterH , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray applied laparoscopically to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynecology2014;21:S90. TrewGH , PistofidisGA , BruckerSY , KrämerB , ZieglerNM , KorellM , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded multicenter study of ActamaxTM Adhesion Barrier. Archives of Gynecology and Obstetrics2017;295(2):383-95. TrewGH , PistofidisGA , BruckerSY , KraemerB , ZieglerNM , KorellM , et al. Twelve month follow-up of a first-In-human (FIH), randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray (Actamax Adhesion Barrier) applied to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynaecology2016;23:S203. ">Trew 2017</a>; <a href="./references#CD001298-bbs2-0032" title="YoungP , JohnsA , TemplemanC , WitzC , WebsterB , FerlandR , et al. Reduction of postoperative adhesions for laparoscopic gynaecological surgery with Oxiplex/AP gel: a pilot study. Fertility and Sterility2005;84(5):1450-6. ">Young 2005</a>). We rated one study at high risk for detection bias, as the surgeons assessing the adhesions were not blinded to the treatment allocation (<a href="./references#CD001298-bbs2-0020" title="MettlerL , HuckeJ , BojahrB , TinnebergHR , LeylandN , AvelarR . A safety and efficacy study of a resorbable hydrogel for reduction of post-operative adhesions following myomectomy. Human Reproduction2008;23(5):1093-100. ">Mettler 2008</a>). The remaining studies provided insufficient information to assess risk of detection bias; therefore, we rated them as unclear risk of bias. </p> </section> <section id="CD001298-sec-0056"> <h4 class="title">Incomplete outcome data</h4> <p>We assessed three studies at high risk of attrition bias (<a href="./references#CD001298-bbs2-0001" title="BrownCB , LucianoAA , MartinD , PeersE , ScrimgeourA , diZeregaGS . Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomised, controlled study. Fertility and Sterility2007;88(5):1413-26. PeersEM , BrownCB , Adept Adhesion Study Group. American Fertility Society score as a measure of effectiveness of 4% icodextrin in a pivotal adhesion reduction trial in the USA. Fertility and Sterility2005;84(Suppl 1):S160. ">Brown 2007</a>; <a href="./references#CD001298-bbs2-0025" title="RosenbergSM , BoardJA . High-molecular weight dextran in human infertility surgery. American Journal of Obstetrics and Gynecology1984;148:380-5. ">Rosenberg 1984</a>; <a href="./references#CD001298-bbs2-0029" title="ThorntonMH , JohnsDB , CampeauJD , HoehlerF , DiZeregaGS . Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open label pilot study. Human Reproduction1998;13(6):1480-5. ">Thornton 1998</a>). </p> <p>Forty‐seven women in <a href="./references#CD001298-bbs2-0001" title="BrownCB , LucianoAA , MartinD , PeersE , ScrimgeourA , diZeregaGS . Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomised, controlled study. Fertility and Sterility2007;88(5):1413-26. PeersEM , BrownCB , Adept Adhesion Study Group. American Fertility Society score as a measure of effectiveness of 4% icodextrin in a pivotal adhesion reduction trial in the USA. Fertility and Sterility2005;84(Suppl 1):S160. ">Brown 2007</a> (N = 402) withdrew from the study prior to its completion; 18 of these due to 'major protocol violations', without any further information; therefore, we considered this study at high risk of attrition bias. </p> <p>One participant in the control group in <a href="./references#CD001298-bbs2-0029" title="ThorntonMH , JohnsDB , CampeauJD , HoehlerF , DiZeregaGS . Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open label pilot study. Human Reproduction1998;13(6):1480-5. ">Thornton 1998</a> was excluded from efficacy analyses as they had a large number of adhesions at baseline, which all reformed. The explanation for this was to make the two study groups more comparable; however, the trial authors stated there were no statistically significant differences between the two groups at baseline, so there seems to be no clear reason for this exclusion; therefore, we considered this study at high risk of attrition bias. </p> <p>Two women in <a href="./references#CD001298-bbs2-0025" title="RosenbergSM , BoardJA . High-molecular weight dextran in human infertility surgery. American Journal of Obstetrics and Gynecology1984;148:380-5. ">Rosenberg 1984</a> withdrew prior to SLL; no explanation was provided; therefore, we considered this study at high risk of attrition bias. </p> <p>We considered 22 studies to be at low risk for attrition bias (<a href="./references#CD001298-bbs2-0004" title="CoddingtonC , GrowD , AhmedM , TonerJ , CookE , DiamondM . Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial. Fertility and Sterility2009;91:1909-13. ">Coddington 2009</a>; <a href="./references#CD001298-bbs2-0005" title="DiamondMP . Reduction of de novo postsurgical adhesions by intraoperative pre coating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo-controlled multicenter study. The Sepracoat Adhesion Study Group. Fertility and Sterility1998;69(6):1067-74. ">Diamond 1998</a>; <a href="./references#CD001298-bbs2-0006" title="DiamonMP , LucianoA , JohnsA , DunnR , YoungP , Bieber E. Reduction of postoperative adhesions by N, O-carboxymethylchitosan: a pilot study. Fertility and Sterility2003;80(3):631-6. ">Diamond 2003</a>; <a href="./references#CD001298-bbs2-0007" title="diZeregaGS , VercoSJ , YoungP , KettelM , KobakW , MartinD , et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Human Reproduction2002;17(4):1031-8. ">diZerega 2002</a>; <a href="./references#CD001298-bbs2-0008" title="FossumGT , SilverbergKM , MillerCE , DiamondMP , HolmdahlL . Gynecologic use of SepraSpray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy: a pilot study. Fertility and Sterility2011;96(2):487-91. ">Fossum 2011</a>; <a href="./references#CD001298-bbs2-0009" title="HellebrekersBWJ , Trimbos-KemperTCM , BoestenL , JansenFW , KolkmanW , TrimbosJB , et al. Preoperative predictors of postsurgical adhesion formation and the prevention of adhesions with plasminogen activator (PAPA-study): results of a clinical pilot study. Fertility and Sterility2009;91(4):1204-14. ">Hellebrekers 2009</a>; <a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a>; <a href="./references#CD001298-bbs2-0011" title="JansenRPS . Failure of peritoneal irrigation with heparin during pelvic operations upon young women to reduce adhesions. Surgery, Gynecology &amp; Obstetrics1988;166:154-60. ">Jansen 1988</a>; <a href="./references#CD001298-bbs2-0013" title="JohnsBD , KeyportGM , HoehlerF , diZeregaG . Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery. Fertility and Sterility2001;76(3):595-604. ">Johns 2001</a>; <a href="./references#CD001298-bbs2-0014" title="LarssonB , LalosO , MarskL , Tronstad S-E, BygdemanM , PehrsonS , JoelssonI . Effect of intraperitoneal instillation of 32% dextran 70 on postoperative adhesion formation after tubal surgery. Acta Obstetricia et Gynecologia Scandinavica1985;64:437-41. ">Larsson 1985</a>; <a href="./references#CD001298-bbs2-0017" title="LundorffP , DonnezJ , KorellM , AudebertAJM , BlockK , diZeregaGS . Clinical evaluation of a viscoelastic gel for reduction of adhesions following gynaecological surgery by laparoscopy in Europe. Human Reproduction2004;20(2):514-20. ">Lundorff 2005</a>; <a href="./references#CD001298-bbs2-0019" title="MettlerL , AudebertA , Lehmann-WillenbrockE , SchiveK , JacobsVR . Prospective clinical trial of SprayGel as a barrier to adhesion formation: an interim analysis. Journal of American Association of Gynecologic Laparoscopists2003;10(3):339-44. MettlerL , AudebertA , Lehmann-WillenbrockE , Schive-PeterhansiK , JacobsV . A randomized prospective, controlled, multicenter clinical trial of a sprayable, site specific adhesion barrier system in patients undergoing myomectomy. Fertility and Sterility2004;82(2):398-404. MettlerL . Pelvic adhesions: laparoscopic approach. Annals of the New York Academy of Sciences2003;997:255-68. ">Mettler 2004</a>; <a href="./references#CD001298-bbs2-0020" title="MettlerL , HuckeJ , BojahrB , TinnebergHR , LeylandN , AvelarR . A safety and efficacy study of a resorbable hydrogel for reduction of post-operative adhesions following myomectomy. Human Reproduction2008;23(5):1093-100. ">Mettler 2008</a>; <a href="./references#CD001298-bbs2-0021" title="PellicanoM , BramanteS , CirilloD , PalombaS , BifulcoG , ZulloF , et al. Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective, randomized, controlled study. Fertility and Sterility2003;80(2):441-4. ">Pellicano 2003</a>; <a href="./references#CD001298-bbs2-0022" title="QuerleuD , Vankeerberghen-DeffenseF , BoutevilleC . The effect of noxytioline and systemic corticosteroids in infertility surgery. A prospective randomized study [Traitement adjuvant des plasties tubaires. Etude prospective randomisee des corticoides par voie generale et de la noxytioline]. Journal de Gynecologie Obstetrique et Biologie de la Reproduction1989;18(7):935-40. ">Querleu 1989</a>; <a href="./references#CD001298-bbs2-0023" title="RockJA , SieglerAM , Boer MieselM , HaneyAF , RosenwaksZ , Pardo-VargasF , et al. The efficacy of postoperative hydrotubation: a randomized prospective multicenter clinical trial. Fertility and Sterility1984;42:373-6. ">Rock 1984</a>; <a href="./references#CD001298-bbs2-0024" title="RoseB , MacNeillC , LarrainR , KopreskiM . Abdominal instillation of high-molecular-weight dextran or lactated Ringer's solution after laparoscopic surgery. Journal of Reproductive Medicine1991;36:537-9. ">Rose 1991</a>; <a href="./references#CD001298-bbs2-0026" title="SitesCK , JensenBA , GlockJL , BlackmanJA , BadgerGJ , JohJV , et al. Transvaginal ultrasonographic assessment of Hyskon and lactated Ringer's solution instillation after laparoscopy. A randomized, controlled trial. Journal of Ultrasound Medicine1997;16(3):195-9. [MEDLINE: 9166816]">Sites 1997</a>; <a href="./references#CD001298-bbs2-0028" title="Ten BroekRPG , Kok-KrantN , VerhoeveHR , vanGoorH , BakkumEA . Efficacy of polyethylene glycol adhesion barrier after gynaecological laparoscopic surgery. Gynecological Surgery2012;9:29-35. ">Ten Broek 2012</a>; <a href="./references#CD001298-bbs2-0030" title="TrewG , PistofidisG , PadosG , LowerA , MettlerL , WallweinerD , et al. Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomised study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery. Human Reproduction2011;26(8):2015-27. ">Trew 2011</a>; <a href="./references#CD001298-bbs2-0031" title="TrewG , PistofidisG , ZieglerN , KorrellM , BruckerS , RitterH , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray applied laparoscopically to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynecology2014;21:S90. TrewGH , PistofidisGA , BruckerSY , KrämerB , ZieglerNM , KorellM , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded multicenter study of ActamaxTM Adhesion Barrier. Archives of Gynecology and Obstetrics2017;295(2):383-95. TrewGH , PistofidisGA , BruckerSY , KraemerB , ZieglerNM , KorellM , et al. Twelve month follow-up of a first-In-human (FIH), randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray (Actamax Adhesion Barrier) applied to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynaecology2016;23:S203. ">Trew 2017</a>; <a href="./references#CD001298-bbs2-0032" title="YoungP , JohnsA , TemplemanC , WitzC , WebsterB , FerlandR , et al. Reduction of postoperative adhesions for laparoscopic gynaecological surgery with Oxiplex/AP gel: a pilot study. Fertility and Sterility2005;84(5):1450-6. ">Young 2005</a>). </p> <p>Seven studies did not provide sufficient information to reveal attrition bias; consequently, we rated the risk of attrition bias as unclear (<a href="./references#CD001298-bbs2-0002" title="ButtramV , MalinakR , ClearyR , CohenS , CowanB , DaniellJ , et al, Adhesion Study Group. Reduction of postoperative pelvic adhesions with intraperitoneal 32% dextran 70: a prospective, randomized clinical trial. Fertility and Sterility1983;40:612-9. ">Buttram 1983</a>; <a href="./references#CD001298-bbs2-0003" title="CheongY , BaileyS , ForbesJ . Randomized Controlled Trial of Hyalobarrier Versus No Hyalobarrier on the Ovulatory Status of Women with Periovarian Adhesions: A Pilot Study. Advances in Therapy2017;34(1):199-206. [PMID: 27900662]">Cheong 2017</a>; <a href="./references#CD001298-bbs2-0012" title="JansenRPS . Controlled clinical approaches to investigating the prevention of peritoneal adhesions. In: Treatment of Postsurgical Adhesions. Vol. 358. New York: Wiley-Liss Inc, 1990:177-92. ">Jansen 1990</a>; <a href="./references#CD001298-bbs2-0015" title="LiuC , LuQ , ZhangZ , XueM , ZhangY , ZhangY , et al. A randomized controlled trial on the efficacy and safety of a new crosslinked hyaluronan gel in reducing adhesions after gynecologic laparoscopic surgeries. The Journal of Minimally Invasive Gynaecology2015;22(5):853-63. LiuC , ZhangZ , LuQ , ZhangZ . The efficacy and safety of a new cross-linked hyaluronan hydrogel in the reduction of postsurgical adhesions after laparoscopic gynecological surgery: a randomized controlled trial. The Journal of Minimally Invasive Gynaecology2014;21:S59-60. ">Liu 2015</a>; <a href="./references#CD001298-bbs2-0016" title="LundorffP , GeldorpH , TronstadSE , LalosO , LarssonB , JohnsDB , et al. Reduction of postsurgical adhesions with ferric hyaluronate gel: a European study. Human Reproduction2001;16(9):1982-8. ">Lundorff 2001</a>; <a href="./references#CD001298-bbs2-0018" title="MaisV , BraccoGI , LittaP , Gargiulo, MelisGB . Reduction of postoperative adhesions with an auto-crosslinked hyaluronan gel in gynaecological laparoscopic surgery: a blinded, controlled, randomised, multicentre study. Human Reproduction2006;21(5):1248-54. ">Mais 2006</a>; <a href="./references#CD001298-bbs2-0027" title="TchartchianG , HackethalA , HerrmannA , BojahrB , WallwienerC , OhlingerR , et al. Evaluation of SprayShieldTM Adhesion Barrier in a single center: randomized controlled study in 15 women undergoing reconstructive surgery after laparoscopic myomectomy. Archives of Gynecology and Obstetrics2014;290(4):697-704. [PMID: 24781718]">Tchartchian 2014</a>). </p> </section> <section id="CD001298-sec-0057"> <h4 class="title">Selective reporting</h4> <p>We assessed one study at high risk for reporting bias (<a href="./references#CD001298-bbs2-0020" title="MettlerL , HuckeJ , BojahrB , TinnebergHR , LeylandN , AvelarR . A safety and efficacy study of a resorbable hydrogel for reduction of post-operative adhesions following myomectomy. Human Reproduction2008;23(5):1093-100. ">Mettler 2008</a>). The trial authors decided 'in hindsight' to change the primary outcome scoring method from the total mAFS score, as stated in the original review protocol, to the mAFS of the posterior uterus, as discussed during data analysis. Consequently, we conducted a sensitivity analysis and found that excluding <a href="./references#CD001298-bbs2-0020" title="MettlerL , HuckeJ , BojahrB , TinnebergHR , LeylandN , AvelarR . A safety and efficacy study of a resorbable hydrogel for reduction of post-operative adhesions following myomectomy. Human Reproduction2008;23(5):1093-100. ">Mettler 2008</a> made no difference to the direction of treatment effect. </p> <p>We obtained study protocols or found trial register entries for five studies (<a href="./references#CD001298-bbs2-0003" title="CheongY , BaileyS , ForbesJ . Randomized Controlled Trial of Hyalobarrier Versus No Hyalobarrier on the Ovulatory Status of Women with Periovarian Adhesions: A Pilot Study. Advances in Therapy2017;34(1):199-206. [PMID: 27900662]">Cheong 2017</a>; <a href="./references#CD001298-bbs2-0008" title="FossumGT , SilverbergKM , MillerCE , DiamondMP , HolmdahlL . Gynecologic use of SepraSpray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy: a pilot study. Fertility and Sterility2011;96(2):487-91. ">Fossum 2011</a>; <a href="./references#CD001298-bbs2-0015" title="LiuC , LuQ , ZhangZ , XueM , ZhangY , ZhangY , et al. A randomized controlled trial on the efficacy and safety of a new crosslinked hyaluronan gel in reducing adhesions after gynecologic laparoscopic surgeries. The Journal of Minimally Invasive Gynaecology2015;22(5):853-63. LiuC , ZhangZ , LuQ , ZhangZ . The efficacy and safety of a new cross-linked hyaluronan hydrogel in the reduction of postsurgical adhesions after laparoscopic gynecological surgery: a randomized controlled trial. The Journal of Minimally Invasive Gynaecology2014;21:S59-60. ">Liu 2015</a>; <a href="./references#CD001298-bbs2-0027" title="TchartchianG , HackethalA , HerrmannA , BojahrB , WallwienerC , OhlingerR , et al. Evaluation of SprayShieldTM Adhesion Barrier in a single center: randomized controlled study in 15 women undergoing reconstructive surgery after laparoscopic myomectomy. Archives of Gynecology and Obstetrics2014;290(4):697-704. [PMID: 24781718]">Tchartchian 2014</a>; <a href="./references#CD001298-bbs2-0031" title="TrewG , PistofidisG , ZieglerN , KorrellM , BruckerS , RitterH , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray applied laparoscopically to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynecology2014;21:S90. TrewGH , PistofidisGA , BruckerSY , KrämerB , ZieglerNM , KorellM , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded multicenter study of ActamaxTM Adhesion Barrier. Archives of Gynecology and Obstetrics2017;295(2):383-95. TrewGH , PistofidisGA , BruckerSY , KraemerB , ZieglerNM , KorellM , et al. Twelve month follow-up of a first-In-human (FIH), randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray (Actamax Adhesion Barrier) applied to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynaecology2016;23:S203. ">Trew 2017</a>). These studies reported all planned outcomes; therefore, we considered them at low risk of reporting bias. </p> <p>We considered the remaining 26 studies as unclear risk of reporting bias, as we were unable to identify any study protocols or trial registries for comparison. </p> </section> <section id="CD001298-sec-0058"> <h4 class="title">Other potential sources of bias</h4> <p>We rated five studies at high risk of other potential source of bias (<a href="./references#CD001298-bbs2-0008" title="FossumGT , SilverbergKM , MillerCE , DiamondMP , HolmdahlL . Gynecologic use of SepraSpray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy: a pilot study. Fertility and Sterility2011;96(2):487-91. ">Fossum 2011</a>; <a href="./references#CD001298-bbs2-0016" title="LundorffP , GeldorpH , TronstadSE , LalosO , LarssonB , JohnsDB , et al. Reduction of postsurgical adhesions with ferric hyaluronate gel: a European study. Human Reproduction2001;16(9):1982-8. ">Lundorff 2001</a>; <a href="./references#CD001298-bbs2-0025" title="RosenbergSM , BoardJA . High-molecular weight dextran in human infertility surgery. American Journal of Obstetrics and Gynecology1984;148:380-5. ">Rosenberg 1984</a>; <a href="./references#CD001298-bbs2-0027" title="TchartchianG , HackethalA , HerrmannA , BojahrB , WallwienerC , OhlingerR , et al. Evaluation of SprayShieldTM Adhesion Barrier in a single center: randomized controlled study in 15 women undergoing reconstructive surgery after laparoscopic myomectomy. Archives of Gynecology and Obstetrics2014;290(4):697-704. [PMID: 24781718]">Tchartchian 2014</a>; <a href="./references#CD001298-bbs2-0029" title="ThorntonMH , JohnsDB , CampeauJD , HoehlerF , DiZeregaGS . Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open label pilot study. Human Reproduction1998;13(6):1480-5. ">Thornton 1998</a>). </p> <p><a href="./references#CD001298-bbs2-0008" title="FossumGT , SilverbergKM , MillerCE , DiamondMP , HolmdahlL . Gynecologic use of SepraSpray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy: a pilot study. Fertility and Sterility2011;96(2):487-91. ">Fossum 2011</a>, <a href="./references#CD001298-bbs2-0025" title="RosenbergSM , BoardJA . High-molecular weight dextran in human infertility surgery. American Journal of Obstetrics and Gynecology1984;148:380-5. ">Rosenberg 1984</a> and <a href="./references#CD001298-bbs2-0029" title="ThorntonMH , JohnsDB , CampeauJD , HoehlerF , DiZeregaGS . Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open label pilot study. Human Reproduction1998;13(6):1480-5. ">Thornton 1998</a> all reported important outcomes in graphical format only, without providing key numerical results such as standard deviations (SD), standard error of the mean (SEM), confidence intervals (CI), and P values. We imputed data from these studies, based on the available data, however, the imputed data are not likely to be entirely accurate. </p> <p>The study groups used in the study by <a href="./references#CD001298-bbs2-0027" title="TchartchianG , HackethalA , HerrmannA , BojahrB , WallwienerC , OhlingerR , et al. Evaluation of SprayShieldTM Adhesion Barrier in a single center: randomized controlled study in 15 women undergoing reconstructive surgery after laparoscopic myomectomy. Archives of Gynecology and Obstetrics2014;290(4):697-704. [PMID: 24781718]">Tchartchian 2014</a> had multiple statistically significant differences at baseline; therefore, we considered it at high risk of other sources of bias. </p> <p><a href="./references#CD001298-bbs2-0016" title="LundorffP , GeldorpH , TronstadSE , LalosO , LarssonB , JohnsDB , et al. Reduction of postsurgical adhesions with ferric hyaluronate gel: a European study. Human Reproduction2001;16(9):1982-8. ">Lundorff 2001</a> reported standard deviations of 0.01 for the mean adhesion score. These standard deviations appear highly likely to be inaccurate, considering the size of the sample involved. We thought that standard errors may have been mistakenly reported as standard deviations; therefore, we imputed data based upon this assumption, however, it is highly likely that these results are inaccurate. </p> <p>We assessed two studies as having other sources of bias that were unclear (<a href="./references#CD001298-bbs2-0011" title="JansenRPS . Failure of peritoneal irrigation with heparin during pelvic operations upon young women to reduce adhesions. Surgery, Gynecology &amp; Obstetrics1988;166:154-60. ">Jansen 1988</a>; <a href="./references#CD001298-bbs2-0028" title="Ten BroekRPG , Kok-KrantN , VerhoeveHR , vanGoorH , BakkumEA . Efficacy of polyethylene glycol adhesion barrier after gynaecological laparoscopic surgery. Gynecological Surgery2012;9:29-35. ">Ten Broek 2012</a>). A potential source of bias in <a href="./references#CD001298-bbs2-0011" title="JansenRPS . Failure of peritoneal irrigation with heparin during pelvic operations upon young women to reduce adhesions. Surgery, Gynecology &amp; Obstetrics1988;166:154-60. ">Jansen 1988</a> was that the practice of adding hydrocortisone sodium succinate to the irrigation solution was stopped after 46 women had received it, because a possible detrimental effect was reported in an earlier study. These 46 women were still included in the analysis. The study by <a href="./references#CD001298-bbs2-0028" title="Ten BroekRPG , Kok-KrantN , VerhoeveHR , vanGoorH , BakkumEA . Efficacy of polyethylene glycol adhesion barrier after gynaecological laparoscopic surgery. Gynecological Surgery2012;9:29-35. ">Ten Broek 2012</a> was "prematurely ended due to financial and organizational reasons. During the conduct of the study, the clinical trial insurance unexpectedly required a separate fee for both laparoscopic procedures in each patient"; we still included this study. </p> <p>We did not identify any potential sources of bias in the other 25 included studies.</p> </section> </section> <section id="CD001298-sec-0059"> <h3 class="title" id="CD001298-sec-0059">Effects of interventions</h3> <p>See: <a href="./full#CD001298-tbl-0001"><b>Summary of findings 1</b> Hydroflotation agents versus no hydroflotation agents (or placebo) for adhesion prevention after gynaecological surgery</a>; <a href="./full#CD001298-tbl-0002"><b>Summary of findings 2</b> Gel agents versus no gel agents (or placebo) for adhesion prevention after gynaecological surgery</a>; <a href="./full#CD001298-tbl-0003"><b>Summary of findings 3</b> Gel agents versus hydroflotation agents used as instillants for adhesion prevention after gynaecological surgery</a>; <a href="./full#CD001298-tbl-0004"><b>Summary of findings 4</b> Steroids (any route) versus no steroids (or placebo) for adhesion prevention after gynaecological surgery</a> </p> <section id="CD001298-sec-0060"> <h4 class="title">1. Hydroflotation agents versus no hydroflotation agents (or placebo)</h4> <p>Ten studies examined the effects of hydroflotation agents versus placebo: <a href="./references#CD001298-bbs2-0001" title="BrownCB , LucianoAA , MartinD , PeersE , ScrimgeourA , diZeregaGS . Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomised, controlled study. Fertility and Sterility2007;88(5):1413-26. PeersEM , BrownCB , Adept Adhesion Study Group. American Fertility Society score as a measure of effectiveness of 4% icodextrin in a pivotal adhesion reduction trial in the USA. Fertility and Sterility2005;84(Suppl 1):S160. ">Brown 2007</a>, <a href="./references#CD001298-bbs2-0007" title="diZeregaGS , VercoSJ , YoungP , KettelM , KobakW , MartinD , et al. A randomized, controlled pilot study of the safety and efficacy of 4% icodextrin solution in the reduction of adhesions following laparoscopic gynaecological surgery. Human Reproduction2002;17(4):1031-8. ">diZerega 2002</a>, and <a href="./references#CD001298-bbs2-0030" title="TrewG , PistofidisG , PadosG , LowerA , MettlerL , WallweinerD , et al. Gynaecological endoscopic evaluation of 4% icodextrin solution: a European, multicentre, double-blind, randomised study of the efficacy and safety in the reduction of de novo adhesions after laparoscopic gynaecological surgery. Human Reproduction2011;26(8):2015-27. ">Trew 2011</a> examined 4% icodextrin versus saline; <a href="./references#CD001298-bbs2-0002" title="ButtramV , MalinakR , ClearyR , CohenS , CowanB , DaniellJ , et al, Adhesion Study Group. Reduction of postoperative pelvic adhesions with intraperitoneal 32% dextran 70: a prospective, randomized clinical trial. Fertility and Sterility1983;40:612-9. ">Buttram 1983</a> and <a href="./references#CD001298-bbs2-0014" title="LarssonB , LalosO , MarskL , Tronstad S-E, BygdemanM , PehrsonS , JoelssonI . Effect of intraperitoneal instillation of 32% dextran 70 on postoperative adhesion formation after tubal surgery. Acta Obstetricia et Gynecologia Scandinavica1985;64:437-41. ">Larsson 1985</a> examined dextran versus saline; <a href="./references#CD001298-bbs2-0005" title="DiamondMP . Reduction of de novo postsurgical adhesions by intraoperative pre coating with Sepracoat (HAL-C) solution: a prospective, randomized, blinded, placebo-controlled multicenter study. The Sepracoat Adhesion Study Group. Fertility and Sterility1998;69(6):1067-74. ">Diamond 1998</a> examined 0.4% hyaluronic acid versus phosphate‐buffered saline (PBS); <a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a>, <a href="./references#CD001298-bbs2-0024" title="RoseB , MacNeillC , LarrainR , KopreskiM . Abdominal instillation of high-molecular-weight dextran or lactated Ringer's solution after laparoscopic surgery. Journal of Reproductive Medicine1991;36:537-9. ">Rose 1991</a>, <a href="./references#CD001298-bbs2-0025" title="RosenbergSM , BoardJA . High-molecular weight dextran in human infertility surgery. American Journal of Obstetrics and Gynecology1984;148:380-5. ">Rosenberg 1984</a> and <a href="./references#CD001298-bbs2-0026" title="SitesCK , JensenBA , GlockJL , BlackmanJA , BadgerGJ , JohJV , et al. Transvaginal ultrasonographic assessment of Hyskon and lactated Ringer's solution instillation after laparoscopy. A randomized, controlled trial. Journal of Ultrasound Medicine1997;16(3):195-9. [MEDLINE: 9166816]">Sites 1997</a> examined dextran versus Hartmann's solution. </p> <section id="CD001298-sec-0061"> <h5 class="title">Primary outcomes</h5> <section id="CD001298-sec-0062"> <h6 class="title">1.1 Pelvic pain</h6> <p>We are uncertain whether 4% icodextrin had any effect on pelvic pain when compared with saline (odds ratio (OR) 1.05, 95% CI 0.52 to 2.09; P = 0.90; one study, 226 women; very low‐quality evidence; <a href="./references#CD001298-fig-0012" title="">Analysis 1.1</a>). </p> </section> <section id="CD001298-sec-0063"> <h6 class="title">1.2 Live birth rate</h6> <p>We are uncertain whether hydroflotation agents had any effect on live birth rates compared with control (OR 0.67, 95% CI 0.29 to 1.58; P = 0.36; I<sup>2</sup> = 0%; two studies, 208 women; low‐quality evidence; <a href="./references#CD001298-fig-0013" title="">Analysis 1.2</a>; <a href="#CD001298-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD001298-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Hydroflotation agent vs no hydroflotation agent, outcome: 1.2 Live birth rate" data-id="CD001298-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hydroflotation agent vs no hydroflotation agent, outcome: 1.2 Live birth rate </p> </div> </div> </div> </section> </section> <section id="CD001298-sec-0064"> <h5 class="title">Secondary outcomes</h5> <section id="CD001298-sec-0065"> <h6 class="title">1.3 Incidence of adhesions at SLL</h6> <p>Hydroflotation agents reduced the incidence of adhesions at SLL when compared with control (OR 0.34, 95% CI 0.22 to 0.55; P &lt; 0.00001; I<sup>2</sup> = 0%; four studies, 566 women; high‐quality evidence; <a href="./references#CD001298-fig-0014" title="">Analysis 1.3</a>; <a href="#CD001298-fig-0005">Figure 5</a>). </p> <div class="figure" id="CD001298-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Hydroflotation agent vs no hydroflotation agent, outcome: 1.3 Incidence of adhesions at SLL" data-id="CD001298-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hydroflotation agent vs no hydroflotation agent, outcome: 1.3 Incidence of adhesions at SLL </p> </div> </div> </div> <p>This suggests that in women with an 84% chance of having adhesions at SLL without hydroflotation agents, the use of fluid agents would result in 54% to 75% of women having adhesions. </p> </section> <section id="CD001298-sec-0066"> <h6 class="title">1.4 Mean adhesion score at SLL per woman</h6> <p>Hydroflotation agents probably made little or no difference to mean adhesion score at SLL when compared with control (standardised mean difference (SMD) ‐0.06, 95% CI ‐0.20 to 0.09; P = 0.44; I<sup>2</sup> = 0%; four studies, 722 women; moderate‐quality evidence; <a href="./references#CD001298-fig-0015" title="">Analysis 1.4</a>; <a href="#CD001298-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD001298-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Hydroflotation agent vs no treatment, outcome: 1.4 Mean adhesion score at SLL" data-id="CD001298-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-06.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hydroflotation agent vs no treatment, outcome: 1.4 Mean adhesion score at SLL </p> </div> </div> </div> <p><a href="./references#CD001298-bbs2-0025" title="RosenbergSM , BoardJA . High-molecular weight dextran in human infertility surgery. American Journal of Obstetrics and Gynecology1984;148:380-5. ">Rosenberg 1984</a> reported data regarding mean change in adhesion score and only in a graphical format, and therefore could not be included in the statistical analysis. Data from this study was imputed and is shown in <a href="./references#CD001298-fig-0020" title="">Analysis 1.9</a> for reference. The study reports significant improvements in adhesion score with the use of a hydroflotation agent, in keeping with findings in our other analyses. </p> </section> <section id="CD001298-sec-0067"> <h6 class="title">1.5 Clinical pregnancy rate</h6> <p>We are uncertain whether the hydroflotation agents had any effect on clinical pregnancy rates when compared with control (OR 0.64, 95% CI 0.36 to 1.14; P = 0.13; I<sup>2</sup> = 0%; three studies, 310 women; moderate‐quality evidence; <a href="./references#CD001298-fig-0016" title="">Analysis 1.5</a>; <a href="#CD001298-fig-0007">Figure 7</a>). </p> <div class="figure" id="CD001298-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Hydroflotation agent vs no treatment, outcome: 1.5 Clinical pregnancy rate" data-id="CD001298-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-07.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hydroflotation agent vs no treatment, outcome: 1.5 Clinical pregnancy rate </p> </div> </div> </div> </section> <section id="CD001298-sec-0068"> <h6 class="title">1.6 Improvement in adhesion score at SLL</h6> <p>We are uncertain whether hydroflotation agents improved the adhesion score at SLL compared with control (OR 1.28, 95% CI 0.93 to 1.76; P = 0.13; I<sup>2</sup> = 38%, moderate heterogeneity; four studies, 665 women; moderate‐quality evidence; <a href="./references#CD001298-fig-0017" title="">Analysis 1.6</a>). </p> <p>Heterogeneity was reduced to I<sup>2</sup> = 0% when <a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a> was removed, and hydroflotation agents did improve the adhesion score at SLL compared with control (OR 1.47, 95% CI 1.03 to 2.10; P = 0.03; three studies, 546 women); however, we were unable to determine a cause for the heterogeneity, therefore, we kept the study in the meta‐analysis. The only difference that we could discern was the use of Hartmann's solution as a control as opposed to saline; however, the review authors believed this difference was unlikely to cause significant heterogeneity, as the solutions are so similar in composition. </p> </section> <section id="CD001298-sec-0069"> <h6 class="title">1.7 Worsening of adhesion score at SLL</h6> <p>We are uncertain whether 4% icodextrin worsened the adhesion score at SLL when compared with saline (OR 0.28, 95% CI 0.07 to 1.21; P = 0.09; one study, 53 women; moderate‐quality evidence; <a href="./references#CD001298-fig-0018" title="">Analysis 1.7</a>). </p> <p><a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a> also reported worsening of adhesion score at SLL, however the outcome was poorly defined in the paper and was therefore not included in this analysis. The data from <a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a> also showed inconclusive results. </p> </section> <section id="CD001298-sec-0070"> <h6 class="title">1.8 Miscarriage rate</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0071"> <h6 class="title">1.9 Ectopic pregnancy rate</h6> <p>We are uncertain whether hydroflotation agents had an effect on ectopic pregnancy rates when compared with control (OR 0.35, 95% CI 0.06 to 1.85; P = 0.21; I<sup>2</sup> = 5%; two studies, 50 women; <a href="./references#CD001298-fig-0019" title="">Analysis 1.8</a>). </p> </section> <section id="CD001298-sec-0072"> <h6 class="title">1.10 Quality of life</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0073"> <h6 class="title">1.11 Adverse outcomes</h6> <p>None of the studies reported any adverse outcomes attributable to the intervention of interest. </p> <section id="CD001298-sec-0074"> <p><b>Data from included studies that could not be included in statistical analyses</b></p> <p><a href="./references#CD001298-bbs2-0024" title="RoseB , MacNeillC , LarrainR , KopreskiM . Abdominal instillation of high-molecular-weight dextran or lactated Ringer's solution after laparoscopic surgery. Journal of Reproductive Medicine1991;36:537-9. ">Rose 1991</a> and <a href="./references#CD001298-bbs2-0026" title="SitesCK , JensenBA , GlockJL , BlackmanJA , BadgerGJ , JohJV , et al. Transvaginal ultrasonographic assessment of Hyskon and lactated Ringer's solution instillation after laparoscopy. A randomized, controlled trial. Journal of Ultrasound Medicine1997;16(3):195-9. [MEDLINE: 9166816]">Sites 1997</a> did not report any of our outcomes of interest. <a href="./references#CD001298-bbs2-0024" title="RoseB , MacNeillC , LarrainR , KopreskiM . Abdominal instillation of high-molecular-weight dextran or lactated Ringer's solution after laparoscopic surgery. Journal of Reproductive Medicine1991;36:537-9. ">Rose 1991</a> compared changes in participants' weight from baseline following instillation of dextran or Hartmann's solution. <a href="./references#CD001298-bbs2-0026" title="SitesCK , JensenBA , GlockJL , BlackmanJA , BadgerGJ , JohJV , et al. Transvaginal ultrasonographic assessment of Hyskon and lactated Ringer's solution instillation after laparoscopy. A randomized, controlled trial. Journal of Ultrasound Medicine1997;16(3):195-9. [MEDLINE: 9166816]">Sites 1997</a> compared volume of fluid within the uterine cavity identified on transvaginal ultrasound at various times postoperatively followijng instillation of dextran or Hartmann's solution. </p> </section> </section> </section> </section> <section id="CD001298-sec-0075"> <h4 class="title">2. Gel agents versus no gel agents (or placebo)</h4> <p>Twelve studies examined the effects of gel agents versus no gel agents (or placebo): <a href="./references#CD001298-bbs2-0003" title="CheongY , BaileyS , ForbesJ . Randomized Controlled Trial of Hyalobarrier Versus No Hyalobarrier on the Ovulatory Status of Women with Periovarian Adhesions: A Pilot Study. Advances in Therapy2017;34(1):199-206. [PMID: 27900662]">Cheong 2017</a>, <a href="./references#CD001298-bbs2-0018" title="MaisV , BraccoGI , LittaP , Gargiulo, MelisGB . Reduction of postoperative adhesions with an auto-crosslinked hyaluronan gel in gynaecological laparoscopic surgery: a blinded, controlled, randomised, multicentre study. Human Reproduction2006;21(5):1248-54. ">Mais 2006</a> and <a href="./references#CD001298-bbs2-0021" title="PellicanoM , BramanteS , CirilloD , PalombaS , BifulcoG , ZulloF , et al. Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective, randomized, controlled study. Fertility and Sterility2003;80(2):441-4. ">Pellicano 2003</a> examined auto‐cross‐linked hyaluronic acid versus no treatment; <a href="./references#CD001298-bbs2-0017" title="LundorffP , DonnezJ , KorellM , AudebertAJM , BlockK , diZeregaGS . Clinical evaluation of a viscoelastic gel for reduction of adhesions following gynaecological surgery by laparoscopy in Europe. Human Reproduction2004;20(2):514-20. ">Lundorff 2005</a> and <a href="./references#CD001298-bbs2-0032" title="YoungP , JohnsA , TemplemanC , WitzC , WebsterB , FerlandR , et al. Reduction of postoperative adhesions for laparoscopic gynaecological surgery with Oxiplex/AP gel: a pilot study. Fertility and Sterility2005;84(5):1450-6. ">Young 2005</a> examined polyethylene oxide and carboxymethylcellulose versus no treatment; <a href="./references#CD001298-bbs2-0008" title="FossumGT , SilverbergKM , MillerCE , DiamondMP , HolmdahlL . Gynecologic use of SepraSpray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy: a pilot study. Fertility and Sterility2011;96(2):487-91. ">Fossum 2011</a> and <a href="./references#CD001298-bbs2-0028" title="Ten BroekRPG , Kok-KrantN , VerhoeveHR , vanGoorH , BakkumEA . Efficacy of polyethylene glycol adhesion barrier after gynaecological laparoscopic surgery. Gynecological Surgery2012;9:29-35. ">Ten Broek 2012</a> examined hyaluronic acid and carboxymethylcellulose versus no treatment; <a href="./references#CD001298-bbs2-0019" title="MettlerL , AudebertA , Lehmann-WillenbrockE , SchiveK , JacobsVR . Prospective clinical trial of SprayGel as a barrier to adhesion formation: an interim analysis. Journal of American Association of Gynecologic Laparoscopists2003;10(3):339-44. MettlerL , AudebertA , Lehmann-WillenbrockE , Schive-PeterhansiK , JacobsV . A randomized prospective, controlled, multicenter clinical trial of a sprayable, site specific adhesion barrier system in patients undergoing myomectomy. Fertility and Sterility2004;82(2):398-404. MettlerL . Pelvic adhesions: laparoscopic approach. Annals of the New York Academy of Sciences2003;997:255-68. ">Mettler 2004</a> and <a href="./references#CD001298-bbs2-0027" title="TchartchianG , HackethalA , HerrmannA , BojahrB , WallwienerC , OhlingerR , et al. Evaluation of SprayShieldTM Adhesion Barrier in a single center: randomized controlled study in 15 women undergoing reconstructive surgery after laparoscopic myomectomy. Archives of Gynecology and Obstetrics2014;290(4):697-704. [PMID: 24781718]">Tchartchian 2014</a> examined polyethylene glycol versus no treatment; <a href="./references#CD001298-bbs2-0020" title="MettlerL , HuckeJ , BojahrB , TinnebergHR , LeylandN , AvelarR . A safety and efficacy study of a resorbable hydrogel for reduction of post-operative adhesions following myomectomy. Human Reproduction2008;23(5):1093-100. ">Mettler 2008</a> examined polyethylene glycol versus Ringer's lactate; <a href="./references#CD001298-bbs2-0029" title="ThorntonMH , JohnsDB , CampeauJD , HoehlerF , DiZeregaGS . Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open label pilot study. Human Reproduction1998;13(6):1480-5. ">Thornton 1998</a> examined 0.5% ferric hyaluronate gel versus Ringer's lactate; <a href="./references#CD001298-bbs2-0031" title="TrewG , PistofidisG , ZieglerN , KorrellM , BruckerS , RitterH , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray applied laparoscopically to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynecology2014;21:S90. TrewGH , PistofidisGA , BruckerSY , KrämerB , ZieglerNM , KorellM , et al. A first-in-human, randomized, controlled, subject- and reviewer-blinded multicenter study of ActamaxTM Adhesion Barrier. Archives of Gynecology and Obstetrics2017;295(2):383-95. TrewGH , PistofidisGA , BruckerSY , KraemerB , ZieglerNM , KorellM , et al. Twelve month follow-up of a first-In-human (FIH), randomized, controlled, subject- and reviewer-blinded study of a degradable hydrogel adhesion barrier spray (Actamax Adhesion Barrier) applied to all sites of surgical trauma following gynecologic laparoscopic surgery. Journal of Minimally Invasive Gynaecology2016;23:S203. ">Trew 2017</a> examined dextran aldehyde and polyethylene glycol versus no treatment. </p> <p>It is worth noting that 0.5% ferric hyaluronate gel (Intergel) was withdrawn from sale in 2003, due to concerns regarding its adverse event profile (<a href="./references#CD001298-bbs2-0063" title="US Food and Drug Administration. MedWatch: Managing Risks at the FDA. https://www.fda.gov/drugs/drug-information-consumers/medwatch-managing-risks-fda [Accessed 23.06.2020].">US Food and Drug Administration 2016</a>, <a href="./references#CD001298-bbs2-0066" title="WisemanDM . Possible Intergel Reaction Syndrome (pIRS). Annals of Surgery2006;244(4):630-632.">Wiseman 2006</a>). </p> <section id="CD001298-sec-0076"> <h5 class="title">Primary outcomes</h5> <section id="CD001298-sec-0077"> <h6 class="title">2.1 Pelvic pain</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0078"> <h6 class="title">2.2 Live birth rate</h6> <p>None of the studies assessed this outcome.</p> </section> </section> <section id="CD001298-sec-0079"> <h5 class="title">Secondary outcomes</h5> <section id="CD001298-sec-0080"> <h6 class="title">2.3 Incidence of adhesions at SLL</h6> <p>Six studies measured the effect of gel agents on the incidence of adhesions at SLL. Gel agents reduced the incidence of adhesions when compared with control (OR 0.26, 95% CI 0.12 to 0.57; P = 0.0015; I<sup>2</sup> = 0%; five studies analysed, 147 women; high‐quality evidence; <a href="./references#CD001298-fig-0021" title="">Analysis 2.1</a>; <a href="#CD001298-fig-0008">Figure 8</a>). </p> <div class="figure" id="CD001298-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Gel agent vs no treatment, outcome: 2.1 Incidence of adhesions at SLL" data-id="CD001298-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-08.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Gel agent vs no treatment, outcome: 2.1 Incidence of adhesions at SLL </p> </div> </div> </div> <p>This suggests that in women with an 84% chance of having adhesions at SLL with no gel agents, the use of gel agents would result in 39% to 75% of women having adhesions.. </p> <p><a href="./references#CD001298-bbs2-0029" title="ThorntonMH , JohnsDB , CampeauJD , HoehlerF , DiZeregaGS . Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open label pilot study. Human Reproduction1998;13(6):1480-5. ">Thornton 1998</a> also reported the incidence of adhesions as the proportion of sites with adhesions at SLL, rather than true incidence. The study reports a significantly lower proportion of sites having adhesions in the treatment group, in keeping with the results of our statistical analysis. These data are included in <a href="./references#CD001298-fig-0026" title="">Analysis 2.6</a> for reference. </p> </section> <section id="CD001298-sec-0081"> <h6 class="title">2.4 Mean adhesion score at SLL per participant</h6> <p>We are uncertain whether gel agents had an effect on mean adhesion scores at SLL when compared with control (SMD ‐0.24, 95% CI ‐0.55 to 0.08; I<sup>2</sup> = 0%; four studies, 159 women; moderate‐quality evidence; <a href="./references#CD001298-fig-0022" title="">Analysis 2.2</a>; <a href="#CD001298-fig-0009">Figure 9</a>). </p> <div class="figure" id="CD001298-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 2 Gel agent vs no treatment, outcome: 2.2 Mean adhesion score at SLL" data-id="CD001298-fig-0009" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-09.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 2 Gel agent vs no treatment, outcome: 2.2 Mean adhesion score at SLL </p> </div> </div> </div> <p><a href="./references#CD001298-bbs2-0008" title="FossumGT , SilverbergKM , MillerCE , DiamondMP , HolmdahlL . Gynecologic use of SepraSpray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy: a pilot study. Fertility and Sterility2011;96(2):487-91. ">Fossum 2011</a> presented data on the mean adhesion scores in graphical format, from which we read the data. Insufficient data were available to enable us to impute standard deviations, therefore, in accordance with Cochrane guidance, we used the average standard deviation from the three studies presenting numerical data. Caution is advised when interpreting this result. Excluding <a href="./references#CD001298-bbs2-0008" title="FossumGT , SilverbergKM , MillerCE , DiamondMP , HolmdahlL . Gynecologic use of SepraSpray Adhesion Barrier for reduction of adhesion development after laparoscopic myomectomy: a pilot study. Fertility and Sterility2011;96(2):487-91. ">Fossum 2011</a> from the meta‐analysis still found inconclusive results (SMD ‐0.48, 95% CI ‐1.13 to 0.17; P = 0.15; I<sup>2</sup> = 0%; three studies, 121 women). </p> <p><a href="./references#CD001298-bbs2-0029" title="ThorntonMH , JohnsDB , CampeauJD , HoehlerF , DiZeregaGS . Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open label pilot study. Human Reproduction1998;13(6):1480-5. ">Thornton 1998</a> also presented data regarding mean adhesion scores in graphical format, without standard deviations. Therefore, we read the data from the graph, and imputed the standard deviations based on available data. Including these data resulted in a high level of heterogeneity (SMD ‐1.24, 95% CI ‐1.77 to ‐0.71; P &lt; 0.001; I<sup>2</sup> = 87%; five studies, 179 women). This was the only study in this comparison that used Ringer's lactate as a control, rather than no treatment, which could account for the heterogeneity. Due to the high level of heterogeneity, we repeated the analysis, using a random‐effects model, (SMD ‐1.31, 95% CI ‐2.97 to 0.35; P = 0.128; I<sup>2</sup> = 87%). The results still crossed the line of no effect. Therefore, we decided to exclude <a href="./references#CD001298-bbs2-0029" title="ThorntonMH , JohnsDB , CampeauJD , HoehlerF , DiZeregaGS . Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open label pilot study. Human Reproduction1998;13(6):1480-5. ">Thornton 1998</a> from the analysis because of the high heterogeneity, the presentation of the results in graphical format, which may have been the potential reason for the heterogeneity, and the inconclusive results, even using a random‐effects model. We included the data in <a href="./references#CD001298-fig-0029" title="">Analysis 2.9</a> for reference only. </p> <p><a href="./references#CD001298-bbs2-0020" title="MettlerL , HuckeJ , BojahrB , TinnebergHR , LeylandN , AvelarR . A safety and efficacy study of a resorbable hydrogel for reduction of post-operative adhesions following myomectomy. Human Reproduction2008;23(5):1093-100. ">Mettler 2008</a> (polyethylene glycol vs Ringer's lactate) reported mean change in adhesion score, meaning that this data could not be included in our statistical analysis. They found that participants in the control group had significantly worse adhesion scores at SLL compared with those in the treatment group, whereas the results from our statistical analysis were inconclusive. Data from this study regarding change in mean adhesion score at SLL is included in <a href="./references#CD001298-fig-0027" title="">Analysis 2.7</a> for reference. </p> <p><a href="./references#CD001298-bbs2-0017" title="LundorffP , DonnezJ , KorellM , AudebertAJM , BlockK , diZeregaGS . Clinical evaluation of a viscoelastic gel for reduction of adhesions following gynaecological surgery by laparoscopy in Europe. Human Reproduction2004;20(2):514-20. ">Lundorff 2005</a> (polyethylene oxide and carboxymethylcellulose versus no treatment) reported mean change in adhesion score per adnexa, rather than per participant, and therefore could not be included in the statistical analysis. <a href="./references#CD001298-bbs2-0017" title="LundorffP , DonnezJ , KorellM , AudebertAJM , BlockK , diZeregaGS . Clinical evaluation of a viscoelastic gel for reduction of adhesions following gynaecological surgery by laparoscopy in Europe. Human Reproduction2004;20(2):514-20. ">Lundorff 2005</a> found that adnexae that had not been treated with polyethylene oxide and carboxymethylcellulose had significantly worse adhesions at SLL than adnexae that had been treated (<a href="./references#CD001298-fig-0028" title="">Analysis 2.8</a>), whereas the results from our statistical analysis were inconclusive. </p> </section> <section id="CD001298-sec-0082"> <h6 class="title">2.5 Clinical pregnancy rate</h6> <p>We are uncertain if auto‐cross‐linked hyaluronic acid has any effect on clinical pregnancy rates compared to no treatment (OR 0.20, 95% CI 0.02 to 2.02; P = 0.1271; one study, 30 women; low‐quality evidence; <a href="./references#CD001298-fig-0023" title="">Analysis 2.3</a>;). </p> </section> <section id="CD001298-sec-0083"> <h6 class="title">2.6 Improvement in adhesion score at SLL</h6> <p>We are uncertain if gel agents have any effect on the number of women with an improved adhesion score at SLL when compared with no treatment (OR 3.78, 95% CI 0.61 to 23.32; P = 0.15; I<sup>2</sup> = 0%; two studies, 58 women; <a href="./references#CD001298-fig-0024" title="">Analysis 2.4</a>; moderate‐quality evidence). </p> </section> <section id="CD001298-sec-0084"> <h6 class="title">2.7 Worsening of adhesion score at SLL</h6> <p>The use of gel agents may decrease the number of women with worse adhesion scores when compared with no treatment (OR 0.16, 95% CI 0.04 to 0.57; P = 0.005; I<sup>2</sup> = 0%; two studies, 58 women; <a href="./references#CD001298-fig-0025" title="">Analysis 2.5</a>; moderate‐quality evidence). </p> </section> <section id="CD001298-sec-0085"> <h6 class="title">2.8 Miscarriage rate</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0086"> <h6 class="title">2.9 Ectopic pregnancy rate</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0087"> <h6 class="title">2.10 Quality of life</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0088"> <h6 class="title">2.11 Adverse outcomes</h6> <p>None of the studies reported adverse outcomes attributable to the intervention of interest. </p> </section> </section> </section> <section id="CD001298-sec-0089"> <h4 class="title">3. Gel agents versus hydroflotation agents used as instillants</h4> <p>Three studies examined the effects of gel agents versus hydroflotation agents used as instillants: <a href="./references#CD001298-bbs2-0013" title="JohnsBD , KeyportGM , HoehlerF , diZeregaG . Reduction of postsurgical adhesions with Intergel adhesion prevention solution: a multicenter study of safety and efficacy after conservative gynecologic surgery. Fertility and Sterility2001;76(3):595-604. ">Johns 2001</a> and <a href="./references#CD001298-bbs2-0016" title="LundorffP , GeldorpH , TronstadSE , LalosO , LarssonB , JohnsDB , et al. Reduction of postsurgical adhesions with ferric hyaluronate gel: a European study. Human Reproduction2001;16(9):1982-8. ">Lundorff 2001</a> examined 0.5% ferric hyaluronate gel versus saline; <a href="./references#CD001298-bbs2-0015" title="LiuC , LuQ , ZhangZ , XueM , ZhangY , ZhangY , et al. A randomized controlled trial on the efficacy and safety of a new crosslinked hyaluronan gel in reducing adhesions after gynecologic laparoscopic surgeries. The Journal of Minimally Invasive Gynaecology2015;22(5):853-63. LiuC , ZhangZ , LuQ , ZhangZ . The efficacy and safety of a new cross-linked hyaluronan hydrogel in the reduction of postsurgical adhesions after laparoscopic gynecological surgery: a randomized controlled trial. The Journal of Minimally Invasive Gynaecology2014;21:S59-60. ">Liu 2015</a> examined cross‐linked hyaluronic acid versus saline. </p> <p>It is worth noting that 0.5% ferric hyaluronate gel (Intergel) was withdrawn from sale in 2003, due to concerns regarding its adverse event profile (<a href="./references#CD001298-bbs2-0063" title="US Food and Drug Administration. MedWatch: Managing Risks at the FDA. https://www.fda.gov/drugs/drug-information-consumers/medwatch-managing-risks-fda [Accessed 23.06.2020].">US Food and Drug Administration 2016</a>, <a href="./references#CD001298-bbs2-0066" title="WisemanDM . Possible Intergel Reaction Syndrome (pIRS). Annals of Surgery2006;244(4):630-632.">Wiseman 2006</a>). </p> <section id="CD001298-sec-0090"> <h5 class="title">Primary outcomes</h5> <section id="CD001298-sec-0091"> <h6 class="title">3.1 Pelvic pain</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0092"> <h6 class="title">3.2 Live birth rate</h6> <p>None of the studies assessed this outcome.</p> </section> </section> <section id="CD001298-sec-0093"> <h5 class="title">Secondary outcomes</h5> <section id="CD001298-sec-0094"> <h6 class="title">3.3 Incidence of adhesions at SLL</h6> <p>Gel agents probably reduce the incidence of adhesions when compared with hydroflotation agents as an instillant (OR 0.50, 95% CI 0.31 to 0.83, P = 0.007; I<sup>2</sup> = 53%, substantial heterogeneity; three studies, 538 women; moderate‐quality evidence; <a href="./references#CD001298-fig-0031" title="">Analysis 3.1</a>; <a href="#CD001298-fig-0010">Figure 10</a>). </p> <div class="figure" id="CD001298-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 3 Gel agent vs hydroflotation agent when used as an instillant, outcome: 3.1 Incidence of adhesions at SLL" data-id="CD001298-fig-0010" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-10.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 3 Gel agent vs hydroflotation agent when used as an instillant, outcome: 3.1 Incidence of adhesions at SLL </p> </div> </div> </div> <p>This suggests that in women with a 46% chance of having adhesions at SLL with a hydroflotation agent, the use of gel agents would result in 21% to 41% of women having adhesions. </p> <p>We found substantial heterogeneity, and were unable to identify a clear methodological cause for it. We repeated the analysis using a random‐effects model, which resulted in 95% confidence intervals that crossed the line of no effect (OR 0.55, 95% CI 0.25 to 1.22; P = 0.12, I<sup>2</sup> = 53%, substantial heterogeneity; three studies, 538 women). </p> <p>As we were unable to identify a clear cause for the heterogeneity, we used the fixed‐effect model for the analysis, but downgraded the quality of evidence due to inconsistency in the results. </p> </section> <section id="CD001298-sec-0095"> <h6 class="title">3.4 Mean adhesion score at SLL per participant</h6> <p>We are uncertain whether gel agents improved mean adhesion scores at SLL when compared with hydroflotation agents (MD ‐0.79, 95% CI ‐0.82 to ‐0.76; P &lt; 0.00001; one study, 77 women; very low‐quality evidence <a href="./references#CD001298-fig-0032" title="">Analysis 3.2</a>). </p> <p>The review authors noted that the standard deviations reported in the publication appeared to be very precise for a study that included only 38 women in each arm, and therefore, we thought this result was incorrect. We contacted the study authors for clarification, however, we did not receive a response. Because the standard deviations were so low, we thought that perhaps the study authors had erroneously reported standard errors, instead. Based on this assumption, we imputed new standard deviations and recalculated (MD ‐0.79, 95% CI ‐0.82 to ‐0.76; P &lt; 0.00001; one study, 77 women; low‐quality evidence). These results still appear to be too accurate for a study of 77 women, but we felt they were more plausible than the initial findings. Therefore, these are the results we used for this analysis; we urge caution when interpreting these results. </p> </section> <section id="CD001298-sec-0096"> <h6 class="title">3.5 Clinical pregnancy rate</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0097"> <h6 class="title">3.6 Improvement in adhesion score at SLL</h6> <p>There was little or no difference in the number of women with an improved adhesion score at SLL between those for whom hyaluronic acid was used and those for whom saline, as an instillant, was used (OR 1.55, 95% CI 0.82 to 2.92; P = 0.17; I<sup>2</sup> = 0%; two studies, 342 women; moderate‐quality evidence; <a href="./references#CD001298-fig-0033" title="">Analysis 3.3</a>). </p> </section> <section id="CD001298-sec-0098"> <h6 class="title">3.7 Worsening of adhesion score at SLL</h6> <p>Hyaluronic acid decreased the number of women with worse adhesion scores compared with saline. (OR 0.28, 95% CI 0.12 to 0.66; P = 0.003; I<sup>2</sup> = 0%; two studies, 342 women; high‐quality evidence; <a href="./references#CD001298-fig-0034" title="">Analysis 3.4</a>. </p> </section> <section id="CD001298-sec-0099"> <h6 class="title">3.8 Miscarriage rate</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0100"> <h6 class="title">3.9 Ectopic pregnancy rate</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0101"> <h6 class="title">3.10 Quality of life</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0102"> <h6 class="title">3.11 Adverse outcomes</h6> <p>None of the studies reported adverse outcomes attributable to the intervention of interest. </p> </section> </section> </section> <section id="CD001298-sec-0103"> <h4 class="title">4. Steroids (including systemic, intraperitoneal, preoperative, and postoperative) versus no steroids (or placebo) </h4> <p>Four studies examined the effects of steroids versus no steroids (or placebo): <a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a> examined intraperitoneal hydrocortisone, intravenous dexamethasone, and oral prednisolone versus no steroids; <a href="./references#CD001298-bbs2-0012" title="JansenRPS . Controlled clinical approaches to investigating the prevention of peritoneal adhesions. In: Treatment of Postsurgical Adhesions. Vol. 358. New York: Wiley-Liss Inc, 1990:177-92. ">Jansen 1990</a> examined oral prednisolone vs no steroids; <a href="./references#CD001298-bbs2-0022" title="QuerleuD , Vankeerberghen-DeffenseF , BoutevilleC . The effect of noxytioline and systemic corticosteroids in infertility surgery. A prospective randomized study [Traitement adjuvant des plasties tubaires. Etude prospective randomisee des corticoides par voie generale et de la noxytioline]. Journal de Gynecologie Obstetrique et Biologie de la Reproduction1989;18(7):935-40. ">Querleu 1989</a> examined intramuscular dexamethasone versus no steroids; <a href="./references#CD001298-bbs2-0023" title="RockJA , SieglerAM , Boer MieselM , HaneyAF , RosenwaksZ , Pardo-VargasF , et al. The efficacy of postoperative hydrotubation: a randomized prospective multicenter clinical trial. Fertility and Sterility1984;42:373-6. ">Rock 1984</a> examined intraperitoneal hydrocortisone versus saline. </p> <p>At the original version of this review authors decided toÂ combine studies of steroids using any mode of delivery. We did not change that approach at this update. </p> <section id="CD001298-sec-0104"> <h5 class="title">Primary outcomes</h5> <section id="CD001298-sec-0105"> <h6 class="title">4.1 Pelvic pain</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0106"> <h6 class="title">4.2 Live birth rate</h6> <p>It is unclear whether steroids affected live birth rates compared with no steroids (OR 0.65, 95% CI 0.26 to 1.62; P = 0.35; I<sup>2</sup> = 0%; two studies, 223 women; low‐quality evidence; <a href="./references#CD001298-fig-0035" title="">Analysis 4.1</a>; <a href="#CD001298-fig-0011">Figure 11</a>), </p> <div class="figure" id="CD001298-fig-0011"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 11</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 4 Steroid (any route) vs no steroid, outcome: 4.1 Live birth rate" data-id="CD001298-fig-0011" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-11.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 4 Steroid (any route) vs no steroid, outcome: 4.1 Live birth rate </p> </div> </div> </div> </section> </section> <section id="CD001298-sec-0107"> <h5 class="title">Secondary outcomes</h5> <section id="CD001298-sec-0108"> <h6 class="title">4.3 Incidence of adhesions at SLL</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0109"> <h6 class="title">4.4 Mean adhesion score at SLL per participant</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0110"> <h6 class="title">4.5 Clinical pregnancy rate</h6> <p>Steroids had little or no effect on clinical pregnancy rates at SLL, when compared with control. (OR 1.01, 95% CI 0.66 to 1.55; P = 0.96; I<sup>2</sup> = 0%; three studies, 410 women; low‐quality evidence; <a href="./references#CD001298-fig-0036" title="">Analysis 4.2</a>). </p> </section> <section id="CD001298-sec-0111"> <h6 class="title">4.6 Improvement in adhesion score at SLL</h6> <p>The use of intravenous dexamethasone and oral prednisolone may increase the number of women with improved adhesion scores at SLL, when compared with control (OR 4.83, 95% CI 1.71 to 13.65; P = 0.0029; one study, 75 women; low‐quality evidence; <a href="./references#CD001298-fig-0037" title="">Analysis 4.3</a>; <a href="./references#CD001298-bbs2-0012" title="JansenRPS . Controlled clinical approaches to investigating the prevention of peritoneal adhesions. In: Treatment of Postsurgical Adhesions. Vol. 358. New York: Wiley-Liss Inc, 1990:177-92. ">Jansen 1990</a>). </p> <p>The data from this study were taken from the 2006 update of this review (<a href="./references#CD001298-bbs2-0068" title="MetwallyM , WatsonA , LilfordR , VandekerckhoveP . Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database of Systematic Reviews2006, Issue 4. Art. No: CD001298. [DOI: 10.1002/14651858.CD001298.pub3]">Metwally 2006</a>). The data are unpublished and were supplied by the study author, with little information about the characteristics of the study. We urge caution in interpreting this result. </p> </section> <section id="CD001298-sec-0112"> <h6 class="title">4.7 Worsening of adhesion score at SLL</h6> <p>The use of steroids may decrease the number of women with worse adhesion scores at SLL when compared with control (OR 0.27, 95% CI 0.12 to 0.58; P = 0.0008; I<sup>2</sup> = 0%; two studies, 187 women; low‐quality evidence; <a href="./references#CD001298-fig-0038" title="">Analysis 4.4</a>). </p> </section> <section id="CD001298-sec-0113"> <h6 class="title">4.8 Miscarriage rate</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0114"> <h6 class="title">4.9 Ectopic pregnancy rate</h6> <p>The results were inconclusive for ectopic pregnancy rates between women who received steroids and those who did not (OR 0.90, 95% CI 0.30 to 2.66; P = 0.85; I<sup>2</sup> = 60%; three studies, 83 women; very low‐quality evidence; <a href="./references#CD001298-fig-0039" title="">Analysis 4.5</a>). </p> <p>We found substantial heterogeneity, which is likely because one study showed a different direction of effect from the other two included studies (<a href="./references#CD001298-bbs2-0023" title="RockJA , SieglerAM , Boer MieselM , HaneyAF , RosenwaksZ , Pardo-VargasF , et al. The efficacy of postoperative hydrotubation: a randomized prospective multicenter clinical trial. Fertility and Sterility1984;42:373-6. ">Rock 1984</a>). I<sup>2</sup> is reduced to 0% with the removal of data from that study however the confidence intervals in the resulting analysis still crossed the line of no effect (OR 0.21, 95% CI 0.03 to 1.36; P = 0.10). Including all three studies and using a random‐effects model still resulted in broad confidence intervals which crossed the line of no effect (OR 0.67, 95% CI 0.08 to 5.70; P = 0.71; three studies, 83 women; I<sup>2</sup> = 60%). </p> <p>As there is no clear methodological cause for the differing direction of effect found in <a href="./references#CD001298-bbs2-0023" title="RockJA , SieglerAM , Boer MieselM , HaneyAF , RosenwaksZ , Pardo-VargasF , et al. The efficacy of postoperative hydrotubation: a randomized prospective multicenter clinical trial. Fertility and Sterility1984;42:373-6. ">Rock 1984</a>, we used the fixed‐effect model for the analysis, but downgraded the quality of evidence due to inconsistency in the results. </p> </section> <section id="CD001298-sec-0115"> <h6 class="title">4.10 Quality of life</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0116"> <h6 class="title">4.11 Adverse outcomes</h6> <p>None of the studies reported adverse outcomes attributable to the intervention of interest. </p> </section> </section> </section> <section id="CD001298-sec-0117"> <h4 class="title">5. Intraperitoneal noxytioline versus no noxytioline (or placebo)</h4> <p>One study examined the effects of noxytioline versus no noxytioline (<a href="./references#CD001298-bbs2-0022" title="QuerleuD , Vankeerberghen-DeffenseF , BoutevilleC . The effect of noxytioline and systemic corticosteroids in infertility surgery. A prospective randomized study [Traitement adjuvant des plasties tubaires. Etude prospective randomisee des corticoides par voie generale et de la noxytioline]. Journal de Gynecologie Obstetrique et Biologie de la Reproduction1989;18(7):935-40. ">Querleu 1989</a>). </p> <section id="CD001298-sec-0118"> <h5 class="title">Primary outcomes</h5> <section id="CD001298-sec-0119"> <h6 class="title">5.1 Pelvic pain</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0120"> <h6 class="title">5.2 Live birth rate</h6> <p>None of the studies assessed this outcome.</p> </section> </section> <section id="CD001298-sec-0121"> <h5 class="title">Secondary outcomes</h5> <section id="CD001298-sec-0122"> <h6 class="title">5.3 Incidence of adhesions at SLL</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0123"> <h6 class="title">5.4 Mean adhesion score at SLL per participant</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0124"> <h6 class="title">5.5 Clinical pregnancy rate</h6> <p>Due to wide confidence intervals we are uncertain whether intraperitoneal noxytioline affected clinical pregnancy rates (OR 0.66, 95% CI 0.30 to 1.47; P = 0.31; one study, 126 women; low‐quality evidence; <a href="./references#CD001298-fig-0040" title="">Analysis 5.1</a>). </p> </section> <section id="CD001298-sec-0125"> <h6 class="title">5.6 Improvement in adhesion score at SLL</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0126"> <h6 class="title">5.7 Worsening of adhesion score at SLL</h6> <p>Due to wide confidence intervals we are uncertain whether intraperitoneal noxytioline affected the number of women with a worse adhesion score at SLL (OR 0.55, 95% CI 0.17 to 1.76; P = 0.32; one study, 87 women; low‐quality evidence; <a href="./references#CD001298-fig-0041" title="">Analysis 5.2</a>). </p> </section> <section id="CD001298-sec-0127"> <h6 class="title">5.8 Miscarriage rate</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0128"> <h6 class="title">5.9 Ectopic pregnancy rate</h6> <p>Due to wide confidence intervals we are uncertain whether intraperitoneal noxytioline affected ectopic pregnancy rates (OR 4.91, 95% CI 0.45 to 53.27; P = 0.19; one study, 33 women; low‐quality evidence; <a href="./references#CD001298-fig-0042" title="">Analysis 5.3</a>). </p> </section> <section id="CD001298-sec-0129"> <h6 class="title">5.10 Quality of life</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0130"> <h6 class="title">5.11 Adverse outcomes</h6> <p>None of the studies reported adverse outcomes attributable to the intervention of interest. </p> </section> </section> </section> <section id="CD001298-sec-0131"> <h4 class="title">6. Intraperitoneal heparin versus no heparin (or placebo)</h4> <p>One study examined the effects of heparin versus no heparin (<a href="./references#CD001298-bbs2-0011" title="JansenRPS . Failure of peritoneal irrigation with heparin during pelvic operations upon young women to reduce adhesions. Surgery, Gynecology &amp; Obstetrics1988;166:154-60. ">Jansen 1988</a>). </p> <section id="CD001298-sec-0132"> <h5 class="title">Primary outcomes</h5> <section id="CD001298-sec-0133"> <h6 class="title">6.1 Pelvic pain</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0134"> <h6 class="title">6.2 Live birth rate</h6> <p>None of the studies assessed this outcome.</p> </section> </section> <section id="CD001298-sec-0135"> <h5 class="title">Secondary outcomes</h5> <section id="CD001298-sec-0136"> <h6 class="title">6.3 Incidence of adhesions at SLL</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0137"> <h6 class="title">6.4 Mean adhesion score at SLL per participant</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0138"> <h6 class="title">6.5 Clinical pregnancy rate</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0139"> <h6 class="title">6.6 Improvement in adhesion score at SLL</h6> <p>Due to wide confidence intervals we are uncertain whether intraperitoneal heparin affected the number of women with improved adhesion scores at SLL (OR 0.87, 95% CI 0.32 to 2.35; P = 0.78; one study, 63 women; low‐quality evidence; <a href="./references#CD001298-fig-0043" title="">Analysis 6.1</a>). </p> </section> <section id="CD001298-sec-0140"> <h6 class="title">6.7 Worsening of adhesion score at SLL</h6> <p>Due to wide confidence intervals we are uncertain whether intraperitoneal heparin affected the number of women with worsened adhesion scores at SLL (OR 1.27, 95% CI 0.56 to 2.91; P = 0.57; one study, 92 women; low‐quality evidence; <a href="./references#CD001298-fig-0044" title="">Analysis 6.2</a>). </p> </section> <section id="CD001298-sec-0141"> <h6 class="title">6.8 Miscarriage rate</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0142"> <h6 class="title">6.9 Ectopic pregnancy rate</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0143"> <h6 class="title">6.10 Quality of life</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0144"> <h6 class="title">6.11 Adverse outcomes</h6> <p>None of the studies reported adverse outcomes attributable to the intervention of interest. </p> </section> </section> </section> <section id="CD001298-sec-0145"> <h4 class="title">7. Systemic promethazine versus no promethazine (or placebo)</h4> <p>One study examined the effects of promethazine versus no promethazine<b><i>(</i> </b><a href="./references#CD001298-bbs2-0012" title="JansenRPS . Controlled clinical approaches to investigating the prevention of peritoneal adhesions. In: Treatment of Postsurgical Adhesions. Vol. 358. New York: Wiley-Liss Inc, 1990:177-92. ">Jansen 1990</a>). </p> <section id="CD001298-sec-0146"> <h5 class="title">Primary outcomes</h5> <section id="CD001298-sec-0147"> <h6 class="title">7.1 Pelvic pain</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0148"> <h6 class="title">7.2 Live birth rate</h6> <p>None of the studies assessed this outcome.</p> </section> </section> <section id="CD001298-sec-0149"> <h5 class="title">Secondary outcomes</h5> <section id="CD001298-sec-0150"> <h6 class="title">7.3 Incidence of adhesions at SLL</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0151"> <h6 class="title">7.4 Mean adhesion score at SLL per participant</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0152"> <h6 class="title">7.5 Clinical pregnancy rate</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0153"> <h6 class="title">7.6 Improvement in adhesion score at SLL</h6> <p>Due to wide confidence intervals we are uncertain whether promethazine affected the number of women with improved adhesion scores at SLL (OR 0.56, 95% CI 0.22 to 1.43; P = 0.22; one study, 75 women; low‐quality evidence; <a href="./references#CD001298-fig-0045" title="">Analysis 7.1</a>). </p> </section> <section id="CD001298-sec-0154"> <h6 class="title">7.7 Worsening of adhesion score at SLL</h6> <p>Due to wide confidence intervals we are uncertain whether promethazine affected the number of women with worsened adhesion scores at SLL (OR 0.59, 95% CI 0.25 to 1.42; P = 0.24; one study, 93 women; low‐quality evidence; <a href="./references#CD001298-fig-0046" title="">Analysis 7.2</a>). </p> </section> <section id="CD001298-sec-0155"> <h6 class="title">7.8 Miscarriage rate</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0156"> <h6 class="title">7.9 Ectopic pregnancy rate</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0157"> <h6 class="title">7.10 Quality of life</h6> <p>None of the studies assessed this outcome.</p> </section> <section id="CD001298-sec-0158"> <h6 class="title">7.11 Adverse outcomes</h6> <p>None of the studies reported adverse outcomes attributable to the intervention of interest. </p> </section> </section> </section> <section id="CD001298-sec-0159"> <h4 class="title">8. Gonadotropin‐releasing hormone (GnRHa) versus no GnRHa (or placebo)</h4> <p>One study examined the use of GnRHa as an anti‐adhesion agent versus no GnRHa (<a href="./references#CD001298-bbs2-0004" title="CoddingtonC , GrowD , AhmedM , TonerJ , CookE , DiamondM . Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial. Fertility and Sterility2009;91:1909-13. ">Coddington 2009</a>; N = 18). </p> <p>The results were inconclusive for the size of the area of adhesions (in cm<sup>2</sup>) at SLL between the women who received GnRHa and those who did not. Data from this study could not be included in a statistical analysis, but the study reported inconclusive results between groups (<a href="./references#CD001298-fig-0047" title="">Analysis 8.1</a>). </p> </section> <section id="CD001298-sec-0160"> <h4 class="title">9. Reteplase plasminogen activator versus no reteplase plasminogen activator (or placebo)</h4> <p>One study examined the use of reteplase plasminogen activator versus saline (<a href="./references#CD001298-bbs2-0009" title="HellebrekersBWJ , Trimbos-KemperTCM , BoestenL , JansenFW , KolkmanW , TrimbosJB , et al. Preoperative predictors of postsurgical adhesion formation and the prevention of adhesions with plasminogen activator (PAPA-study): results of a clinical pilot study. Fertility and Sterility2009;91(4):1204-14. ">Hellebrekers 2009</a>; N = 25) </p> <p>The results were inconclusive for the incidence of adhesions at SLL between the women who received reteplase plasminogen activator and those who did not. Data from this study could not be included in a statistical analysis, but the study reported inconclusive results between groups (<a href="./references#CD001298-fig-0048" title="">Analysis 9.1</a>). </p> </section> <section id="CD001298-sec-0161"> <h4 class="title">10. N,O‐carboxymethyl chitosan versus no N,O‐carboxymethyl chitosan (or placebo)</h4> <p>One study examined the effects of N,O‐carboxymethyl chitosan versus no N,O‐carboxymethyl chitosan (<a href="./references#CD001298-bbs2-0006" title="DiamonMP , LucianoA , JohnsA , DunnR , YoungP , Bieber E. Reduction of postoperative adhesions by N, O-carboxymethylchitosan: a pilot study. Fertility and Sterility2003;80(3):631-6. ">Diamond 2003</a>; N = 33) </p> <p>This study reported data regarding adhesion extent and severity, however did not report overall adhesion score. This data is available in <a href="./references#CD001298-fig-0049" title="">Analysis 10.1</a> and <a href="./references#CD001298-fig-0050" title="">Analysis 10.2</a> for reference. The study states that N,O‐carboxymethyl chitosan resulted in significantly improved adhesion severity and extent compared with control, however did not provide enough data to allow for statistical analysis. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD001298-sec-0162" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD001298-sec-0162"></div> <section id="CD001298-sec-0163"> <h3 class="title" id="CD001298-sec-0163">Summary of main results</h3> <p>One study, evaluating a hydroflotation agent, measured pelvic pain as an outcome; we are uncertain whether it had any effect. Due to wide confidence intervals, which crossed the line of no effect, it is unclear whether hydroflotation agents or steroids affected live birth rates. No other studies measured these outcomes. </p> <p>Hydroflotation agents and gel agents (including those containing hyaluronic acid, polyethylene glycol (PEG) and polyethylene oxide (PEO) compared with no treatment reduced the incidence of adhesions at second‐look laparoscopy (SLL). </p> <p>Hydroflotation agents compared with no treatment probably made little or no difference to mean adhesion scores at SLL. We are uncertain whether gel agents compared with no treatment had an effect on mean adhesion scores at SLL. </p> <p>Steroids (compared with no treatment or placebo) may decrease the likelihood of a worse adhesion score, and may increase the likelihood of an improved adhesion score at SLL. </p> <p>Due to wide confidence intervals that crossed the line of no effect, it is unclear whether noxytioline, heparin, or promethazine affected adhesion formation. </p> <p>Due to wide confidence intervals that crossed the line of no effect, it is unclear whether hydroflotation agents, gel agents, steroids, or noxytioline affected clinical pregnancy rate. Wide confidence intervals that crossed the line of no effect also mean it is unclear whether hydroflotation agents, gel agents, or steroids affected ectopic pregnancy rates. No studies reported data regarding clinical or ectopic pregnancy rates for any other intervention. No studies reported the effect of any intervention on miscarriage rates. </p> <p>In many comparisons, wide confidence intervals that crossed the line of no effect meant we could not exclude the possibility that interventions may have resulted in clinical harms rather than clinical benefits. </p> <p>None of the studies reported quality of life.</p> <p>The fluid and pharmacological agents examined in this review appeared to be safe; investigators in all included studies, apart from two, stated that they were going to assess serious adverse outcomes that may be due to these agents, and none reported any. </p> <p>Several studies could not be included in any statistical analyses, but were included in the review; the findings of these studies were broadly consistent with the findings of our statistical analyses. </p> </section> <section id="CD001298-sec-0164"> <h3 class="title" id="CD001298-sec-0164">Overall completeness and applicability of evidence</h3> <p>Adhesion formation is a complex process that is affected by many factors. The ongoing pathological process, the magnitude of surgical insult, infection, and haemostasis after surgery may influence the formation of adhesions after surgery. The studies included in this review included heterogeneous women, with diverse gynaecological pathology, who were undergoing both minimal access procedures and open surgery. </p> <p>In addition, some studies looked at adhesion prophylaxis as a primary prevention of de novo adhesions after surgery, whilst others looked at secondary prevention after surgical adhesiolysis to prevent re‐formation. Unfortunately, we were unable to conduct a subgroup analysis, comparing the effects of anti‐adhesion agents on de novo adhesions versus re‐formed adhesions, as too few studies discriminated between the different types of adhesions. </p> <p>Only one study measured pelvic pain. It is important to note, that although a causal relationship has been established between adhesions and infertility (or bowel obstruction), the correlation between adhesions and pelvic pain is uncertain (<a href="./references#CD001298-bbs2-0053" title="HammoudA , GagoLA , DiamondMP . Adhesions in patients with chronic pelvic pain: a role for adhesiolysis?Fertility and Sterility2004;82:1483-91.">Hammoud 2004</a>). </p> <p>Three studies reported live birth rate, although these were mainly the earlier studies, conducted in 1984, 1985, and 2003. </p> <p>We noted a gap in knowledge about the effects that anti‐adhesion agents have on quality of life; we did not identify any studies that examined this. </p> <p>Studies included in this review were conducted in the USA, Europe, Australia, the Netherlands, Italy, Sweden, the UK, Germany, China, Canada and the Netherlands Antilles; these results are applicable to developed countries. </p> </section> <section id="CD001298-sec-0165"> <h3 class="title" id="CD001298-sec-0165">Quality of the evidence</h3> <p>We assessed the quality of the evidence using the GRADE approach. Quality ranged from very low to high. The main reasons for downgrading the evidence were imprecision (small sample sizes, wide confidence intervals), and poor reporting of study methods. </p> <p>We included pilot studies, and although eight studies performed a power calculation, most studies were not statistically powered to detect differences between treatments, although this fact would not have affected internal validity. We were unable to include the results of a number of studies because of the way researchers assessed adhesions. We contacted study authors for complete results, so we could include them in the meta‐analyses, but we did not receive a reply from most of them. </p> <p>Despite the fact that the American Fertility Society developed a scoring system (AFS or mAFS), and advised that it be used in trials, this was not always the case, and we had to calculate a standardised mean difference, or, as mentioned, we were unable to use results. The review authors are not aware of one method of assessing adhesions shown to have more bearing on clinical outcomes (pelvic pain, clinical pregnancy and live birth rates) than another. The different methods of reporting adhesions led to previous versions of this review including a variety of similar secondary outcomes for measuring adhesions, to enable maximum study inclusion (<a href="./references#CD001298-bbs2-0067" title="AhmadG , MackieFL , IlesDA , O'FlynnH , DiasS , MetwallyM , et al. Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database of Systematic Reviews2014, Issue 7. Art. No: CD001298. [DOI: 10.1002/14651858.CD001298.pub4]">Ahmad 2014</a>, <a href="./references#CD001298-bbs2-0068" title="MetwallyM , WatsonA , LilfordR , VandekerckhoveP . Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database of Systematic Reviews2006, Issue 4. Art. No: CD001298. [DOI: 10.1002/14651858.CD001298.pub3]">Metwally 2006</a>, <a href="./references#CD001298-bbs2-0069" title="WatsonA , Vandekerckhove, LilfordR . Subfertility: Pelvic surgery: Pharmacological and liquid adjuncts to prevent adhesions. Cochrane Database of Systematic Reviews2000, Issue 4. Art. No: CD001298. [DOI: 10.1002/14651858.CD001298]">Watson 2000</a>). At this update no changes were made to the secondary outcomes included in the previous update (<a href="./references#CD001298-bbs2-0067" title="AhmadG , MackieFL , IlesDA , O'FlynnH , DiasS , MetwallyM , et al. Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database of Systematic Reviews2014, Issue 7. Art. No: CD001298. [DOI: 10.1002/14651858.CD001298.pub4]">Ahmad 2014</a>). Incomplete data limited our ability to interpret some results. </p> <p><a href="./references#CD001298-bbs2-0012" title="JansenRPS . Controlled clinical approaches to investigating the prevention of peritoneal adhesions. In: Treatment of Postsurgical Adhesions. Vol. 358. New York: Wiley-Liss Inc, 1990:177-92. ">Jansen 1990</a> was included in the previous version, and we used the same data in this review. The study author provided the results, but little information on the characteristics of the study; therefore, these results should also be interpreted with caution. </p> </section> <section id="CD001298-sec-0166"> <h3 class="title" id="CD001298-sec-0166">Potential biases in the review process</h3> <p>The review authors made every effort to identify all studies that should be considered for inclusion. Although the previously included studies were all reassessed for bias, some information was required from the study authors themselves. We attempted to contact them, but received no responses. </p> </section> <section id="CD001298-sec-0167"> <h3 class="title" id="CD001298-sec-0167">Agreements and disagreements with other studies or reviews</h3> <p>We identified a systematic review, with meta‐analysis, of the efficacy of auto‐cross‐linked hyaluronan gel for adhesion prevention in laparoscopy and hysteroscopy. It concluded that the gel prevented both intraperitoneal adhesions after laparoscopic myomectomy, and intrauterine adhesions after hysteroscopic surgery (<a href="./references#CD001298-bbs2-0059" title="MaisV , CirronisMG , PeirettiM , FerrucciG , CossuE , MelisGB . Efficacy of auto-crosslinked hyaluronan gel for adhesion prevention in laparoscopy and hysteroscopy: a systematic review and meta-analysis of randomized controlled trials.. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2012 January;160(1):1-5.">Mais 2012</a>). </p> <p>A Cochrane Review, analysing adhesion prevention after non‐gynaecological abdominal surgery included a single study looking at fluid and pharmacological agents (<a href="./references#CD001298-bbs2-0056" title="KumarS , WongPF , LeaperDJ . Intra-peritoneal prophylactic agents for preventing adhesions and adhesive intestinal obstruction after non-gynaecological abdominal surgery. Cochrane Database of Systematic Reviews2009, Issue 21. Art. No: CD005080. [DOI: 10.1002/14651858.CD005080.pub2]">Kumar 2009</a>). In this study, women underwent surgery during which the gastrointestinal tract was opened (<a href="./references#CD001298-bbs2-0062" title="TangCL , JayneDG , Seow-ChoenF , NgYY , EuKW , MustaphaN . A randomized controlled trial of 0.5% ferric hyaluronate gel (Intergel) in the prevention of adhesions following abdominal surgery. Annals of Surgery2006r;243(4):449-55.">Tang 2006</a>). An unacceptably higher rate of postoperative complications was reported for women receiving 0.5% ferric hyaluronate gel. Recruitment was suspended, and efficacy was not assessed. </p> <p>Both the Society of Obstetricians and Gynaecologists of Canada and the American Society of Reproductive Medicine Practice Committee have published documents stating that evidence of efficacy of fluid or pharmacological agents was insufficient (<a href="./references#CD001298-bbs2-0047" title="Practice Committee of American Society for Reproductive Medicine in collaboration with Society of Reproductive Surgeons. Pathogenesis, consequences, and control of peritoneal adhesions in gynecologic surgery: a committee opinion. Fertility and Sterility2013;99(6):1550-5.">ASRM 2013</a>; <a href="./references#CD001298-bbs2-0061" title="RobertsonD , LefebvreG , LeylandN , WolfmanW , AllaireC , AwadallaA , et al, Society of Obstetricians and Gynaecologists of Canada. SOGC clinical practice guidelines: adhesion prevention in gynaecological surgery. International Journal of Gynaecology and Obstetrics2010;111(2):193-7.">Robertson 2010</a>). The Anti‐adhesions in Gynaecology Expert Panel for the European Society for Gynaecological Endoscopy has published a consensus position that is consistent with the conclusion of our review: evidence for pharmacological agents is lacking; gels and 4% icodextrin probably reduce adhesions (<a href="./references#CD001298-bbs2-0049" title="De WildeRL , TrewG . Postoperative abdominal adhesions and their prevention in gynaecological surgery. Expert consensus position. Part 2—steps to reduce adhesions. Gynaecological Surgery2007;4(4):243-53.">De Wilde 2007</a>). The same panel published guidelines to encourage the adoption of adhesion reduction strategies, advising clinicians to consider agents with data supporting safety and efficacy (<a href="./references#CD001298-bbs2-0050" title="De WildeRL , BrölmannH , KoninckxPR , LundorffP , LowerAM , WattiezA , et al, the Anti-Adhesions in Gynecology Expert Panel (ANGEL). Prevention of adhesions in gynaecological surgery: the 2012 European field guideline. Gynecological Surgery2012;9(4):365-8.">De Wilde 2012</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD001298-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD001298-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-FIG-02" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study" data-id="CD001298-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-FIG-03" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item, presented as percentages across all included studies" data-id="CD001298-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each 'Risk of bias' item, presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Hydroflotation agent vs no hydroflotation agent, outcome: 1.2 Live birth rate" data-id="CD001298-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hydroflotation agent vs no hydroflotation agent, outcome: 1.2 Live birth rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Hydroflotation agent vs no hydroflotation agent, outcome: 1.3 Incidence of adhesions at SLL" data-id="CD001298-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hydroflotation agent vs no hydroflotation agent, outcome: 1.3 Incidence of adhesions at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Hydroflotation agent vs no treatment, outcome: 1.4 Mean adhesion score at SLL" data-id="CD001298-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hydroflotation agent vs no treatment, outcome: 1.4 Mean adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-FIG-07" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Hydroflotation agent vs no treatment, outcome: 1.5 Clinical pregnancy rate" data-id="CD001298-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-FIG-07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Hydroflotation agent vs no treatment, outcome: 1.5 Clinical pregnancy rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-FIG-08" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Gel agent vs no treatment, outcome: 2.1 Incidence of adhesions at SLL" data-id="CD001298-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-FIG-08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Gel agent vs no treatment, outcome: 2.1 Incidence of adhesions at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-FIG-09" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 2 Gel agent vs no treatment, outcome: 2.2 Mean adhesion score at SLL" data-id="CD001298-fig-0009" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-FIG-09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Forest plot of comparison: 2 Gel agent vs no treatment, outcome: 2.2 Mean adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-FIG-10" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 3 Gel agent vs hydroflotation agent when used as an instillant, outcome: 3.1 Incidence of adhesions at SLL" data-id="CD001298-fig-0010" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-FIG-10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p>Forest plot of comparison: 3 Gel agent vs hydroflotation agent when used as an instillant, outcome: 3.1 Incidence of adhesions at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-FIG-11" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 4 Steroid (any route) vs no steroid, outcome: 4.1 Live birth rate" data-id="CD001298-fig-0011" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-FIG-11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 11</div> <div class="figure-caption"> <p>Forest plot of comparison: 4 Steroid (any route) vs no steroid, outcome: 4.1 Live birth rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-FIG-11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Hydroflotation agent vs no hydroflotation agent (or placebo), Outcome 1: Pelvic pain at SLL" data-id="CD001298-fig-0012" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Hydroflotation agent vs no hydroflotation agent (or placebo), Outcome 1: Pelvic pain at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Hydroflotation agent vs no hydroflotation agent (or placebo), Outcome 2: Live birth rate" data-id="CD001298-fig-0013" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Hydroflotation agent vs no hydroflotation agent (or placebo), Outcome 2: Live birth rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Hydroflotation agent vs no hydroflotation agent (or placebo), Outcome 3: Incidence of adhesions at SLL" data-id="CD001298-fig-0014" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Hydroflotation agent vs no hydroflotation agent (or placebo), Outcome 3: Incidence of adhesions at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Hydroflotation agent vs no hydroflotation agent (or placebo), Outcome 4: Mean adhesion score at SLL" data-id="CD001298-fig-0015" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Hydroflotation agent vs no hydroflotation agent (or placebo), Outcome 4: Mean adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Hydroflotation agent vs no hydroflotation agent (or placebo), Outcome 5: Clinical pregnancy rate" data-id="CD001298-fig-0016" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Hydroflotation agent vs no hydroflotation agent (or placebo), Outcome 5: Clinical pregnancy rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Hydroflotation agent vs no hydroflotation agent (or placebo), Outcome 6: Number of participants with improved adhesion score at SLL" data-id="CD001298-fig-0017" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Hydroflotation agent vs no hydroflotation agent (or placebo), Outcome 6: Number of participants with improved adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Hydroflotation agent vs no hydroflotation agent (or placebo), Outcome 7: Number of participants with worse adhesion score at SLL" data-id="CD001298-fig-0018" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Hydroflotation agent vs no hydroflotation agent (or placebo), Outcome 7: Number of participants with worse adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Hydroflotation agent vs no hydroflotation agent (or placebo), Outcome 8: Ectopic pregnancy rate (per pregnancy)" data-id="CD001298-fig-0019" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Hydroflotation agent vs no hydroflotation agent (or placebo), Outcome 8: Ectopic pregnancy rate (per pregnancy) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0020"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>Imputed mean change in adhesion score at SLL</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mean change in adhesion score in hydroflotation agent group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mean change in adhesion score in placebo group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of participants</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Rosenberg 1984</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Hydroflotation agent vs no hydroflotation agent (or placebo), Outcome 9: Imputed mean change in adhesion score at SLL </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0020">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001298-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Gel agents vs no gel agents (or placebo), Outcome 1: Incidence of adhesions at SLL" data-id="CD001298-fig-0021" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Gel agents vs no gel agents (or placebo), Outcome 1: Incidence of adhesions at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Gel agents vs no gel agents (or placebo), Outcome 2: Mean adhesion score at SLL" data-id="CD001298-fig-0022" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Gel agents vs no gel agents (or placebo), Outcome 2: Mean adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Gel agents vs no gel agents (or placebo), Outcome 3: Clinical pregnancy rate" data-id="CD001298-fig-0023" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Gel agents vs no gel agents (or placebo), Outcome 3: Clinical pregnancy rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Gel agents vs no gel agents (or placebo), Outcome 4: Number of participants with improved adhesion score at SLL" data-id="CD001298-fig-0024" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Gel agents vs no gel agents (or placebo), Outcome 4: Number of participants with improved adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Gel agents vs no gel agents (or placebo), Outcome 5: Number of participants with worse adhesion score at SLL" data-id="CD001298-fig-0025" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Gel agents vs no gel agents (or placebo), Outcome 5: Number of participants with worse adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0026"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>Proportion of sites with adhesions at SLL</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Proportion in gel agent group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Proportion in placebo group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of participants</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Thornton 1998</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.280</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.629</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.168</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Gel agents vs no gel agents (or placebo), Outcome 6: Proportion of sites with adhesions at SLL </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0026">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001298-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Gel agents vs no gel agents (or placebo), Outcome 7: Mean change in adhesion score at SLL" data-id="CD001298-fig-0027" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Gel agents vs no gel agents (or placebo), Outcome 7: Mean change in adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0028"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>Change in mean adnexal adhesion score at SLL</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change in mean adnexal adhesion score in gel agent group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of participants/adnexa</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change in mean adnexal adhesion score in no gel agent group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of participants/adnexa</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Lundorff 2005</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐2.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25/45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24/41</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: Gel agents vs no gel agents (or placebo), Outcome 8: Change in mean adnexal adhesion score at SLL </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0028">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001298-fig-0029"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>Imputed mean adhesion score at SLL</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mean adhesion score at SLL in gel agent group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD in gel agent group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mean adhesion score at SLL in placebo group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD in placebo group</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Thornton 1998</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.67</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2: Gel agents vs no gel agents (or placebo), Outcome 9: Imputed mean adhesion score at SLL </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0029">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001298-fig-0030"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>Imputed number of sites with adhesions at SLL</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of sites with adhesions in gel agent group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total number of sites in gel agent group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of sites with adhesions in placebo group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total number of sites in placebo group</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Thornton 1998</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>189</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>157</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2: Gel agents vs no gel agents (or placebo), Outcome 10: Imputed number of sites with adhesions at SLL </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0030">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001298-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Gel agents vs hydroflotation agents used as instillants, Outcome 1: Incidence of adhesions at SLL" data-id="CD001298-fig-0031" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Gel agents vs hydroflotation agents used as instillants, Outcome 1: Incidence of adhesions at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Gel agents vs hydroflotation agents used as instillants, Outcome 2: Mean adhesion score at SLL" data-id="CD001298-fig-0032" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Gel agents vs hydroflotation agents used as instillants, Outcome 2: Mean adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Gel agents vs hydroflotation agents used as instillants, Outcome 3: Number of participants with improved adhesion score at SLL" data-id="CD001298-fig-0033" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Gel agents vs hydroflotation agents used as instillants, Outcome 3: Number of participants with improved adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Gel agents vs hydroflotation agents used as instillants, Outcome 4: Number of participants with worse adhesion score at SLL" data-id="CD001298-fig-0034" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Gel agents vs hydroflotation agents used as instillants, Outcome 4: Number of participants with worse adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Steroids (any route) vs no steroids (or placebo), Outcome 1: Live birth rate" data-id="CD001298-fig-0035" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Steroids (any route) vs no steroids (or placebo), Outcome 1: Live birth rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Steroids (any route) vs no steroids (or placebo), Outcome 2: Clinical pregnancy rate" data-id="CD001298-fig-0036" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Steroids (any route) vs no steroids (or placebo), Outcome 2: Clinical pregnancy rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Steroids (any route) vs no steroids (or placebo), Outcome 3: Number of participants with improved adhesion score at SLL" data-id="CD001298-fig-0037" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: Steroids (any route) vs no steroids (or placebo), Outcome 3: Number of participants with improved adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Steroids (any route) vs no steroids (or placebo), Outcome 4: Number of participants with worse adhesion score at SLL" data-id="CD001298-fig-0038" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: Steroids (any route) vs no steroids (or placebo), Outcome 4: Number of participants with worse adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-004.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Steroids (any route) vs no steroids (or placebo), Outcome 5: Ectopic pregnancy rate (per pregnancy)" data-id="CD001298-fig-0039" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-004.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-004.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4: Steroids (any route) vs no steroids (or placebo), Outcome 5: Ectopic pregnancy rate (per pregnancy) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-004.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Intraperitoneal (IP) noxytioline vs no noxytioline (or placebo), Outcome 1: Clinical pregnancy rate" data-id="CD001298-fig-0040" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Intraperitoneal (IP) noxytioline vs no noxytioline (or placebo), Outcome 1: Clinical pregnancy rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Intraperitoneal (IP) noxytioline vs no noxytioline (or placebo), Outcome 2: Number of participants with worse adhesion score at SLL" data-id="CD001298-fig-0041" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Intraperitoneal (IP) noxytioline vs no noxytioline (or placebo), Outcome 2: Number of participants with worse adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Intraperitoneal (IP) noxytioline vs no noxytioline (or placebo), Outcome 3: Ectopic pregnancy rate (per pregnancy)" data-id="CD001298-fig-0042" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: Intraperitoneal (IP) noxytioline vs no noxytioline (or placebo), Outcome 3: Ectopic pregnancy rate (per pregnancy) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Intraperitoneal heparin (IP) vs no intraperitoneal heparin (or placebo), Outcome 1: Number of participants with improved adhesion score at SLL" data-id="CD001298-fig-0043" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Intraperitoneal heparin (IP) vs no intraperitoneal heparin (or placebo), Outcome 1: Number of participants with improved adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Intraperitoneal heparin (IP) vs no intraperitoneal heparin (or placebo), Outcome 2: Number of participants with worse adhesion score at SLL" data-id="CD001298-fig-0044" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: Intraperitoneal heparin (IP) vs no intraperitoneal heparin (or placebo), Outcome 2: Number of participants with worse adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Systemic promethazine vs no promethazine (or placebo), Outcome 1: Number of participants with improved adhesion score at SLL" data-id="CD001298-fig-0045" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Systemic promethazine vs no promethazine (or placebo), Outcome 1: Number of participants with improved adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/urn:x-wiley:14651858:media:CD001298:CD001298-CMP-007.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Systemic promethazine vs no promethazine (or placebo), Outcome 2: Number of participants with worse adhesion score at SLL" data-id="CD001298-fig-0046" src="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-007.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_t/tCD001298-CMP-007.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7: Systemic promethazine vs no promethazine (or placebo), Outcome 2: Number of participants with worse adhesion score at SLL </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/media/CDSR/CD001298/image_n/nCD001298-CMP-007.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001298-fig-0047"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>Area of adhesions (cm²)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Area of adhesions at first surgery in GnRH analogue group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Area of adhesions at SLL in GnRH analogue group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Area of adhesions at first surgery in placebo group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Area of adhesions at SLL in placebo group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of participants</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Coddington 2009</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4 (0.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.7 (2.2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.4 (0.1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.2 (3.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: GnRH analogue vs no GnRH (or placebo), Outcome 1: Area of adhesions (cm²) </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0047">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001298-fig-0048"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>Incidence of adhesions at SLL</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mean incidence score in plasminogen activator group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Mean incidence score in placebo group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>SD</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of participants</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Hellebrekers 2009</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9: Plasminogen activator vs no plasminogen activator (or placebo), Outcome 1: Incidence of adhesions at SLL </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0048">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001298-fig-0049"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>Change in adhesion extent</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change in adhesion extent in N,O‐carboxymethyl chitosan group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change in adhesion extent in placebo group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of participants</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Diamond 2003</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10: N,O‐carboxymethyl chitosan versus no N,O‐carboxymethyl chitosan (or placebo), Outcome 1: Change in adhesion extent </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0049">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001298-fig-0050"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>Change in adhesion severity</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change in adhesion severity in N,O‐carboxymethyl chitosan group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Change in adhesion severity in placebo group</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of participants</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Diamond 2003</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10: N,O‐carboxymethyl chitosan versus no N,O‐carboxymethyl chitosan (or placebo), Outcome 2: Change in adhesion severity </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-fig-0050">Navigate to figure in review</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD001298-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Hydroflotation agents versus no hydroflotation agents (or placebo) for adhesion prevention after gynaecological surgery</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Hydroflotation agents</b> versus<b>no hydroflotation agents (or placebo)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women undergoing gynaecological surgery<br/><b>Settings:</b> hospital<br/><b>Intervention:</b> hydroflotation agents<br/><b>Control:</b> no hydroflotation agents (or placebo) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>No hydroflotation agents (or placebo)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Hydroflotation agents</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pelvic pain</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>806 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>814 per 1000</b><br/>(684 to 897) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.05</b> <br/>(0.52 to 2.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>226<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Live birth rate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>129 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>90 per 1000</b><br/>(41 to 189) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.67</b> <br/>(0.29 to 1.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>208<br/>(2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of adhesions at second‐look laparoscopy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>842 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>645 per 1000</b><br/>(540 to 746) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.34</b> <br/>(0.22 to 0.55) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>566<br/>(4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean adhesion score at second‐look laparoscopy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean adhesion score at second‐look laparoscopy ranged across the control groups from <b>2.19 to 8.42</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean adhesion score at second‐look laparoscopy in the intervention groups was <b>0.06 standard deviations lower</b> (0.2 lower to 0.09 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>722<br/>(4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.06 (‐0.2 to 0.09)<sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical pregnancy rate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>256 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>180 per 1000</b><br/>(110 to 281) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.64</b> <br/>(0.36 to 1.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>310<br/>(3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>d</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>No studies reported any adverse events attributable to the intervention</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the median control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>SMD</b> : standardised mean difference; <b>mAFS</b>: modified American Fertility Society </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/><b>High quality.</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality.</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality.</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality.</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of attrition bias in <a href="./references#CD001298-bbs2-0001" title="BrownCB , LucianoAA , MartinD , PeersE , ScrimgeourA , diZeregaGS . Adept (icodextrin 4% solution) reduces adhesions after laparoscopic surgery for adhesiolysis: a double-blind, randomised, controlled study. Fertility and Sterility2007;88(5):1413-26. PeersEM , BrownCB , Adept Adhesion Study Group. American Fertility Society score as a measure of effectiveness of 4% icodextrin in a pivotal adhesion reduction trial in the USA. Fertility and Sterility2005;84(Suppl 1):S160. ">Brown 2007</a><br/><sup>b</sup>Downgraded two levels due to imprecision: insufficient sample size to provide adequate statistical power, wide 95% confidence intervals that cross the line of no effect, and fail to exclude both appreciable benefit and harm<br/><sup>c</sup>Scale: mean of the 'mean adhesion score' used. A lower mean 'mean adhesion score' represents an improvement in adhesion disease. A variety of adhesion scoring systems were used (e.g. Hulka, mAFS or system developed by authors for purpose of study); therefore for comparison, we calculated standardised mean difference.<br/><sup>d</sup>Downgraded one level due to imprecision: wide 95% confidence intervals that cross the line of no effect, and insufficient sample size to provide adequate statistical power </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Hydroflotation agents versus no hydroflotation agents (or placebo) for adhesion prevention after gynaecological surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001298-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Gel agents versus no gel agents (or placebo) for adhesion prevention after gynaecological surgery</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Gel agents</b> versus<b>no gel agents (or placebo)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women undergoing gynaecological surgery<br/><b>Settings:</b> hospital<br/><b>Intervention:</b> gel agents<br/><b>Control</b>: no gel agents (or placebo) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>No gel agents (or placebo)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Gel agents</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Pelvic pain</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="middle"> <p>Not reported by any studies in this comparison</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Live birth rate</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="middle"> <p>Not reported by any studies in this comparison</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of adhesions at second‐look laparoscopy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>842 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>581 per 1000</b> </p> <p>(391 to 752)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.26</b> <br/>(0.12 to 0.57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>147<br/>(5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean adhesion score at second‐look laparoscopy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean adhesion score at second‐look laparoscopy ranged across the control groups from <b>2.19 to 8.42</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean adhesion score at second‐look laparoscopy in the intervention groups was 0.24<b>standard deviations lower</b> (0.55 lower to 0.08 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>159<br/>(4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SMD ‐0.24 (‐0.55 to 0.08)<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical pregnancy</b> </p> <p><b>rate</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>256 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>64 per 1000</b> </p> <p>(6 to 410)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.20</b> </p> <p>(0.02 to 2.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝</p> <p>Low<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>No studies reported any adverse events attributable to the intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the median control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>SMD</b> : standardised mean difference; <b>mAFS</b>: modified American Fertility Society </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/><b>High quality.</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality.</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality.</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality.</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to imprecision: insufficient sample size to produce adequate statistical power.<br/><sup>b</sup>Scale: mean of the 'mean adhesion score' used. A lower mean 'mean adhesion score' represents an improvement in the adhesion disease. A variety of adhesion scoring systems were used (e.g. Hulka, mAFS, system developed by trial authors for purpose of study); therefore for comparison, we calculated standardised mean difference.<br/><sup>c</sup>Downgraded two levels due to imprecision: insufficient sample size to provide adequate statistical power, wide 95% confidence intervals that cross the line of no effect, and fail to exclude both appreciable benefit and harm </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Gel agents versus no gel agents (or placebo) for adhesion prevention after gynaecological surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001298-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Gel agents versus hydroflotation agents used as instillants for adhesion prevention after gynaecological surgery</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Gel agents versus hydroflotation agents used as instillants</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women during gynaecological surgery<br/><b>Settings:</b> hospital<br/><b>Intervention:</b> gel agents<br/><b>Comparison:</b> hydroflotation agents used as instillants </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Hydroflotation agents used as instillants</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Gel agents</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pelvic pain</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Not reported by any study in this comparison</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Live birth rate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Not reported by any study in this comparison</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of adhesions at second‐look laparoscopy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>457 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>297 per 1000</b> </p> <p>(207 to 412)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.50</b> <br/>(0.31 to 0.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>538<br/>(3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean adhesion score at second‐look laparoscopy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean adhesion score at second‐look laparoscopy in the hydroflotation group was <b>1.25</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean adhesion score at second‐look laparoscopy in the intervention group was <b>0.79 lower</b> (0.82 to 0.76 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>77<br/>(1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low<sup>b,c</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical pregnancy rate</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Not reported by any study in this comparison</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>No studies reported any adverse events attributable to the interventions</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the median hydroflotation group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>OR:</b> odds ratio; <b>MD</b> : mean difference; <b>mAFS</b>: modified American Fertility Society </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/><b>High quality.</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality.</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality.</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality.</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to inconsistency of results (substantial heterogeneity, I² = 53%)<br/><sup>b</sup>Downgraded one level due to imprecision: insufficient sample size to provide adequate statistical power.<br/><sup>c</sup>Downgraded two levels due to high risk of bias: standard deviations reported by study authors appeared far too small to be accurate in a study with so few participants. Data were imputed assuming standard errors were mistakenly reported as standard deviations, however, caution is urged in interpretation, due to apparently erroneous data reported by study authors.<br/><sup>d</sup>Scale: a lower mean 'mean adhesion score' represents an improvement in the adhesion disease. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Gel agents versus hydroflotation agents used as instillants for adhesion prevention after gynaecological surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001298-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Steroids (any route) versus no steroids (or placebo) for adhesion prevention after gynaecological surgery</span></div> <tbody> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign=""> <p><b>Steroids (any route)</b> versus<b>no steroids (or placebo)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women after gynaecological surgery<br/><b>Settings:</b> postsurgical<br/><b>Intervention:</b> steroids (any route)<br/><b>Control:</b> no steroids (or placebo) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="3" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Assumed risk</b> </p> </th> <th align="center" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>No steroids (or placebo)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Steroids (any route)</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Pelvic pain</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Not reported by any study in this comparison</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Live birth rate</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>129 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>88 per 1000</b><br/>(38 to 194) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.65</b> <br/>(0.26‐1.62) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>223<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Incidence of adhesions at second‐look laparoscopy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Not reported by any study in this comparison</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean adhesion score at second‐look laparoscopy</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Not reported by any study in this comparison</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Clinical pregnancy rate</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>256 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>258 per 1000</b><br/>(185 to 348) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.01</b> <br/>(0.66 to 1.55) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>410<br/>(3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>No studies reported any adverse events attributable to the intervention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> is the median control group risk across studies. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> confidence interval; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/><b>High quality.</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality.</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality.</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality.</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels due to imprecision: insufficient sample size to provide adequate statistical power, wide 95% confidence intervals that cross the line of no effect, and fail to exclude both appreciable benefit and harm.<br/><sup>b</sup>We used unpublished data from study author for <a href="./references#CD001298-bbs2-0010" title="JansenRPS . Failure of intraperitoneal adjuncts to improve the outcome of pelvic operations in young women. American Journal of Obstetrics and Gynecology1985;153:363-71. ">Jansen 1985</a>, but there was little information about characteristics of study; therefore, caution in interpreting this result is urged. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Steroids (any route) versus no steroids (or placebo) for adhesion prevention after gynaecological surgery</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/full#CD001298-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001298-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Hydroflotation agent vs no hydroflotation agent (or placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Pelvic pain at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Live birth rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.29, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Incidence of adhesions at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>566</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.22, 0.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Mean adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>722</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐0.20, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Clinical pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>310</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.36, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Number of participants with improved adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>665</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.93, 1.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Number of participants with worse adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.07, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Ectopic pregnancy rate (per pregnancy) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.06, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Imputed mean change in adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Hydroflotation agent vs no hydroflotation agent (or placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001298-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Gel agents vs no gel agents (or placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Incidence of adhesions at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.12, 0.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Mean adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.24 [‐0.55, 0.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Clinical pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.09 [0.50, 52.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Number of participants with improved adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.78 [0.61, 23.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Number of participants with worse adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.04, 0.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Proportion of sites with adhesions at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Mean change in adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.84 [‐1.21, ‐0.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 Change in mean adnexal adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.9 Imputed mean adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.10 Imputed number of sites with adhesions at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Gel agents vs no gel agents (or placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001298-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Gel agents vs hydroflotation agents used as instillants</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Incidence of adhesions at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>538</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.31, 0.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Mean adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.79 [‐0.82, ‐0.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Number of participants with improved adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>342</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [0.82, 2.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Number of participants with worse adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>342</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.12, 0.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Gel agents vs hydroflotation agents used as instillants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001298-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Steroids (any route) vs no steroids (or placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Live birth rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>223</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.26, 1.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Clinical pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>410</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.66, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Number of participants with improved adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.83 [1.71, 13.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 Number of participants with worse adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>182</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.12, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.5 Ectopic pregnancy rate (per pregnancy) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.30, 2.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Steroids (any route) vs no steroids (or placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001298-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Intraperitoneal (IP) noxytioline vs no noxytioline (or placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Clinical pregnancy rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>126</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.30, 1.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Number of participants with worse adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.17, 1.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Ectopic pregnancy rate (per pregnancy) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.91 [0.45, 53.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Intraperitoneal (IP) noxytioline vs no noxytioline (or placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001298-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Intraperitoneal heparin (IP) vs no intraperitoneal heparin (or placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Number of participants with improved adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.32, 2.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Number of participants with worse adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.56, 2.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Intraperitoneal heparin (IP) vs no intraperitoneal heparin (or placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001298-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Systemic promethazine vs no promethazine (or placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 Number of participants with improved adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.22, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.2 Number of participants with worse adhesion score at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.25, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Systemic promethazine vs no promethazine (or placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001298-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">GnRH analogue vs no GnRH (or placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 Area of adhesions (cm²) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">GnRH analogue vs no GnRH (or placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001298-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Plasminogen activator vs no plasminogen activator (or placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.1 Incidence of adhesions at SLL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Plasminogen activator vs no plasminogen activator (or placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001298-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">N,O‐carboxymethyl chitosan versus no N,O‐carboxymethyl chitosan (or placebo)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.1 Change in adhesion extent <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.2 Change in adhesion severity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">N,O‐carboxymethyl chitosan versus no N,O‐carboxymethyl chitosan (or placebo)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001298.pub5/references#CD001298-tbl-0014">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD001298.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD001298-note-0011">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD001298-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="ja#CD001298-note-0012">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD001298-note-0009">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD001298-note-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="th#CD001298-note-0008">ภาษาไทย</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001298\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001298\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001298\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001298\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001298\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001298\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001298\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001298\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001298\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001298\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001298\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001298\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001298\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001298\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001298\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001298\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001298\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001298\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=f00EizoA&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001298.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001298.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD001298.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD001298.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001298.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727813892"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001298.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727813896"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001298.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eb53d9ba59368',t:'MTc0MDcyNzgxNC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 